8207000	Zinc (II) ion	Freije JM	Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas.	The Journal of biological chemistry	1994	127
11752579	Zinc (II) ion	Narla G	KLF6, a candidate tumor suppressor gene mutated in prostate cancer.	Science	2001	126
15863613	Zinc (II) ion	Liuzzi JP	Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response.	Proceedings of the National Academy of Sciences of the United States of America	2005	129
16950869	Zinc (II) ion	Liuzzi JP	Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells.	Proceedings of the National Academy of Sciences of the United States of America	2006	136
16971064	Zinc (II) ion	Guo Y	Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma.	Gene	2006	104
17140767	Zinc (II) ion	Toshimitsu K	Dietary habits and nutrient intake in non-alcoholic steatohepatitis.	Nutrition	2007	55
17261637	Zinc (II) ion	Gromada J	Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.	Endocrine reviews	2007	158
19797115	Zinc (II) ion	Dennler S	Cloning of the human GLI2 Promoter: transcriptional activation by transforming growth factor-beta via SMAD3/beta-catenin cooperation.	The Journal of biological chemistry	2009	48
21750654	Zinc (II) ion	Yori JL	Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer.	Neoplasia	2011	46
21993621	Zinc (II) ion	Yusa K	Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells.	Nature	2011	192
22341971	Zinc (II) ion	Quadri M	Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease.	American journal of human genetics	2012	65
22341972	Zinc (II) ion	Tuschl K	Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man.	American journal of human genetics	2012	52
22566642	Zinc (II) ion	Schjoldager KT	Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells.	Proceedings of the National Academy of Sciences of the United States of America	2012	35
22937066	Zinc (II) ion	Lin ZS	Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.	PloS one	2012	39
23175232	Zinc (II) ion	Oikawa T	Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers.	Hepatology	2013	51
24051378	Zinc (II) ion	Tamaki M	The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance.	The Journal of clinical investigation	2013	51
25278688	Zinc (II) ion	Williams JA	New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases.	World journal of gastroenterology	2014	20
25287711	Zinc (II) ion	Rutter GA	SLC30A8 mutations in type 2 diabetes.	Diabetologia	2015	19
25531323	Zinc (II) ion	Weber CE	Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.	Oncogene	2015	30
26551060	Zinc (II) ion	Wang J	Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors.	Nature biotechnology	2015	48
26566661	Zinc (II) ion	Schjoldager KT	Deconstruction of O-glycosylation--GalNAc-T isoforms direct distinct subsets of the O-glycoproteome.	EMBO reports	2015	16
27511929	Zinc (II) ion	Tanumihardjo SA	Biomarkers of Nutrition for Development (BOND)-Vitamin A Review.	The Journal of nutrition	2016	18
27995398	Zinc (II) ion	Riley LG	A SLC39A8 variant causes manganese deficiency, and glycosylation and mitochondrial disorders.	Journal of inherited metabolic disease	2017	7
28211215	Zinc (II) ion	Yao Z	ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways.	Molecular oncology	2017	22
28481222	Zinc (II) ion	Lin W	Hepatic metal ion transporter ZIP8 regulates manganese homeostasis and manganese-dependent enzyme activity.	The Journal of clinical investigation	2017	10
28536273	Zinc (II) ion	Aydemir TB	Metal Transporter Zip14 (Slc39a14) Deletion in Mice Increases Manganese Deposition and Produces Neurotoxic Signatures and Diminished Motor Activity.	The Journal of neuroscience 	2017	6
11259441	ADP	Vander Heiden MG	Bcl-xL promotes the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane.	The Journal of biological chemistry	2001	108
17167487	ADP	Hafner M	Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance.	Nature	2006	74
20080715	ADP	Gu M	Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism.	Proceedings of the National Academy of Sciences of the United States of America	2010	73
21106934	ADP	Amengual J	A mitochondrial enzyme degrades carotenoids and protects against oxidative stress.	FASEB journal 	2011	61
21159641	ADP	Maldonado EN	Free tubulin modulates mitochondrial membrane potential in cancer cells.	Cancer research	2010	46
21498777	ADP	Leffler CW	Carbon monoxide as an endogenous vascular modulator.	American journal of physiology. Heart and circulatory physiology	2011	39
21803289	ADP	Birkenfeld AL	Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice.	Cell metabolism	2011	54
21912398	ADP	Szendroedi J	The role of mitochondria in insulin resistance and type 2 diabetes mellitus.	Nature reviews. Endocrinology	2011	107
23471966	ADP	Maldonado EN	Voltage-dependent anion channels modulate mitochondrial metabolism in cancer cells: regulation by free tubulin and erastin.	The Journal of biological chemistry	2013	36
23530243	ADP	Giorgio V	Dimers of mitochondrial ATP synthase form the permeability transition pore.	Proceedings of the National Academy of Sciences of the United States of America	2013	201
24093679	ADP	Gowans GJ	AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation.	Cell metabolism	2013	80
26112889	ADP	Winnik S	Protective effects of sirtuins in cardiovascular diseases: from bench to bedside.	European heart journal	2015	42
26542978	ADP	Ross FA	Differential regulation by AMP and ADP of AMPK complexes containing different γ subunit isoforms.	The Biochemical journal	2016	19
28723898	ADP	Zhang CS	Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK.	Nature	2017	11
9500542	Adenosine triphosphate	Bull LN	A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis.	Nature genetics	1998	117
9806540	Adenosine triphosphate	Strautnieks SS	A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis.	Nature genetics	1998	142
10858438	Adenosine triphosphate	Costet P	Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor.	The Journal of biological chemistry	2000	160
11033082	Adenosine triphosphate	Coghlan MP	Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.	Chemistry & biology	2000	240
11035776	Adenosine triphosphate	Venkateswaran A	Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha.	Proceedings of the National Academy of Sciences of the United States of America	2000	196
11098051	Adenosine triphosphate	Pecqueur C	Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation.	The Journal of biological chemistry	2001	87
11099417	Adenosine triphosphate	Berge KE	Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters.	Science	2000	215
11387316	Adenosine triphosphate	Ananthanarayanan M	Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.	The Journal of biological chemistry	2001	115
11739410	Adenosine triphosphate	Madesh M	VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release.	The Journal of cell biology	2001	114
12202460	Adenosine triphosphate	Chiang JY	Bile acid regulation of gene expression: roles of nuclear hormone receptors.	Endocrine reviews	2002	93
12208868	Adenosine triphosphate	Yu L	Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol.	The Journal of clinical investigation	2002	135
12438266	Adenosine triphosphate	Cuezva JM	The bioenergetic signature of cancer: a marker of tumor progression.	Cancer research	2002	96
12444248	Adenosine triphosphate	Yu L	Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion.	Proceedings of the National Academy of Sciences of the United States of America	2002	131
12717402	Adenosine triphosphate	Neuschwander-Tetri BA	Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.	Hepatology	2003	371
14512887	Adenosine triphosphate	Pérez-Carreras M	Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.	Hepatology	2003	111
14517806	Adenosine triphosphate	Jaeschke H	Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury.	Gastroenterology	2003	124
14576852	Adenosine triphosphate	Ambudkar SV	P-glycoprotein: from genomics to mechanism.	Oncogene	2003	169
14592845	Adenosine triphosphate	Rye KA	Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I.	Arteriosclerosis, thrombosis, and vascular biology	2004	78
14612543	Adenosine triphosphate	Hasmann M	FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.	Cancer research	2003	157
14722619	Adenosine triphosphate	Scott JW	CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations.	The Journal of clinical investigation	2004	228
15210959	Adenosine triphosphate	Wang N	ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.	Proceedings of the National Academy of Sciences of the United States of America	2004	194
15223063	Adenosine triphosphate	Galati G	Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties.	Free radical biology & medicine	2004	84
15734146	Adenosine triphosphate	Plum L	The role of insulin receptor signaling in the brain.	Trends in endocrinology and metabolism	2005	111
15766665	Adenosine triphosphate	Gumireddy K	ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent.	Cancer cell	2005	84
15833929	Adenosine triphosphate	Maher JM	Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver.	Drug metabolism and disposition	2005	72
15841208	Adenosine triphosphate	Timmins JM	Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.	The Journal of clinical investigation	2005	149
15845415	Adenosine triphosphate	Leslie EM	Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.	Toxicology and applied pharmacology	2005	197
16146333	Adenosine triphosphate	Mao Q	Role of the breast cancer resistance protein (ABCG2) in drug transport.	The AAPS journal	2005	86
16148943	Adenosine triphosphate	Koo SH	The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism.	Nature	2005	306
16183915	Adenosine triphosphate	Oram JF	ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease.	Physiological reviews	2005	128
16365197	Adenosine triphosphate	Naik SU	Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.	Circulation	2006	91
16644802	Adenosine triphosphate	Viollet B	Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.	The Journal of physiology	2006	96
16709632	Adenosine triphosphate	Daval M	Functions of AMP-activated protein kinase in adipose tissue.	The Journal of physiology	2006	68
17006453	Adenosine triphosphate	Krishnamurthy PC	Identification of a mammalian mitochondrial porphyrin transporter.	Nature	2006	105
17095732	Adenosine triphosphate	Oram JF	ATP-Binding cassette cholesterol transporters and cardiovascular disease.	Circulation research	2006	115
17237342	Adenosine triphosphate	Satrústegui J	Mitochondrial transporters as novel targets for intracellular calcium signaling.	Physiological reviews	2007	65
17377202	Adenosine triphosphate	Łowicka E	Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists.	Pharmacological reports 	2007	107
17404808	Adenosine triphosphate	Alrefai WA	Bile acid transporters: structure, function, regulation and pathophysiological implications.	Pharmaceutical research	2007	68
17567459	Adenosine triphosphate	Pessayre D	Role of mitochondria in non-alcoholic fatty liver disease.	Journal of gastroenterology and hepatology	2007	65
17615395	Adenosine triphosphate	Lutsenko S	Function and regulation of human copper-transporting ATPases.	Physiological reviews	2007	160
17936707	Adenosine triphosphate	Li X	SIRT1 deacetylates and positively regulates the nuclear receptor LXR.	Molecular cell	2007	204
18271871	Adenosine triphosphate	Tall AR	Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins.	Journal of internal medicine	2008	125
18309108	Adenosine triphosphate	Kim JA	Role of mitochondrial dysfunction in insulin resistance.	Circulation research	2008	193
18321858	Adenosine triphosphate	Pang T	Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells.	The Journal of biological chemistry	2008	50
18336669	Adenosine triphosphate	Lu SC	S-Adenosylmethionine in cell growth, apoptosis and liver cancer.	Journal of gastroenterology and hepatology	2008	50
18375237	Adenosine triphosphate	Kamanna VS	Mechanism of action of niacin.	The American journal of cardiology	2008	65
18393293	Adenosine triphosphate	Komuta M	Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.	Hepatology	2008	74
18395287	Adenosine triphosphate	Ouyang X	Fructose consumption as a risk factor for non-alcoholic fatty liver disease.	Journal of hepatology	2008	150
18521185	Adenosine triphosphate	Chen WM	Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels.	The Journal of clinical investigation	2008	75
18691054	Adenosine triphosphate	Zhou SF	Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.	Current medicinal chemistry	2008	75
18752326	Adenosine triphosphate	Ma KL	Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice.	Hepatology	2008	59
19185005	Adenosine triphosphate	Schaap FG	High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis.	Hepatology	2009	54
19196246	Adenosine triphosphate	Richter EA	AMPK and the biochemistry of exercise: implications for human health and disease.	The Biochemical journal	2009	85
19231010	Adenosine triphosphate	Caballero F	Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH.	Journal of hepatology	2009	62
19245656	Adenosine triphosphate	Viollet B	AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.	Acta physiologica	2009	89
19549820	Adenosine triphosphate	Gao H	Opposing effects of SWI/SNF and Mi-2/NuRD chromatin remodeling complexes on epigenetic reprogramming by EBF and Pax5.	Proceedings of the National Academy of Sciences of the United States of America	2009	50
19666485	Adenosine triphosphate	Gottschalk AJ	Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler.	Proceedings of the National Academy of Sciences of the United States of America	2009	126
19711346	Adenosine triphosphate	Zhu Z	Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.	International journal of cancer	2010	106
19843643	Adenosine triphosphate	Furuta M	miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.	Carcinogenesis	2010	176
19900593	Adenosine triphosphate	Bogoyevitch MA	c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges.	Biochimica et biophysica acta	2010	69
20016054	Adenosine triphosphate	Warner MH	Mechanisms behind the non-thyroidal illness syndrome: an update.	The Journal of endocrinology	2010	47
20020268	Adenosine triphosphate	Hinson JA	Mechanisms of acetaminophen-induced liver necrosis.	Handbook of experimental pharmacology	2010	131
20103563	Adenosine triphosphate	Klaassen CD	Xenobiotic, bile acid, and cholesterol transporters: function and regulation.	Pharmacological reviews	2010	166
20225132	Adenosine triphosphate	Jitrapakdee S	Regulation of insulin secretion: role of mitochondrial signalling.	Diabetologia	2010	70
20442200	Adenosine triphosphate	Yang XR	High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.	Gut	2010	73
20466882	Adenosine triphosphate	Najafi-Shoushtari SH	MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis.	Science	2010	279
20466885	Adenosine triphosphate	Rayner KJ	MiR-33 contributes to the regulation of cholesterol homeostasis.	Science	2010	348
20682318	Adenosine triphosphate	Cheung ST	Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance.	Gastroenterology	2011	40
20683952	Adenosine triphosphate	Wang XQ	Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway.	Hepatology	2010	56
20812902	Adenosine triphosphate	Ni Z	Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).	Current drug metabolism	2010	48
21081504	Adenosine triphosphate	Darshi M	ChChd3, an inner mitochondrial membrane protein, is essential for maintaining crista integrity and mitochondrial function.	The Journal of biological chemistry	2011	76
21103971	Adenosine triphosphate	Stieger B	The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.	Handbook of experimental pharmacology	2011	44
21103974	Adenosine triphosphate	Keppler D	Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.	Handbook of experimental pharmacology	2011	55
21216854	Adenosine triphosphate	Schmid AI	Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.	Diabetes care	2011	39
21319191	Adenosine triphosphate	Li T	Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.	Hepatology	2011	47
21568705	Adenosine triphosphate	Zhao R	Mechanisms of membrane transport of folates into cells and across epithelia.	Annual review of nutrition	2011	65
21878559	Adenosine triphosphate	Hardwick RN	Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease.	Drug metabolism and disposition	2011	40
21885853	Adenosine triphosphate	Ramirez CM	MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1.	Arteriosclerosis, thrombosis, and vascular biology	2011	62
21932399	Adenosine triphosphate	Borel F	Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs.	Hepatology	2012	44
21947382	Adenosine triphosphate	Stephenne X	Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status.	Diabetologia	2011	50
21965623	Adenosine triphosphate	Dawson S	In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.	Drug metabolism and disposition	2012	39
21979151	Adenosine triphosphate	Cole LK	Phosphatidylcholine biosynthesis and lipoprotein metabolism.	Biochimica et biophysica acta	2012	50
22119192	Adenosine triphosphate	Kim J	MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression.	Experimental neurology	2012	54
22154776	Adenosine triphosphate	Finn AV	Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques.	Journal of the American College of Cardiology	2012	54
22229890	Adenosine triphosphate	Jaeschke H	Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity.	Drug metabolism reviews	2012	138
22266115	Adenosine triphosphate	Zaytseva YY	Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.	Cancer research	2012	35
22460906	Adenosine triphosphate	Liu L	Deregulated MYC expression induces dependence upon AMPK-related kinase 5.	Nature	2012	83
22539746	Adenosine triphosphate	Thomas HE	mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.	Science translational medicine	2012	32
22814620	Adenosine triphosphate	Jouan-Lanhouet S	TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.	Cell death and differentiation	2012	85
22886304	Adenosine triphosphate	Carracedo A	A metabolic prosurvival role for PML in breast cancer.	The Journal of clinical investigation	2012	65
23049480	Adenosine triphosphate	Kushnareva Y	Bax activation initiates the assembly of a multimeric catalyst that facilitates Bax pore formation in mitochondrial outer membranes.	PLoS biology	2012	39
23112875	Adenosine triphosphate	Lanaspa MA	Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver.	PloS one	2012	43
23237509	Adenosine triphosphate	Eklund KK	Immune functions of serum amyloid A.	Critical reviews in immunology	2012	38
23298225	Adenosine triphosphate	Bijland S	Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation.	Clinical science	2013	39
23409044	Adenosine triphosphate	Plovanich M	MICU2, a paralog of MICU1, resides within the mitochondrial uniporter complex to regulate calcium handling.	PloS one	2013	84
23449803	Adenosine triphosphate	Shirasaki T	MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells.	Journal of virology	2013	55
23456818	Adenosine triphosphate	Schmidts M	Exome sequencing identifies DYNC2H1 mutations as a common cause of asphyxiating thoracic dystrophy (Jeune syndrome) without major polydactyly, renal or retinal involvement.	Journal of medical genetics	2013	35
23471659	Adenosine triphosphate	Ye J	Mechanisms of insulin resistance in obesity.	Frontiers of medicine	2013	47
23483818	Adenosine triphosphate	Basaranoglu M	From fatty liver to fibrosis: a tale of "second hit".	World journal of gastroenterology	2013	39
23688078	Adenosine triphosphate	Choi YH	ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.	Current pharmaceutical design	2014	42
23776229	Adenosine triphosphate	Feng S	Canonical transient receptor potential 3 channels regulate mitochondrial calcium uptake.	Proceedings of the National Academy of Sciences of the United States of America	2013	26
23782937	Adenosine triphosphate	Yu XH	Foam cells in atherosclerosis.	Clinica chimica acta; international journal of clinical chemistry	2013	55
24277820	Adenosine triphosphate	Jansen RS	ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release.	Proceedings of the National Academy of Sciences of the United States of America	2013	37
24385509	Adenosine triphosphate	Westerterp M	ATP-binding cassette transporters, atherosclerosis, and inflammation.	Circulation research	2014	55
24407242	Adenosine triphosphate	Win S	JNK interaction with Sab mediates ER stress induced inhibition of mitochondrial respiration and cell death.	Cell death & disease	2014	28
24459177	Adenosine triphosphate	Keppler D	The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia.	Drug metabolism and disposition	2014	23
24550282	Adenosine triphosphate	Faubert B	Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α.	Proceedings of the National Academy of Sciences of the United States of America	2014	49
24652937	Adenosine triphosphate	Morais VA	PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling.	Science	2014	65
24692138	Adenosine triphosphate	Rui L	Energy metabolism in the liver.	Comprehensive Physiology	2014	103
24705351	Adenosine triphosphate	Zhai B	Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma.	Molecular cancer therapeutics	2014	45
24746669	Adenosine triphosphate	Wang Z	Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression.	Developmental cell	2014	37
24751933	Adenosine triphosphate	Hussain MM	Intestinal lipid absorption and lipoprotein formation.	Current opinion in lipidology	2014	26
24781191	Adenosine triphosphate	Arif T	Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo.	Molecular therapy. Nucleic acids	2014	23
24849361	Adenosine triphosphate	Boehm-Cagan A	Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene.	The Journal of neuroscience 	2014	37
24874432	Adenosine triphosphate	Takahashi K	Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy.	Molecular cancer research 	2014	29
24901049	Adenosine triphosphate	Li JX	The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury.	Cell death & disease	2014	34
24961373	Adenosine triphosphate	Chen L	OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin.	Proceedings of the National Academy of Sciences of the United States of America	2014	33
24969777	Adenosine triphosphate	Jansen RS	ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report.	Arteriosclerosis, thrombosis, and vascular biology	2014	37
25236865	Adenosine triphosphate	Mao Q	Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.	The AAPS journal	2015	45
25262208	Adenosine triphosphate	Miranda-Lorenzo I	Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.	Nature methods	2014	36
25315773	Adenosine triphosphate	Takatsu H	Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane.	The Journal of biological chemistry	2014	23
25465468	Adenosine triphosphate	Song BJ	Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications.	Redox biology	2014	20
25475361	Adenosine triphosphate	Nigam SK	What do drug transporters really do?	Nature reviews. Drug discovery	2015	55
25524771	Adenosine triphosphate	Meiler S	MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2015	19
25751139	Adenosine triphosphate	Wang W	AMPK modulates Hippo pathway activity to regulate energy homeostasis.	Nature cell biology	2015	73
25801706	Adenosine triphosphate	Israelson A	Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.	Neuron	2015	19
26005677	Adenosine triphosphate	Basaranoglu M	Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction.	Hepatobiliary surgery and nutrition	2015	20
26054020	Adenosine triphosphate	Guo W	MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer.	Hepatology	2015	25
26437365	Adenosine triphosphate	Goedeke L	MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels.	Nature medicine	2015	28
26499806	Adenosine triphosphate	Chen Z	Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.	Cancer letters	2016	53
26501192	Adenosine triphosphate	Wagschal A	Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis.	Nature medicine	2015	36
26744319	Adenosine triphosphate	Wang MD	HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress.	Oncotarget	2016	11
26892966	Adenosine triphosphate	Sorci-Thomas MG	Microdomains, Inflammation, and Atherosclerosis.	Circulation research	2016	18
27076077	Adenosine triphosphate	Yoshihara E	ERRγ Is Required for the Metabolic Maturation of Therapeutically Functional Glucose-Responsive β Cells.	Cell metabolism	2016	14
27144356	Adenosine triphosphate	Lee JY	Crystal structure of the human sterol transporter ABCG5/ABCG8.	Nature	2016	19
27387377	Adenosine triphosphate	Nguyen DG	Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro.	PloS one	2016	17
27940204	Adenosine triphosphate	Jiang S	Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.	Pharmacological research	2017	7
27940374	Adenosine triphosphate	Adorni MP	Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages.	Atherosclerosis	2017	5
10727395	Guanosine triphosphate	Thöny B	Tetrahydrobiopterin biosynthesis, regeneration and functions.	The Biochemical journal	2000	169
15832810	Guanosine triphosphate	Xu C	Induction of phase I, II and III drug metabolism/transport by xenobiotics.	Archives of pharmacal research	2005	174
16182514	Guanosine triphosphate	Carmen GY	Signalling mechanisms regulating lipolysis.	Cellular signalling	2006	87
18519636	Guanosine triphosphate	Xue W	DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma.	Genes & development	2008	75
19595305	Guanosine triphosphate	Young A	Ras signaling and therapies.	Advances in cancer research	2009	86
21536732	Guanosine triphosphate	Finch AJ	Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome.	Genes & development	2011	66
12021244	Urea	Schwartz RE	Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells.	The Journal of clinical investigation	2002	172
15562440	Urea	Lee KD	In vitro hepatic differentiation of human mesenchymal stem cells.	Hepatology	2004	175
15670778	Urea	Seo MJ	Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo.	Biochemical and biophysical research communications	2005	101
16082501	Urea	Curis E	Almost all about citrulline in mammals.	Amino acids	2005	71
16317693	Urea	Calès P	A novel panel of blood markers to assess the degree of liver fibrosis.	Hepatology	2005	88
16928726	Urea	Aurich I	Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers.	Gut	2007	80
16945998	Urea	Herrera MB	Isolation and characterization of a stem cell population from adult human liver.	Stem cells	2006	93
17616115	Urea	Hwang SH	Orally bioavailable potent soluble epoxide hydrolase inhibitors.	Journal of medicinal chemistry	2007	100
18243183	Urea	Campard D	Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells.	Gastroenterology	2008	56
19022918	Urea	Aurich H	Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo.	Gut	2009	77
19240267	Urea	Møller N	Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects.	Endocrine reviews	2009	147
19736565	Urea	Song Z	Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells.	Cell research	2009	121
20167786	Urea	Zhao S	Regulation of cellular metabolism by protein lysine acetylation.	Science	2010	554
20821352	Urea	Ghodsizadeh A	Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells.	Stem cell reviews	2010	44
22031499	Urea	Tostões RM	Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing.	Hepatology	2012	31
22095466	Urea	Chen YF	Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol.	Hepatology	2012	72
22659344	Urea	Takayama K	Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1α transduction.	Journal of hepatology	2012	36
22795084	Urea	Siarheyeva A	An allosteric inhibitor of protein arginine methyltransferase 3.	Structure	2012	31
23352505	Urea	Kostadinova R	A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity.	Toxicology and applied pharmacology	2013	49
24145431	Urea	Qiu J	Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB-mediated mechanism.	Proceedings of the National Academy of Sciences of the United States of America	2013	27
24440487	Urea	Schwartz RE	Pluripotent stem cell-derived hepatocyte-like cells.	Biotechnology advances	2014	56
25700560	Urea	Polletta L	SIRT5 regulation of ammonia-induced autophagy and mitophagy.	Autophagy	2015	25
26560030	Urea	Rabinovich S	Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis.	Nature	2015	20
27070809	Urea	Miller PG	Design and demonstration of a pumpless 14 compartment microphysiological system.	Biotechnology and bioengineering	2016	14
27760784	Urea	Tsamandouras N	Quantitative Assessment of Population Variability in Hepatic Drug Metabolism Using a Perfused Three-Dimensional Human Liver Microphysiological System.	The Journal of pharmacology and experimental therapeutics	2017	7
6300903	Iron	Dautry-Varsat A	pH and the recycling of transferrin during receptor-mediated endocytosis.	Proceedings of the National Academy of Sciences of the United States of America	1983	262
8260699	Iron	Wang GL	Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction.	Blood	1993	137
9105754	Iron	Bottone EJ	Yersinia enterocolitica: the charisma continues.	Clinical microbiology reviews	1997	152
9131263	Iron	Maines MD	The heme oxygenase system: a regulator of second messenger gases.	Annual review of pharmacology and toxicology	1997	368
9380735	Iron	Poss KD	Heme oxygenase 1 is required for mammalian iron reutilization.	Proceedings of the National Academy of Sciences of the United States of America	1997	217
10409623	Iron	Kawabata H	Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family.	The Journal of biological chemistry	1999	106
10522552	Iron	Ponka P	Cell biology of heme.	The American journal of the medical sciences	1999	112
10573511	Iron	Angulo P	Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.	Hepatology	1999	237
11113132	Iron	Pigeon C	A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload.	The Journal of biological chemistry	2001	327
11296694	Iron	Chitturi S	Etiopathogenesis of nonalcoholic steatohepatitis.	Seminars in liver disease	2001	93
11447267	Iron	Nicolas G	Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice.	Proceedings of the National Academy of Sciences of the United States of America	2001	219
11473047	Iron	Marchesini G	Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.	Diabetes	2001	400
11563810	Iron	Whitfield JB	Gamma glutamyl transferase.	Critical reviews in clinical laboratory sciences	2001	138
11812557	Iron	Beutler E	Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.	Lancet	2002	119
12105842	Iron	Bugianesi E	Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.	Gastroenterology	2002	260
12370282	Iron	Nicolas G	The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.	The Journal of clinical investigation	2002	319
12393428	Iron	Weinstein DA	Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease.	Blood	2002	109
12433676	Iron	Nemeth E	Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.	Blood	2003	263
12512031	Iron	Ruhl CE	Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.	Gastroenterology	2003	120
12606179	Iron	Bridle KR	Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.	Lancet	2003	135
12809815	Iron	Clark JM	The prevalence and etiology of elevated aminotransferase levels in the United States.	The American journal of gastroenterology	2003	274
14647275	Iron	Papanikolaou G	Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis.	Nature genetics	2004	207
14744237	Iron	Caro AA	Oxidative stress, toxicology, and pharmacology of CYP2E1.	Annual review of pharmacology and toxicology	2004	93
15124018	Iron	Nemeth E	IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.	The Journal of clinical investigation	2004	477
15346644	Iron	Lee DH	Is serum gamma glutamyltransferase a marker of oxidative stress?	Free radical research	2004	108
15486069	Iron	Nemeth E	Hepcidin is decreased in TFR2 hemochromatosis.	Blood	2005	105
15886319	Iron	Kemna E	Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS.	Blood	2005	110
15998830	Iron	Lin L	Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin.	Blood	2005	89
16075058	Iron	Niederkofler V	Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload.	The Journal of clinical investigation	2005	125
16075059	Iron	Huang FW	A mouse model of juvenile hemochromatosis.	The Journal of clinical investigation	2005	119
16604073	Iron	Babitt JL	Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.	Nature genetics	2006	294
16848710	Iron	Nemeth E	Regulation of iron metabolism by hepcidin.	Annual review of nutrition	2006	144
16946298	Iron	Verga Falzacappa MV	STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation.	Blood	2007	144
16952548	Iron	Bekri S	Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.	Gastroenterology	2006	92
17475779	Iron	De Domenico I	The molecular mechanism of hepcidin-mediated ferroportin down-regulation.	Molecular biology of the cell	2007	114
17488680	Iron	Origa R	Liver iron concentrations and urinary hepcidin in beta-thalassemia.	Haematologica	2007	85
17540841	Iron	Lin L	Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4.	Blood	2007	77
17607365	Iron	Babitt JL	Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance.	The Journal of clinical investigation	2007	155
17699374	Iron	Wish JB	Assessing iron status: beyond serum ferritin and transferrin saturation.	Clinical journal of the American Society of Nephrology 	2006	65
17721544	Iron	Tanno T	High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.	Nature medicine	2007	193
17938254	Iron	Silvestri L	Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis.	Blood	2008	80
18166790	Iron	Kemna EH	Hepcidin: from discovery to differential diagnosis.	Haematologica	2008	55
18199861	Iron	Allen KJ	Iron-overload-related disease in HFE hereditary hemochromatosis.	The New England journal of medicine	2008	106
18326817	Iron	Xia Y	Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.	Blood	2008	81
18326822	Iron	Pinto JP	Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha.	Blood	2008	64
18671304	Iron	Miura K	Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity.	Hepatology	2008	68
18760763	Iron	Whatley SD	C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload.	American journal of human genetics	2008	51
18976966	Iron	Silvestri L	The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.	Cell metabolism	2008	147
19084217	Iron	Benyamin B	Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels.	American journal of human genetics	2009	51
19254567	Iron	Gao J	Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression.	Cell metabolism	2009	95
19286138	Iron	Tai AW	A functional genomic screen identifies cellular cofactors of hepatitis C virus replication.	Cell host & microbe	2009	206
19321419	Iron	Soe-Lin S	Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2009	47
19352007	Iron	Mastrogiannaki M	HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice.	The Journal of clinical investigation	2009	130
19414861	Iron	Tanno T	Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.	Blood	2009	109
19650691	Iron	Tolosano E	Heme scavenging and the other facets of hemopexin.	Antioxidants & redox signaling	2010	63
19805308	Iron	Huang ML	Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant.	Proceedings of the National Academy of Sciences of the United States of America	2009	52
20471131	Iron	European Association For The Study Of The Liver.	EASL clinical practice guidelines for HFE hemochromatosis.	Journal of hepatology	2010	47
20492708	Iron	Galanello R	Beta-thalassemia.	Orphanet journal of rare diseases	2010	107
20542038	Iron	Pietrangelo A	Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.	Gastroenterology	2010	87
20682781	Iron	Zhao N	ZRT/IRT-like protein 14 (ZIP14) promotes the cellular assimilation of iron from transferrin.	The Journal of biological chemistry	2010	47
20870325	Iron	Shovlin CL	Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment.	Blood reviews	2010	83
20887198	Iron	Ganz T	Hepcidin and disorders of iron metabolism.	Annual review of medicine	2011	121
21346250	Iron	Ganz T	Hepcidin and iron regulation, 10 years later.	Blood	2011	178
21393479	Iron	Steinbicker AU	Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation.	Blood	2011	54
21527524	Iron	Galesloot TE	Serum hepcidin: reference ranges and biochemical correlates in the general population.	Blood	2011	50
21572427	Iron	Portugal S	Host-mediated regulation of superinfection in malaria.	Nature medicine	2011	91
21855608	Iron	Brissot P	Non-transferrin bound iron: a key role in iron overload and iron toxicity.	Biochimica et biophysica acta	2012	82
21953442	Iron	Kowdley KV	Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.	Hepatology	2012	75
22052915	Iron	Boyle JJ	Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection.	Circulation research	2012	34
22055506	Iron	Nandal A	Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2.	Cell metabolism	2011	43
22093287	Iron	Bode JG	Hepatic acute phase proteins--regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling.	European journal of cell biology	2012	70
22306005	Iron	Ganz T	Hepcidin and iron homeostasis.	Biochimica et biophysica acta	2012	166
22440905	Iron	Zager RA	Plasma and urinary heme oxygenase-1 in AKI.	Journal of the American Society of Nephrology 	2012	33
22682227	Iron	Qiao B	Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination.	Cell metabolism	2012	57
22719876	Iron	Kawaguchi T	Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.	PloS one	2012	50
22728873	Iron	D'Alessio F	The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation.	Journal of hepatology	2012	43
22998881	Iron	Rostoker G	Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study.	The American journal of medicine	2012	33
23114598	Iron	Liu Q	Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis.	The Journal of clinical investigation	2012	50
23139325	Iron	Drakesmith H	Hepcidin and the iron-infection axis.	Science	2012	133
23291219	Iron	Haase VH	Regulation of erythropoiesis by hypoxia-inducible factors.	Blood reviews	2013	70
23640898	Iron	Leidgens S	Each member of the poly-r(C)-binding protein 1 (PCBP) family exhibits iron chaperone activity toward ferritin.	The Journal of biological chemistry	2013	29
23754414	Iron	Martin DN	Identification of transferrin receptor 1 as a hepatitis C virus entry factor.	Proceedings of the National Academy of Sciences of the United States of America	2013	70
24186312	Iron	Fung E	Manipulation of the hepcidin pathway for therapeutic purposes.	Haematologica	2013	32
24598129	Iron	Sonnweber T	Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB.	Gut	2014	25
24904118	Iron	Wu XG	HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression.	Blood	2014	21
24910614	Iron	Spottiswoode N	Iron, anemia and hepcidin in malaria.	Frontiers in pharmacology	2014	24
25389409	Iron	Schaer DJ	Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development.	Frontiers in physiology	2014	34
25838035	Iron	Kim Y	A review of potential metabolic etiologies of the observed association between red meat consumption and development of type 2 diabetes mellitus.	Metabolism	2015	16
25858146	Iron	Tesfay L	Hepcidin regulation in prostate and its disruption in prostate cancer.	Cancer research	2015	20
26403645	Iron	Sun X	Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.	Hepatology	2016	34
26471505	Iron	Pavlides M	Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.	Journal of hepatology	2016	14
26675351	Iron	Vinchi F	Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.	Blood	2016	27
26685902	Iron	Zhou Z	Hepatocytes: a key cell type for innate immunity.	Cellular & molecular immunology	2016	13
26794443	Iron	Xie Y	Ferroptosis: process and function.	Cell death and differentiation	2016	40
26975792	Iron	Powell LW	Haemochromatosis.	Lancet	2016	14
12644700	Heme	Xie W	Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor.	Proceedings of the National Academy of Sciences of the United States of America	2003	79
15369674	Heme	Quigley JG	Identification of a human heme exporter that is essential for erythropoiesis.	Cell	2004	123
16894358	Heme	Mense SM	Heme: a versatile signaling molecule controlling the activities of diverse regulators ranging from transcription factors to MAP kinases.	Cell research	2006	76
17919492	Heme	Shan Y	Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes.	Gastroenterology	2007	56
17928358	Heme	Atamna H	Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways.	FASEB journal 	2008	52
21745276	Heme	Jaeschke H	Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity.	Liver international 	2012	88
21756853	Heme	Ke B	HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling.	Journal of hepatology	2012	33
21951555	Heme	Soleymaninejadian E	Immunomodulatory properties of mesenchymal stem cells: cytokines and factors.	American journal of reproductive immunology	2012	49
22232210	Heme	van de Steeg E	Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.	The Journal of clinical investigation	2012	48
22441209	Heme	Ganz T	Macrophages and systemic iron homeostasis.	Journal of innate immunity	2012	51
22698995	Heme	Hou W	The let-7 microRNA enhances heme oxygenase-1 by suppressing Bach1 and attenuates oxidant injury in human hepatocytes.	Biochimica et biophysica acta	2012	37
23475203	Heme	Li F	Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy.	Nature medicine	2013	29
23615880	Heme	Wang W	Glycine metabolism in animals and humans: implications for nutrition and health.	Amino acids	2013	45
23858469	Heme	Teng H	Oxygen-sensitive mitochondrial accumulation of cystathionine β-synthase mediated by Lon protease.	Proceedings of the National Academy of Sciences of the United States of America	2013	33
24843120	Heme	Frey AG	Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
24995976	Heme	Jais A	Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man.	Cell	2014	50
25306858	Heme	Kühn LC	Iron regulatory proteins and their role in controlling iron metabolism.	Metallomics 	2015	22
26721592	Heme	Pang C	Caffeic acid prevents acetaminophen-induced liver injury by activating the Keap1-Nrf2 antioxidative defense system.	Free radical biology & medicine	2016	13
27212246	Heme	D'Avola D	Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria.	Journal of hepatology	2016	12
2549856	Cyclic AMP	Cohen P	The structure and regulation of protein phosphatases.	Annual review of biochemistry	1989	405
10835102	Cyclic AMP	Vaudry D	Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.	Pharmacological reviews	2000	164
12588810	Cyclic AMP	Puigserver P	Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.	Endocrine reviews	2003	480
12606503	Cyclic AMP	Daitoku H	Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR.	Diabetes	2003	84
16400329	Cyclic AMP	Watanabe M	Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.	Nature	2006	409
16563471	Cyclic AMP	Lips P	Vitamin D physiology.	Progress in biophysics and molecular biology	2006	173
18571301	Cyclic AMP	Pandi-Perumal SR	Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways.	Progress in neurobiology	2008	84
19386608	Cyclic AMP	Yanagida K	Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6.	The Journal of biological chemistry	2009	61
19805477	Cyclic AMP	Vaudry D	Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.	Pharmacological reviews	2009	182
20068138	Cyclic AMP	Arakawa M	Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.	Diabetes	2010	102
20493887	Cyclic AMP	Lakics V	Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues.	Neuropharmacology	2010	63
21346730	Cyclic AMP	Altarejos JY	CREB and the CRTC co-activators: sensors for hormonal and metabolic signals.	Nature reviews. Molecular cell biology	2011	233
22269949	Cyclic AMP	Chen W	Berardinelli-seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation.	Molecular and cellular biology	2012	31
22553202	Cyclic AMP	Nin V	Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.	The Journal of biological chemistry	2012	40
22685290	Cyclic AMP	Du Y	Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18.	The Journal of biological chemistry	2012	112
23979134	Cyclic AMP	Yang Z	MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein.	The Journal of biological chemistry	2013	29
24393785	Cyclic AMP	Pernicova I	Metformin--mode of action and clinical implications for diabetes and cancer.	Nature reviews. Endocrinology	2014	151
24703698	Cyclic AMP	Song WJ	Glucagon regulates hepatic kisspeptin to impair insulin secretion.	Cell metabolism	2014	35
25043713	Cyclic AMP	Lopez-Sanchez I	GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis.	Nature communications	2014	28
25122662	Cyclic AMP	Xu L	Genomic analysis of fibrolamellar hepatocellular carcinoma.	Human molecular genetics	2015	16
26099526	Cyclic AMP	Xu MJ	Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans.	Gastroenterology	2015	23
27551494	Cyclic AMP	Manteniotis S	Functional characterization of the ectopically expressed olfactory receptor 2AT4 in human myelogenous leukemia.	Cell death discovery	2016	11
27770549	Cyclic AMP	Zhang L	Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay.	Hepatology	2017	12
28132808	Cyclic AMP	Maus M	Store-Operated Ca2+ Entry Controls Induction of Lipolysis and the Transcriptional Reprogramming to Lipid Metabolism.	Cell metabolism	2017	10
12551730	Serotonin	Vaswani M	Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.	Progress in neuro-psychopharmacology & biological psychiatry	2003	89
14652237	Serotonin	Stearns V	Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.	Journal of the National Cancer Institute	2003	171
15887161	Serotonin	Modlin IM	Current status of gastrointestinal carcinoids.	Gastroenterology	2005	117
18691982	Serotonin	Spina E	Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.	Clinical therapeutics	2008	54
22403795	Serotonin	Camilleri M	Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.	American journal of physiology. Gastrointestinal and liver physiology	2012	34
22550966	Serotonin	Huang AR	Medication-related falls in the elderly: causative factors and preventive strategies.	Drugs & aging	2012	54
286319	Adenosine monophosphate	Wigler M	DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.	Proceedings of the National Academy of Sciences of the United States of America	1979	484
8557660	Adenosine monophosphate	Stapleton D	Mammalian AMP-activated protein kinase subfamily.	The Journal of biological chemistry	1996	142
10409121	Adenosine monophosphate	Winder WW	AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes.	The American journal of physiology	1999	165
10856709	Adenosine monophosphate	Kerner J	Fatty acid import into mitochondria.	Biochimica et biophysica acta	2000	90
14511394	Adenosine monophosphate	Hawley SA	Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.	Journal of biology	2003	485
14614828	Adenosine monophosphate	Woods A	LKB1 is the upstream kinase in the AMP-activated protein kinase cascade.	Current biology 	2003	431
14749280	Adenosine monophosphate	Havel PJ	Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism.	Diabetes	2004	107
15371448	Adenosine monophosphate	Zang M	AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells.	The Journal of biological chemistry	2004	103
16604088	Adenosine monophosphate	Watt MJ	CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK.	Nature medicine	2006	77
16621799	Adenosine monophosphate	Wang Y	Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex.	The Journal of biological chemistry	2006	60
16634986	Adenosine monophosphate	Whitehead JP	Adiponectin--a key adipokine in the metabolic syndrome.	Diabetes, obesity & metabolism	2006	100
16709629	Adenosine monophosphate	Xue B	AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues.	The Journal of physiology	2006	78
16823475	Adenosine monophosphate	Long YC	AMP-activated protein kinase signaling in metabolic regulation.	The Journal of clinical investigation	2006	179
16936205	Adenosine monophosphate	Yoon MJ	Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.	Diabetes	2006	99
17021375	Adenosine monophosphate	Ahima RS	Adipose tissue as an endocrine organ.	Obesity	2006	127
17476361	Adenosine monophosphate	Shu Y	Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.	The Journal of clinical investigation	2007	182
17671740	Adenosine monophosphate	Kohjima M	Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.	International journal of molecular medicine	2007	76
17855357	Adenosine monophosphate	Göransson O	Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase.	The Journal of biological chemistry	2007	124
18202144	Adenosine monophosphate	Ahima RS	Adipokines and the peripheral and neural control of energy balance.	Molecular endocrinology	2008	56
18212742	Adenosine monophosphate	Ben Sahra I	The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.	Oncogene	2008	260
18360697	Adenosine monophosphate	Kohjima M	SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.	International journal of molecular medicine	2008	68
18482975	Adenosine monophosphate	Hou X	SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.	The Journal of biological chemistry	2008	218
18687677	Adenosine monophosphate	Lan F	SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation.	The Journal of biological chemistry	2008	202
19032584	Adenosine monophosphate	Purohit V	Molecular mechanisms of alcoholic fatty liver.	Alcoholism, clinical and experimental research	2009	74
19273282	Adenosine monophosphate	Viollet B	Targeting the AMPK pathway for the treatment of Type 2 diabetes.	Frontiers in bioscience	2009	52
19276890	Adenosine monophosphate	Gong J	CIDE proteins and metabolic disorders.	Current opinion in lipidology	2009	60
19416711	Adenosine monophosphate	Zhang BB	AMPK: an emerging drug target for diabetes and the metabolic syndrome.	Cell metabolism	2009	206
19694967	Adenosine monophosphate	Schreurs M	Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome.	Obesity reviews 	2010	50
19833968	Adenosine monophosphate	Lamia KA	AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation.	Science	2009	222
20150538	Adenosine monophosphate	Ix JH	Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.	Journal of the American Society of Nephrology 	2010	56
20637208	Adenosine monophosphate	Saxena NK	Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma.	Gastroenterology	2010	45
20640476	Adenosine monophosphate	Cantó C	AMP-activated protein kinase and its downstream transcriptional pathways.	Cellular and molecular life sciences 	2010	96
20810185	Adenosine monophosphate	Rautou PE	Autophagy in liver diseases.	Journal of hepatology	2010	99
20810672	Adenosine monophosphate	Memmott RM	Metformin prevents tobacco carcinogen--induced lung tumorigenesis.	Cancer prevention research	2010	142
20960377	Adenosine monophosphate	Sozio MS	The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.	Seminars in liver disease	2010	44
21035759	Adenosine monophosphate	Misu H	A liver-derived secretory protein, selenoprotein P, causes insulin resistance.	Cell metabolism	2010	69
21147110	Adenosine monophosphate	Calvisi DF	Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.	Gastroenterology	2011	98
21205641	Adenosine monophosphate	Egan DF	Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy.	Science	2011	612
21282364	Adenosine monophosphate	Xiao F	Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways.	Diabetes	2011	67
21475304	Adenosine monophosphate	Vara D	Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.	Cell death and differentiation	2011	49
21567395	Adenosine monophosphate	Lim JY	AMP-activated protein kinase inhibits TGF-β-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300.	Journal of cellular physiology	2012	33
21576456	Adenosine monophosphate	Dávalos A	miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling.	Proceedings of the National Academy of Sciences of the United States of America	2011	188
22318606	Adenosine monophosphate	Lin YY	Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK.	Nature	2012	38
22517326	Adenosine monophosphate	Hawley SA	The ancient drug salicylate directly activates AMP-activated protein kinase.	Science	2012	200
22560219	Adenosine monophosphate	Min HK	Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease.	Cell metabolism	2012	90
22648736	Adenosine monophosphate	Dasarathy S	Consilience in sarcopenia of cirrhosis.	Journal of cachexia, sarcopenia and muscle	2012	36
22728651	Adenosine monophosphate	Lee CW	AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells.	Cancer research	2012	54
22773548	Adenosine monophosphate	Chen HP	Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies.	Gut	2013	68
22778263	Adenosine monophosphate	Racioppi L	Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology.	The Journal of biological chemistry	2012	46
23035112	Adenosine monophosphate	Lanaspa MA	Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver.	The Journal of biological chemistry	2012	75
23278683	Adenosine monophosphate	Tacar O	Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems.	The Journal of pharmacy and pharmacology	2013	184
23562077	Adenosine monophosphate	Mansuy-Aubert V	Imbalance between neutrophil elastase and its inhibitor α1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure.	Cell metabolism	2013	39
23688501	Adenosine monophosphate	Sid B	Role of AMPK activation in oxidative cell damage: Implications for alcohol-induced liver disease.	Biochemical pharmacology	2013	31
23696823	Adenosine monophosphate	Endo H	Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis.	PloS one	2013	39
23707189	Adenosine monophosphate	López M	Energy balance regulation by thyroid hormones at central level.	Trends in molecular medicine	2013	27
23720287	Adenosine monophosphate	Treyer A	Hepatocyte polarity.	Comprehensive Physiology	2013	35
23942093	Adenosine monophosphate	Zheng L	Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.	Clinical cancer research 	2013	43
24026768	Adenosine monophosphate	Matsuda M	Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.	Reviews in endocrine & metabolic disorders	2014	20
24100703	Adenosine monophosphate	Sanli T	AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway.	Cancer biology & therapy	2014	45
24314860	Adenosine monophosphate	Wang S	Novel insights of dietary polyphenols and obesity.	The Journal of nutritional biochemistry	2014	80
24467442	Adenosine monophosphate	Hawley SA	Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells.	The Biochemical journal	2014	34
24988476	Adenosine monophosphate	Napolitano A	Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.	PloS one	2014	33
25018645	Adenosine monophosphate	Coughlan KA	AMPK activation: a therapeutic target for type 2 diabetes?	Diabetes, metabolic syndrome and obesity 	2014	43
25130427	Adenosine monophosphate	Gu Q	Genetic ablation of solute carrier family 7a3a leads to hepatic steatosis in zebrafish during fasting.	Hepatology	2014	21
25548474	Adenosine monophosphate	Ceni E	Pathogenesis of alcoholic liver disease: role of oxidative metabolism.	World journal of gastroenterology	2014	34
25742316	Adenosine monophosphate	Ford RJ	Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity.	The Biochemical journal	2015	19
25794703	Adenosine monophosphate	Scheen AJ	Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control.	Diabetes & metabolism	2015	17
26054542	Adenosine monophosphate	Han SH	Deletion of Lkb1 in Renal Tubular Epithelial Cells Leads to CKD by Altering Metabolism.	Journal of the American Society of Nephrology 	2016	15
26110512	Adenosine monophosphate	Skeffington KL	Hypoxia, AMPK activation and uterine artery vasoreactivity.	The Journal of physiology	2016	11
26160430	Adenosine monophosphate	Bupathi M	Hepatocellular carcinoma: Where there is unmet need.	Molecular oncology	2015	17
26708719	Adenosine monophosphate	Cubero FJ	Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.	Gastroenterology	2016	13
26742071	Adenosine monophosphate	Kim Y	Polyphenols and Glycemic Control.	Nutrients	2016	19
27378194	Adenosine monophosphate	Gadducci A	Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.	Critical reviews in oncology/hematology	2016	11
27577854	Adenosine monophosphate	Smith BK	Treatment of nonalcoholic fatty liver disease: role of AMPK.	American journal of physiology. Endocrinology and metabolism	2016	15
28089566	Adenosine monophosphate	Howell JJ	Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.	Cell metabolism	2017	14
28146130	Adenosine monophosphate	Chen Q	Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD).	Nutrients	2017	6
28467931	Adenosine monophosphate	Cokorinos EC	Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice.	Cell metabolism	2017	9
10998348	NAD	Penning TM	Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.	The Biochemical journal	2000	123
11274184	NAD	He CH	Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation.	The Journal of biological chemistry	2001	114
16335928	NAD	Napper AD	Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.	Journal of medicinal chemistry	2005	94
17718403	NAD	Zakhari S	Overview: how is alcohol metabolized by the body?	Alcohol research & health 	2006	116
18239056	NAD	You M	Involvement of mammalian sirtuin 1 in the action of ethanol in the liver.	American journal of physiology. Gastrointestinal and liver physiology	2008	76
22146883	NAD	Chen HC	SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis.	Annals of surgical oncology	2012	41
22682224	NAD	Cantó C	The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.	Cell metabolism	2012	200
23526469	NAD	Marquardt JU	Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients.	Hepatology	2013	30
24184811	NAD	Li Y	Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.	Gastroenterology	2014	44
28380384	NAD	Krishnaiah SY	Clock Regulation of Metabolites Reveals Coupling between Transcription and Metabolism.	Cell metabolism	2017	9
10836148	Uridine 5'-diphosphate	Tukey RH	Human UDP-glucuronosyltransferases: metabolism, expression, and disease.	Annual review of pharmacology and toxicology	2000	208
15734728	Uridine 5'-diphosphate	Hukkanen J	Metabolism and disposition kinetics of nicotine.	Pharmacological reviews	2005	317
16176115	Uridine 5'-diphosphate	Anderson GD	Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.	Clinical pharmacokinetics	2005	139
17987447	Uridine 5'-diphosphate	Srinivasan K	Black pepper and its pungent principle-piperine: a review of diverse physiological effects.	Critical reviews in food science and nutrition	2007	57
18480185	Uridine 5'-diphosphate	Nakamura A	Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines.	Drug metabolism and disposition	2008	77
18838504	Uridine 5'-diphosphate	Ohno S	Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction.	Drug metabolism and disposition	2009	67
19228077	Uridine 5'-diphosphate	Keating GM	Sorafenib: a review of its use in advanced hepatocellular carcinoma.	Drugs	2009	80
19483103	Uridine 5'-diphosphate	Waxman DJ	Sex differences in the expression of hepatic drug metabolizing enzymes.	Molecular pharmacology	2009	136
20451521	Uridine 5'-diphosphate	Czaja AJ	Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis.	Gastroenterology	2010	51
21994437	Uridine 5'-diphosphate	Ohtsuki S	Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.	Drug metabolism and disposition	2012	45
22448619	Uridine 5'-diphosphate	Brill MJ	Impact of obesity on drug metabolism and elimination in adults and children.	Clinical pharmacokinetics	2012	33
23132334	Uridine 5'-diphosphate	Reese MJ	In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.	Drug metabolism and disposition	2013	38
23223517	Uridine 5'-diphosphate	Hardwick RN	Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease.	Drug metabolism and disposition	2013	25
23462933	Uridine 5'-diphosphate	McGill MR	Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis.	Pharmaceutical research	2013	70
23500526	Uridine 5'-diphosphate	Rowland A	The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification.	The international journal of biochemistry & cell biology	2013	52
25233931	Uridine 5'-diphosphate	Murphy SE	Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups.	Carcinogenesis	2014	36
25422324	Uridine 5'-diphosphate	Wu Q	Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.	The Journal of biological chemistry	2015	15
26417955	Uridine 5'-diphosphate	Gammal RS	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.	Clinical pharmacology and therapeutics	2016	20
26453144	Uridine 5'-diphosphate	Bock KW	The UDP-glycosyltransferase (UGT) superfamily expressed in humans, insects and plants: Animal-plant arms-race and co-evolution.	Biochemical pharmacology	2016	13
27051594	Uridine 5'-diphosphate	Adeva-Andany MM	Glycogen metabolism in humans.	BBA clinical	2016	21
27530469	Uridine 5'-diphosphate	Talavera Pons S	Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C.	British journal of clinical pharmacology	2017	7
8298639	Copper	Bull PC	The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene.	Nature genetics	1993	208
9414160	Copper	Brown DR	The cellular prion protein binds copper in vivo.	Nature	1997	191
12696868	Copper	Speers AE	Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne 3 + 2 cycloaddition.	Journal of the American Chemical Society	2003	154
12955875	Copper	Ferenci P	Diagnosis and phenotypic classification of Wilson disease.	Liver international 	2003	80
15123248	Copper	Speers AE	Profiling enzyme activities in vivo using click chemistry methods.	Chemistry & biology	2004	185
15747110	Copper	Bugianesi E	Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.	Diabetologia	2005	117
15772423	Copper	Draganov DI	Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities.	Journal of lipid research	2005	134
21593220	Copper	Zhang S	Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin.	Human molecular genetics	2011	38
25496901	Copper	Bandmann O	Wilson's disease and other neurological copper disorders.	The Lancet. Neurology	2015	39
26160837	Copper	Wang TH	Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.	Oncotarget	2015	23
26415222	Copper	Rigiracciolo DC	Copper activates HIF-1α/GPER/VEGF signalling in cancer cells.	Oncotarget	2015	18
21321970	4,4'-Methylenedianiline	Jomova K	Arsenic: toxicity, oxidative stress and human disease.	Journal of applied toxicology 	2011	92
24968737	4,4'-Methylenedianiline	Sharifi N	Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial.	Endocrine	2014	29
2981404	Calcium	McCord JM	Oxygen-derived free radicals in postischemic tissue injury.	The New England journal of medicine	1985	445
3266596	Calcium	Herz J	Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor.	The EMBO journal	1988	171
10684258	Calcium	Hazan RB	Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.	The Journal of cell biology	2000	195
11481452	Calcium	Gong G	Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.	Proceedings of the National Academy of Sciences of the United States of America	2001	159
12093242	Calcium	Kirpichnikov D	Metformin: an update.	Annals of internal medicine	2002	188
12198651	Calcium	Xie Q	Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation.	Hepatology	2002	86
12520530	Calcium	Holick MF	Vitamin D: A millenium perspective.	Journal of cellular biochemistry	2003	207
12708612	Calcium	Weber LW	Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model.	Critical reviews in toxicology	2003	208
14990712	Calcium	Takada A	Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry.	Journal of virology	2004	84
15178689	Calcium	Zhao K	Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury.	The Journal of biological chemistry	2004	157
15284207	Calcium	Bai X	Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.	Endocrinology	2004	74
16011470	Calcium	Sampath H	Polyunsaturated fatty acid regulation of genes of lipid metabolism.	Annual review of nutrition	2005	96
17201070	Calcium	Fischer CP	Interleukin-6 in acute exercise and training: what is the biological relevance?	Exercise immunology review	2006	85
17452316	Calcium	Zhang DW	Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation.	The Journal of biological chemistry	2007	146
17984303	Calcium	Tsung A	HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling.	The Journal of experimental medicine	2007	176
18048764	Calcium	Eizirik DL	The role for endoplasmic reticulum stress in diabetes mellitus.	Endocrine reviews	2008	306
18473749	Calcium	Zhou SF	Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4.	Current drug metabolism	2008	79
19151922	Calcium	Dudek J	Functions and pathologies of BiP and its interaction partners.	Cellular and molecular life sciences 	2009	46
19236889	Calcium	Siu ER	Cadmium-induced testicular injury.	Toxicology and applied pharmacology	2009	59
19372102	Calcium	Gomez-Pinilla PJ	Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract.	American journal of physiology. Gastrointestinal and liver physiology	2009	110
20346437	Calcium	Zhong H	Integrating pathway analysis and genetics of gene expression for genome-wide association studies.	American journal of human genetics	2010	127
20546739	Calcium	Kremer AE	Lysophosphatidic acid is a potential mediator of cholestatic pruritus.	Gastroenterology	2010	46
20795941	Calcium	Holick MF	Vitamin D: evolutionary, physiological and health perspectives.	Current drug targets	2011	67
21068004	Calcium	Basantani MK	Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome.	Journal of lipid research	2011	55
21145844	Calcium	Malhi H	Endoplasmic reticulum stress in liver disease.	Journal of hepatology	2011	244
21266974	Calcium	Proctor MJ	An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study.	British journal of cancer	2011	71
21331046	Calcium	Huang W	Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.	Nature	2011	61
21407177	Calcium	Zhang K	The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosis.	The EMBO journal	2011	88
21420431	Calcium	Holzer P	Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.	Pharmacology & therapeutics	2011	38
21572519	Calcium	Zheng L	Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.	PloS one	2011	62
21659653	Calcium	Jahnen-Dechent W	Fetuin-A regulation of calcified matrix metabolism.	Circulation research	2011	61
21685359	Calcium	Sack U	Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.	Journal of the National Cancer Institute	2011	50
22156524	Calcium	Shimojima M	Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry.	Journal of virology	2012	41
23597567	Calcium	Zhao W	1B50-1, a mAb raised against recurrent tumor cells, targets liver tumor-initiating cells by binding to the calcium channel α2δ1 subunit.	Cancer cell	2013	27
23687099	Calcium	Neeland IJ	Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults.	Obesity	2013	55
23728943	Calcium	Cleary SP	Identification of driver genes in hepatocellular carcinoma by exome sequencing.	Hepatology	2013	63
24781336	Calcium	Zhai X	Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC.	Medical oncology	2014	29
25328135	Calcium	Bai XL	Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling.	Oncogene	2015	19
25541060	Calcium	Wang W	Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells.	Cancer letters	2015	17
25683387	Calcium	Al Rifai M	The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).	Atherosclerosis	2015	25
25999530	Calcium	Stewart AF	Human β-cell proliferation and intracellular signaling: part 3.	Diabetes	2015	26
26750181	Calcium	Ellulu MS	Atherosclerotic cardiovascular disease: a review of initiators and protective factors.	Inflammopharmacology	2016	13
27647893	Calcium	Naon D	Critical reappraisal confirms that Mitofusin 2 is an endoplasmic reticulum-mitochondria tether.	Proceedings of the National Academy of Sciences of the United States of America	2016	38
28409320	Calcium	Garbossa SG	Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.	Reviews in endocrine & metabolic disorders	2017	6
28504650	Calcium	Kraakman MJ	Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes.	The Journal of clinical investigation	2017	10
16702335	Coenzyme A	Stipanuk MH	Mammalian cysteine metabolism: new insights into regulation of cysteine metabolism.	The Journal of nutrition	2006	75
24125941	Coenzyme A	Yamashita A	Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms.	Progress in lipid research	2014	29
19269153	Epigallocatechin gallate	Tsang WP	Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells.	The Journal of nutritional biochemistry	2010	81
19542190	Epigallocatechin gallate	McLarty J	Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro.	Cancer prevention research	2009	67
21827739	Epigallocatechin gallate	Singh BN	Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.	Biochemical pharmacology	2011	171
3003504	Glutathione	Carlberg I	Glutathione reductase.	Methods in enzymology	1985	215
10385608	Glutathione	Lu SC	Regulation of hepatic glutathione synthesis: current concepts and controversies.	FASEB journal 	1999	121
10944550	Glutathione	Borst P	A family of drug transporters: the multidrug resistance-associated proteins.	Journal of the National Cancer Institute	2000	219
12505313	Glutathione	Vahter M	Mechanisms of arsenic biotransformation.	Toxicology	2002	98
14556645	Glutathione	Videla LA	Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients.	Clinical science	2004	78
15526190	Glutathione	Hayakawa T	A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19.	Archives of toxicology	2005	68
16011466	Glutathione	Burk RF	Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis.	Annual review of nutrition	2005	90
18158646	Glutathione	Franco R	The central role of glutathione in the pathophysiology of human diseases.	Archives of physiology and biochemistry	2007	86
18291570	Glutathione	Ozer J	The current state of serum biomarkers of hepatotoxicity.	Toxicology	2008	146
18601945	Glutathione	Lu SC	Regulation of glutathione synthesis.	Molecular aspects of medicine	2009	216
18786561	Glutathione	Yuan L	Glutathione in liver diseases and hepatotoxicity.	Molecular aspects of medicine	2009	54
19236887	Glutathione	Liu J	Role of oxidative stress in cadmium toxicity and carcinogenesis.	Toxicology and applied pharmacology	2009	71
19508889	Glutathione	Kim S	Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells.	Toxicology in vitro 	2009	87
19558212	Glutathione	Marí M	Mitochondrial glutathione, a key survival antioxidant.	Antioxidants & redox signaling	2009	140
19812348	Glutathione	Kazui M	Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite.	Drug metabolism and disposition	2010	105
20032990	Glutathione	Uitto J	Pseudoxanthoma elasticum: molecular genetics and putative pathomechanisms.	The Journal of investigative dermatology	2010	54
20351271	Glutathione	Suzuki S	Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.	Proceedings of the National Academy of Sciences of the United States of America	2010	177
20423748	Glutathione	Kalhan SC	Plasma metabolomic profile in nonalcoholic fatty liver disease.	Metabolism	2011	79
20924967	Glutathione	Goel A	Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs.	Nutrition and cancer	2010	83
21182908	Glutathione	Piao MJ	Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis.	Toxicology letters	2011	67
21985599	Glutathione	Marra M	Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.	Journal of translational medicine	2011	46
22001757	Glutathione	Chambers JC	Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.	Nature genetics	2011	141
22188542	Glutathione	Xue M	Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation.	The Biochemical journal	2012	52
22525041	Glutathione	Crawford A	Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease.	Gene	2012	31
22995213	Glutathione	Lu SC	Glutathione synthesis.	Biochimica et biophysica acta	2013	154
23115326	Glutathione	Vanmassenhove J	Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature.	Nephrology, dialysis, transplantation 	2013	67
23752353	Glutathione	Yang L	Fucoidan derived from Undaria pinnatifida induces apoptosis in human hepatocellular carcinoma SMMC-7721 cells via the ROS-mediated mitochondrial pathway.	Marine drugs	2013	25
23824744	Glutathione	Huang Q	Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics.	Cancer research	2013	60
23872024	Glutathione	Shearn CT	Increased carbonylation of the lipid phosphatase PTEN contributes to Akt2 activation in a murine model of early alcohol-induced steatosis.	Free radical biology & medicine	2013	25
23928499	Glutathione	Giustarini D	Analysis of GSH and GSSG after derivatization with N-ethylmaleimide.	Nature protocols	2013	28
24905542	Glutathione	Xie Y	Mechanisms of acetaminophen-induced cell death in primary human hepatocytes.	Toxicology and applied pharmacology	2014	48
24913818	Glutathione	Egner PA	Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China.	Cancer prevention research	2014	32
25793315	Glutathione	Sun L	cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions.	Cell research	2015	20
25889822	Glutathione	Gomez-Cabrera MC	Redox modulation of mitochondriogenesis in exercise. Does antioxidant supplementation blunt the benefits of exercise training?	Free radical biology & medicine	2015	18
26844296	Glutathione	Dóka É	A novel persulfide detection method reveals protein persulfide- and polysulfide-reducing functions of thioredoxin and glutathione systems.	Science advances	2016	20
27015352	Glutathione	Sun X	Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis.	Hepatology	2016	14
27055559	Glutathione	Shitara K	Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205).	Gastric cancer 	2017	11
27628030	Glutathione	Mehmood T	Deoxyelephantopin induces apoptosis in HepG2 cells via oxidative stress, NF-κB inhibition and mitochondrial dysfunction.	BioFactors	2017	6
8770536	Oxygen	Hayes JD	The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.	Critical reviews in biochemistry and molecular biology	1995	479
9738173	Oxygen	-	Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.	Pediatrics	1998	336
9751731	Oxygen	Chandel NS	Mitochondrial reactive oxygen species trigger hypoxia-induced transcription.	Proceedings of the National Academy of Sciences of the United States of America	1998	378
9874807	Oxygen	Janowski BA	Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta.	Proceedings of the National Academy of Sciences of the United States of America	1999	175
11729749	Oxygen	Kmieć Z	Cooperation of liver cells in health and disease.	Advances in anatomy, embryology, and cell biology	2001	103
11832451	Oxygen	Okuda M	Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein.	Gastroenterology	2002	204
12171785	Oxygen	Brasier AR	Vascular inflammation and the renin-angiotensin system.	Arteriosclerosis, thrombosis, and vascular biology	2002	90
12524467	Oxygen	Fisher JW	Erythropoietin: physiology and pharmacology update.	Experimental biology and medicine	2003	95
12559387	Oxygen	Schenkman JB	The many roles of cytochrome b5.	Pharmacology & therapeutics	2003	110
12671019	Oxygen	Yeo EJ	YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.	Journal of the National Cancer Institute	2003	89
12829641	Oxygen	Basu R	Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance.	Diabetes	2003	87
15104534	Oxygen	Marxsen JH	Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.	The Biochemical journal	2004	80
15315937	Oxygen	Higgins DF	Hypoxic induction of Ctgf is directly mediated by Hif-1.	American journal of physiology. Renal physiology	2004	83
15536017	Oxygen	Bartke A	Life extension in the dwarf mouse.	Current topics in developmental biology	2004	116
15647377	Oxygen	John GB	The mitochondrial inner membrane protein mitofilin controls cristae morphology.	Molecular biology of the cell	2005	113
15766528	Oxygen	Kamata H	Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases.	Cell	2005	499
15922018	Oxygen	Krueger SK	Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.	Pharmacology & therapeutics	2005	90
16406828	Oxygen	Begriche K	Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.	Mitochondrion	2006	138
16446448	Oxygen	Vartanian V	The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase.	Proceedings of the National Academy of Sciences of the United States of America	2006	80
16455479	Oxygen	Boffetta P	Alcohol and cancer.	The Lancet. Oncology	2006	150
16496318	Oxygen	Zhan SS	Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo.	Hepatology	2006	68
16642001	Oxygen	Erler JT	Lysyl oxidase is essential for hypoxia-induced metastasis.	Nature	2006	431
16687579	Oxygen	Jaeschke H	Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions.	American journal of physiology. Gastrointestinal and liver physiology	2006	124
16728594	Oxygen	Matoba S	p53 regulates mitochondrial respiration.	Science	2006	485
16923312	Oxygen	Albano E	Alcohol, oxidative stress and free radical damage.	The Proceedings of the Nutrition Society	2006	97
17142801	Oxygen	Leonard MO	Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury.	FASEB journal 	2006	60
17401425	Oxygen	Hussain SP	TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.	Oncogene	2007	116
17479184	Oxygen	Frangogiannis NG	Chemokines in ischemia and reperfusion.	Thrombosis and haemostasis	2007	69
17557118	Oxygen	Peyssonnaux C	Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs).	The Journal of clinical investigation	2007	161
17586614	Oxygen	Cooper SA	Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.	American journal of physiology. Heart and circulatory physiology	2007	67
17786216	Oxygen	Matouk IJ	The H19 non-coding RNA is essential for human tumor growth.	PloS one	2007	185
18094066	Oxygen	Wei Y	Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species.	American journal of physiology. Regulatory, integrative and comparative physiology	2008	52
18395093	Oxygen	Horiguchi N	Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury.	Gastroenterology	2008	70
18413749	Oxygen	Derdak Z	The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells.	Cancer research	2008	56
18420577	Oxygen	Housley MP	O-GlcNAc regulates FoxO activation in response to glucose.	The Journal of biological chemistry	2008	101
18430557	Oxygen	Gentile CL	The role of fatty acids in the development and progression of nonalcoholic fatty liver disease.	The Journal of nutritional biochemistry	2008	54
18452647	Oxygen	Shibuya M	Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis.	BMB reports	2008	53
18635552	Oxygen	Szczesny B	Long patch base excision repair in mammalian mitochondrial genomes.	The Journal of biological chemistry	2008	66
18755895	Oxygen	Ma F	Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis.	Proceedings of the National Academy of Sciences of the United States of America	2008	57
18801366	Oxygen	Lim SO	Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.	Gastroenterology	2008	80
19383922	Oxygen	Kopetz S	Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress.	Cancer research	2009	48
19398236	Oxygen	Mandrekar P	Signalling pathways in alcohol-induced liver inflammation.	Journal of hepatology	2009	115
19433855	Oxygen	Wallace KL	NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines.	Blood	2009	48
19447517	Oxygen	Baffy G	Kupffer cells in non-alcoholic fatty liver disease: the emerging view.	Journal of hepatology	2009	107
19448996	Oxygen	Cederbaum AI	Role of oxidative stress in alcohol-induced liver injury.	Archives of toxicology	2009	132
19789382	Oxygen	Vollmar B	The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair.	Physiological reviews	2009	72
19805739	Oxygen	Brooks GA	Cell-cell and intracellular lactate shuttles.	The Journal of physiology	2009	122
19889935	Oxygen	Burdette D	Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway.	The Journal of general virology	2010	46
20019356	Oxygen	Klaunig JE	Oxidative stress and oxidative damage in carcinogenesis.	Toxicologic pathology	2010	171
20227042	Oxygen	He G	Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation.	Cancer cell	2010	113
20230822	Oxygen	Lin W	Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner.	Gastroenterology	2010	67
20463368	Oxygen	Michelakis ED	Metabolic modulation of glioblastoma with dichloroacetate.	Science translational medicine	2010	201
20665378	Oxygen	Rosmorduc O	Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease.	Seminars in liver disease	2010	52
20685364	Oxygen	Jiang JX	Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo.	Gastroenterology	2010	42
20818739	Oxygen	Abu-Amara M	Liver ischemia/reperfusion injury: processes in inflammatory networks--a review.	Liver transplantation 	2010	59
20942471	Oxygen	Laleu B	First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.	Journal of medicinal chemistry	2010	75
20969928	Oxygen	Ferbeyre G	The role of Stat5 transcription factors as tumor suppressors or oncogenes.	Biochimica et biophysica acta	2011	40
21098019	Oxygen	Lin W	HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB.	The Journal of biological chemistry	2011	39
21099112	Oxygen	Gardenghi S	Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.	The Journal of clinical investigation	2010	69
21145849	Oxygen	Begriche K	Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.	Journal of hepatology	2011	48
21293192	Oxygen	Stein S	Protective roles of SIRT1 in atherosclerosis.	Cell cycle	2011	60
21350183	Oxygen	Chiang DJ	Obesity, diabetes mellitus, and liver fibrosis.	American journal of physiology. Gastrointestinal and liver physiology	2011	42
21386137	Oxygen	Ozden O	Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative stress.	Aging	2011	55
21386818	Oxygen	Zhu AX	HCC and angiogenesis: possible targets and future directions.	Nature reviews. Clinical oncology	2011	94
21497090	Oxygen	Bosch M	Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility.	Current biology 	2011	52
21514287	Oxygen	Koek GH	The role of oxidative stress in non-alcoholic steatohepatitis.	Clinica chimica acta; international journal of clinical chemistry	2011	64
21664213	Oxygen	Aubert J	Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.	Clinics and research in hepatology and gastroenterology	2011	51
21712410	Oxygen	Mathieu J	HIF induces human embryonic stem cell markers in cancer cells.	Cancer research	2011	146
21825039	Oxygen	Ding ZB	Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.	Clinical cancer research 	2011	38
21931870	Oxygen	Ivanov AV	Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells.	PloS one	2011	42
21953216	Oxygen	Urtasun R	Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.	Hepatology	2012	51
21994322	Oxygen	Burdette D	Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex.	The Journal of general virology	2012	36
22011623	Oxygen	Gong K	Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma.	Free radical biology & medicine	2011	36
22079466	Oxygen	Piao LS	CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma.	Cancer letters	2012	53
22223731	Oxygen	Derwall M	Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2012	51
22281437	Oxygen	Lozy F	Autophagy and cancer cell metabolism.	Seminars in cell & developmental biology	2012	54
22393286	Oxygen	Akhtar MJ	Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species.	International journal of nanomedicine	2012	51
22395444	Oxygen	Sharma V	Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2).	Apoptosis 	2012	55
22454632	Oxygen	Ponugoti B	Role of forkhead transcription factors in diabetes-induced oxidative stress.	Experimental diabetes research	2012	51
22459037	Oxygen	Jaeschke H	Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species.	Transplantation reviews	2012	53
22533670	Oxygen	Giralt A	SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging.	The Biochemical journal	2012	50
22562464	Oxygen	Luo Z	The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth.	Cancer research	2012	68
22618020	Oxygen	Jiang JX	Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.	Free radical biology & medicine	2012	73
22701472	Oxygen	Arcidiacono B	Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms.	Experimental diabetes research	2012	74
22703180	Oxygen	Pantopoulos K	Mechanisms of mammalian iron homeostasis.	Biochemistry	2012	71
22897481	Oxygen	Sheng SL	Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.	The FEBS journal	2012	42
22927446	Oxygen	Gong K	Autophagy-related gene 7 (ATG7) and reactive oxygen species/extracellular signal-regulated kinase regulate tetrandrine-induced autophagy in human hepatocellular carcinoma.	The Journal of biological chemistry	2012	33
22940046	Oxygen	Leung TM	CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.	Journal of hepatology	2013	65
23103253	Oxygen	Elorza A	HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5.	Molecular cell	2012	33
23108410	Oxygen	Higgs MR	Hepatitis C virus-induced activation of β-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events.	Oncogene	2013	27
23181220	Oxygen	Kongara S	The interplay between autophagy and ROS in tumorigenesis.	Frontiers in oncology	2012	40
23485523	Oxygen	Hernández-Gea V	Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy.	Journal of hepatology	2013	40
23508104	Oxygen	Kim KH	Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts.	Molecular and cellular biology	2013	59
23519123	Oxygen	Jin M	Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc/jnk/sp1 pathway.	Cell death & disease	2013	37
23783559	Oxygen	Niranjan R	The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes.	Molecular neurobiology	2014	33
23841983	Oxygen	Yu E	Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans.	Circulation	2013	34
24040957	Oxygen	Paik YH	Role of NADPH oxidases in liver fibrosis.	Antioxidants & redox signaling	2014	43
24200681	Oxygen	Meynard D	The liver: conductor of systemic iron balance.	Blood	2014	30
24382987	Oxygen	Ohnishi S	DNA damage in inflammation-related carcinogenesis and cancer stem cells.	Oxidative medicine and cellular longevity	2013	29
24466275	Oxygen	Liu AM	miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.	PloS one	2014	26
24509161	Oxygen	Crosas-Molist E	The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression.	Free radical biology & medicine	2014	20
24636985	Oxygen	Wu T	Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis.	Genes & development	2014	44
24832602	Oxygen	Park EJ	β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells.	Cell death & disease	2014	26
24901008	Oxygen	Landskron G	Chronic inflammation and cytokines in the tumor microenvironment.	Journal of immunology research	2014	178
25009380	Oxygen	Cichoż-Lach H	Oxidative stress as a crucial factor in liver diseases.	World journal of gastroenterology	2014	31
25242319	Oxygen	Huang	HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression.	Cell reports	2014	39
25440060	Oxygen	Walter KM	Hif-2α promotes degradation of mammalian peroxisomes by selective autophagy.	Cell metabolism	2014	20
25622857	Oxygen	Wang F	Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma.	Molecular cancer	2015	16
25779952	Oxygen	Vellinga TT	SIRT1/PGC1α-Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer.	Clinical cancer research 	2015	20
25818486	Oxygen	Roy K	NADPH oxidases and cancer.	Clinical science	2015	28
26028023	Oxygen	Chen CC	The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation.	Oncogene	2016	14
26335400	Oxygen	Richter K	Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences.	Redox biology	2015	25
26420419	Oxygen	Reich M	TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro.	Gut	2016	16
26627594	Oxygen	Qian P	The Dlk1-Gtl2 Locus Preserves LT-HSC Function by Inhibiting the PI3K-mTOR Pathway to Restrict Mitochondrial Metabolism.	Cell stem cell	2016	19
26871664	Oxygen	Ince C	THE ENDOTHELIUM IN SEPSIS.	Shock	2016	19
26934227	Oxygen	Ma C	NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.	Nature	2016	37
27070352	Oxygen	Cobb LJ	Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers.	Aging	2016	18
27443527	Oxygen	Roberts RF	Defending the mitochondria: The pathways of mitophagy and mitochondrial-derived vesicles.	The international journal of biochemistry & cell biology	2016	14
27484637	Oxygen	Prieto-Domínguez N	Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy.	Journal of pineal research	2016	11
27679493	Oxygen	Li M	MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47phox-oxidative stress pathway in neutrophils.	Gut	2017	17
28126520	Oxygen	Kietzmann T	Metabolic zonation of the liver: The oxygen gradient revisited.	Redox biology	2017	12
28288320	Oxygen	Dinda B	Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders.	European journal of medicinal chemistry	2017	7
12845534	Ammonia	Mackenzie B	Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family.	Pflugers Archiv 	2004	127
17596885	Ammonia	Banas A	Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes.	Hepatology	2007	102
18624899	Ammonia	Banas A	Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure.	Journal of gastroenterology and hepatology	2009	68
20849805	Ammonia	Bajaj JS	Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy.	Gastroenterology	2011	39
23720285	Ammonia	Weiner ID	Renal ammonia metabolism and transport.	Comprehensive Physiology	2013	30
23817325	Ammonia	Butterworth RF	The liver-brain axis in liver failure: neuroinflammation and encephalopathy.	Nature reviews. Gastroenterology & hepatology	2013	26
24801166	Ammonia	Monga SP	Role and regulation of β-catenin signaling during physiological liver growth.	Gene expression	2014	22
26639393	Ammonia	Ghallab A	Model-guided identification of a therapeutic strategy to reduce hyperammonemia in liver diseases.	Journal of hepatology	2016	12
27318325	Ammonia	Davuluri G	Metabolic adaptation of skeletal muscle to hyperammonemia drives the beneficial effects of l-leucine in cirrhosis.	Journal of hepatology	2016	12
10935643	Dexamethasone	Xie W	Humanized xenobiotic response in mice expressing nuclear receptor SXR.	Nature	2000	148
11238541	Dexamethasone	Rask E	Tissue-specific dysregulation of cortisol metabolism in human obesity.	The Journal of clinical endocrinology and metabolism	2001	96
11706036	Dexamethasone	Kast HR	Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.	The Journal of biological chemistry	2002	126
19026649	Dexamethasone	Basma H	Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.	Gastroenterology	2009	148
19245695	Dexamethasone	Haram K	The HELLP syndrome: clinical issues and management. A Review.	BMC pregnancy and childbirth	2009	55
21127173	Dexamethasone	England SJ	Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus.	Blood	2011	45
26423795	Dexamethasone	Sarantopoulos J	Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors.	Clinical cancer research 	2016	20
26622051	Dexamethasone	Dhindsa S	Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.	Diabetes care	2016	16
27646843	Dexamethasone	Yee AJ	Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial.	The Lancet. Oncology	2016	14
1596899	Folic acid	Weitman SD	Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.	Cancer research	1992	138
7647779	Folic acid	Frosst P	A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.	Nature genetics	1995	660
26418287	Folic acid	Nilsson E	Epigenetic Alterations in Human Liver From Subjects With Type 2 Diabetes in Parallel With Reduced Folate Levels.	The Journal of clinical endocrinology and metabolism	2015	19
26449608	Folic acid	Craciun FL	RNA Sequencing Identifies Novel Translational Biomarkers of Kidney Fibrosis.	Journal of the American Society of Nephrology 	2016	10
15217303	Tenofovir	Kearney BP	Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics.	Clinical pharmacokinetics	2004	74
18198941	Tenofovir	Denton PW	Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.	PLoS medicine	2008	165
21199525	Tenofovir	Yuen MF	Treatment of chronic hepatitis B: Evolution over two decades.	Journal of gastroenterology and hepatology	2011	44
22748590	Tenofovir	DeJesus E	Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.	Lancet	2012	77
10573521	Acetaminophen	Theise ND	The canals of Hering and hepatic stem cells in humans.	Hepatology	1999	119
16820551	Acetaminophen	Watkins PB	Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.	JAMA	2006	81
18046720	Acetaminophen	Zakhari S	Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease.	Hepatology	2007	82
19246379	Acetaminophen	Wang K	Circulating microRNAs, potential biomarkers for drug-induced liver injury.	Proceedings of the National Academy of Sciences of the United States of America	2009	311
19416960	Acetaminophen	Harrill AH	Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans.	Genome research	2009	57
21386809	Acetaminophen	Tujios S	Mechanisms of drug-induced liver injury: from bedside to bench.	Nature reviews. Gastroenterology & hepatology	2011	53
23453390	Acetaminophen	Han D	Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria.	Trends in pharmacological sciences	2013	33
24118944	Acetaminophen	Thulin P	Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts.	Liver international 	2014	21
24388027	Acetaminophen	Leise MD	Drug-induced liver injury.	Mayo Clinic proceedings	2014	47
24700364	Acetaminophen	Rodrigo-Torres D	The biliary epithelium gives rise to liver progenitor cells.	Hepatology	2014	38
25445704	Acetaminophen	Olayanju A	Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2.	Free radical biology & medicine	2015	23
25568858	Acetaminophen	Krenkel O	Immune mechanisms in acetaminophen-induced acute liver failure.	Hepatobiliary surgery and nutrition	2014	21
26055245	Acetaminophen	Szabo G	Inflammasome activation and function in liver disease.	Nature reviews. Gastroenterology & hepatology	2015	51
26344055	Acetaminophen	Stutchfield BM	CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure.	Gastroenterology	2015	21
26756674	Acetaminophen	Bhise NS	A liver-on-a-chip platform with bioprinted hepatic spheroids.	Biofabrication	2016	26
27142208	Acetaminophen	Sarges P	Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature.	Drug safety	2016	12
27224670	Acetaminophen	Mikus M	Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury.	Liver international 	2017	7
27913221	Acetaminophen	Woolbright BL	Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure.	Journal of hepatology	2017	16
27997988	Acetaminophen	Michalopoulos GK	Hepatostat: Liver regeneration and normal liver tissue maintenance.	Hepatology	2017	10
17162245	Ursodeoxycholic acid	Dufour JF	Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis.	Clinical gastroenterology and hepatology 	2006	64
18752324	Ursodeoxycholic acid	Corpechot C	Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.	Hepatology	2008	56
20193641	Ursodeoxycholic acid	Amaral JD	The role of p53 in apoptosis.	Discovery medicine	2010	55
20568301	Ursodeoxycholic acid	Lleo A	Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis.	Hepatology	2010	58
21145828	Ursodeoxycholic acid	Ratziu V	A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis.	Journal of hepatology	2011	52
22271046	Ursodeoxycholic acid	Corpechot C	Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis.	Hepatology	2012	35
22902550	Ursodeoxycholic acid	Castro RE	miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.	Journal of hepatology	2013	59
23141891	Ursodeoxycholic acid	Poupon R	Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action.	Clinics and research in hepatology and gastroenterology	2012	33
23246637	Ursodeoxycholic acid	Carbone M	Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid.	Gastroenterology	2013	27
25042122	Ursodeoxycholic acid	Wang L	CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis.	Hepatology	2015	24
25500425	Ursodeoxycholic acid	Hirschfield GM	Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.	Gastroenterology	2015	62
25678132	Ursodeoxycholic acid	Ghonem NS	Fibrates and cholestasis.	Hepatology	2015	17
25920087	Ursodeoxycholic acid	Beuers U	New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond.	Journal of hepatology	2015	26
26642859	Ursodeoxycholic acid	Llopis M	Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease.	Gut	2016	21
27207975	Ursodeoxycholic acid	Sabino J	Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.	Gut	2016	18
27638959	Ursodeoxycholic acid	Takahashi S	Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans.	Journal of lipid research	2016	12
8833906	Phosphoenolpyruvic acid	Shimano H	Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.	The Journal of clinical investigation	1996	190
12959935	Phosphoenolpyruvic acid	Barthel A	Novel concepts in insulin regulation of hepatic gluconeogenesis.	American journal of physiology. Endocrinology and metabolism	2003	85
16034410	Phosphoenolpyruvic acid	Yang Q	Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.	Nature	2005	450
17464996	Phosphoenolpyruvic acid	Cai J	Directed differentiation of human embryonic stem cells into functional hepatic cells.	Hepatology	2007	146
19587243	Phosphoenolpyruvic acid	Samuel VT	Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2009	54
20736318	Phosphoenolpyruvic acid	Nagashima T	Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice.	Molecular pharmacology	2010	45
21965330	Phosphoenolpyruvic acid	Wang RH	Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.	The Journal of clinical investigation	2011	91
22318941	Phosphoenolpyruvic acid	Wang B	Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha.	Hepatology	2012	60
23716591	Phosphoenolpyruvic acid	Ramírez CM	MicroRNA 33 regulates glucose metabolism.	Molecular and cellular biology	2013	38
25009184	Phosphoenolpyruvic acid	Zhang P	Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion.	Proceedings of the National Academy of Sciences of the United States of America	2014	42
26571396	Phosphoenolpyruvic acid	Satapati S	Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.	The Journal of clinical investigation	2015	39
2471267	L-Glutamic acid	Cunningham BC	High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis.	Science	1989	329
21372407	L-Glutamic acid	Takeuchi F	Confirmation of ALDH2 as a Major locus of drinking behavior and of its variants regulating multiple metabolic phenotypes in a Japanese population.	Circulation journal 	2011	39
22369515	L-Glutamic acid	Eder M	68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.	Bioconjugate chemistry	2012	70
23179945	L-Glutamic acid	Afshar-Oromieh A	PET imaging with a 68Gagallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.	European journal of nuclear medicine and molecular imaging	2013	94
24187469	L-Glutamic acid	Ma YY	Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.	World journal of gastroenterology	2013	51
25302781	L-Glutamic acid	Sookoian S	Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity.	Hepatology	2015	31
16513647	L-Phenylalanine	Jain AK	Phosphorylation of tyrosine 568 controls nuclear export of Nrf2.	The Journal of biological chemistry	2006	63
18250299	L-Phenylalanine	Kwon HJ	Molecular basis for LDL receptor recognition by PCSK9.	Proceedings of the National Academy of Sciences of the United States of America	2008	84
25777547	L-Phenylalanine	Denisov IG	Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer.	Biochemistry	2015	16
19223655	D-Galactose	Leturque A	GLUT2 mutations, translocation, and receptor function in diet sugar managing.	American journal of physiology. Endocrinology and metabolism	2009	45
19783995	D-Galactose	Rumjantseva V	Dual roles for hepatic lectin receptors in the clearance of chilled platelets.	Nature medicine	2009	49
16783407	Methotrexate	Chan ES	Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis.	British journal of pharmacology	2006	65
18370855	Methotrexate	Polgar O	ABCG2: structure, function and role in drug response.	Expert opinion on drug metabolism & toxicology	2008	50
21245207	Methotrexate	Niemi M	Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake.	Pharmacological reviews	2011	96
24657513	Methotrexate	Gerfaud-Valentin M	Adult-onset Still's disease.	Autoimmunity reviews	2014	35
24970651	Methotrexate	Esch MB	Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury.	Lab on a chip	2014	26
25456364	Methotrexate	Kennedy GA	Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.	The Lancet. Oncology	2014	35
26247164	Methotrexate	Axelrad J	Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents.	Clinical gastroenterology and hepatology 	2016	11
27827824	Methotrexate	Abu Zaid M	Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.	Blood	2017	7
15123604	L-Methionine	Bohren KM	A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus.	The Journal of biological chemistry	2004	86
15189131	L-Methionine	Stipanuk MH	Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine.	Annual review of nutrition	2004	150
16267554	L-Methionine	Croft MT	Algae acquire vitamin B12 through a symbiotic relationship with bacteria.	Nature	2005	143
16924677	L-Methionine	Kutay H	Downregulation of miR-122 in the rodent and human hepatocellular carcinomas.	Journal of cellular biochemistry	2006	181
17464973	L-Methionine	Mato JM	Role of S-adenosyl-L-methionine in liver health and injury.	Hepatology	2007	79
19119140	L-Methionine	Li ZZ	Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.	The Journal of biological chemistry	2009	112
19577569	L-Methionine	Syn WK	Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease.	Gastroenterology	2009	86
19853062	L-Methionine	Spindler SR	Caloric restriction: from soup to nuts.	Ageing research reviews	2010	59
20034933	L-Methionine	He S	A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis.	The Journal of biological chemistry	2010	140
20373368	L-Methionine	Valenti L	Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.	Hepatology	2010	120
20967826	L-Methionine	Syn WK	Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.	Hepatology	2011	65
20978355	L-Methionine	Berres ML	Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.	The Journal of clinical investigation	2010	46
21878620	L-Methionine	Huang Y	Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease.	The Journal of biological chemistry	2011	51
21878621	L-Methionine	Teng YW	Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas.	The Journal of biological chemistry	2011	51
22389872	L-Methionine	Catenacci DV	Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence.	Cancer discovery	2011	39
22427237	L-Methionine	Syn WK	NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease.	Gut	2012	53
23073625	L-Methionine	Lu SC	S-adenosylmethionine in liver health, injury, and cancer.	Physiological reviews	2012	76
23241961	L-Methionine	Yang H	MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.	The Journal of clinical investigation	2013	35
23703580	L-Methionine	Staels B	Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.	Hepatology	2013	51
23916847	L-Methionine	Murphy SK	Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.	Gastroenterology	2013	52
23959575	L-Methionine	Hammerich L	Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.	Hepatology	2014	33
24222941	L-Methionine	Dongiovanni P	PNPLA3 I148M polymorphism and progressive liver disease.	World journal of gastroenterology	2013	32
24743734	L-Methionine	González-Rodríguez A	Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD.	Cell death & disease	2014	60
24902765	L-Methionine	Coombes JD	Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice.	Gut	2015	17
25736301	L-Methionine	Tanaka N	Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet.	Biochimica et biophysica acta	2015	20
26201023	L-Methionine	Afonso MB	Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.	Clinical science	2015	18
28167322	L-Methionine	Mridha AR	NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.	Journal of hepatology	2017	12
19208360	Deoxyuridine triphosphate	Dominguez M	Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.	Gastroenterology	2009	71
18981013	Progesterone	Luu TH	A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study.	Clinical cancer research 	2008	64
20813970	Progesterone	Esteva FJ	PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.	The American journal of pathology	2010	100
20863372	Progesterone	Hoefnagel LD	Receptor conversion in distant breast cancer metastases.	Breast cancer research 	2010	52
21914172	Progesterone	Sihto H	Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.	Breast cancer research 	2011	50
22178456	Progesterone	Amir E	Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.	Cancer treatment reviews	2012	35
22704583	Progesterone	Paterson AH	Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.	The Lancet. Oncology	2012	37
23328895	Progesterone	Isoherranen N	Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?	Drug metabolism and disposition	2013	27
26617202	Progesterone	Takashima T	Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.	The Lancet. Oncology	2016	11
17569885	Eicosapentaenoic acid	Itoh M	Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects.	Arteriosclerosis, thrombosis, and vascular biology	2007	63
24818764	Eicosapentaenoic acid	Sanyal AJ	No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial.	Gastroenterology	2014	40
25581263	Eicosapentaenoic acid	Arendt BM	Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids.	Hepatology	2015	16
25632018	Eicosapentaenoic acid	Betancor MB	A nutritionally-enhanced oil from transgenic Camelina sativa effectively replaces fish oil as a source of eicosapentaenoic acid for fish.	Scientific reports	2015	17
26597785	Eicosapentaenoic acid	Park HG	Palmitic acid (16:0) competes with omega-6 linoleic and omega-3 ɑ-linolenic acids for FADS2 mediated Δ6-desaturation.	Biochimica et biophysica acta	2016	11
15102878	Ceramide (d18:1/12:0)	Khovidhunkit W	Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host.	Journal of lipid research	2004	240
16445986	Ceramide (d18:1/12:0)	Summers SA	Ceramides in insulin resistance and lipotoxicity.	Progress in lipid research	2006	209
16492686	Ceramide (d18:1/12:0)	Wei Y	Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells.	American journal of physiology. Endocrinology and metabolism	2006	206
17620421	Ceramide (d18:1/12:0)	Kolak M	Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity.	Diabetes	2007	79
18338393	Ceramide (d18:1/12:0)	Hruska KS	Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).	Human mutation	2008	124
18388185	Ceramide (d18:1/12:0)	Greco D	Gene expression in human NAFLD.	American journal of physiology. Gastrointestinal and liver physiology	2008	89
18567738	Ceramide (d18:1/12:0)	Smith EL	The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.	FASEB journal 	2008	67
19777393	Ceramide (d18:1/12:0)	de la Monte SM	Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.	Current opinion in investigational drugs	2009	47
20361178	Ceramide (d18:1/12:0)	DeFronzo RA	Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009.	Diabetologia	2010	140
20712405	Ceramide (d18:1/12:0)	Tanida I	Autophagosome formation and molecular mechanism of autophagy.	Antioxidants & redox signaling	2011	111
21695182	Ceramide (d18:1/12:0)	Lee H	Mitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation.	PloS one	2011	52
22425588	Ceramide (d18:1/12:0)	Magkos F	Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects.	Gastroenterology	2012	39
22577490	Ceramide (d18:1/12:0)	Longato L	Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease.	Oxidative medicine and cellular longevity	2012	36
23139352	Ceramide (d18:1/12:0)	Boon J	Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance.	Diabetes	2013	45
23550081	Ceramide (d18:1/12:0)	Hocking S	Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots.	Endocrine reviews	2013	33
25295788	Ceramide (d18:1/12:0)	Turpin SM	Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.	Cell metabolism	2014	80
25295789	Ceramide (d18:1/12:0)	Raichur S	CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance.	Cell metabolism	2014	56
26621917	Ceramide (d18:1/12:0)	Kakazu E	Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner.	Journal of lipid research	2016	18
26670557	Ceramide (d18:1/12:0)	Jiang C	Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.	Nature communications	2015	37
26780287	Ceramide (d18:1/12:0)	Luukkonen PK	Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.	Journal of hepatology	2016	20
15178557	Mevalonic acid	Dubuc G	Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia.	Arteriosclerosis, thrombosis, and vascular biology	2004	125
19605471	Mevalonic acid	Borawski J	Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication.	Journal of virology	2009	85
19846523	Mevalonic acid	Norman KL	Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms.	Journal of virology	2010	50
21262914	Mevalonic acid	Cao Z	MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase.	Cancer research	2011	50
2112087	L-Leucine	Akira S	A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.	The EMBO journal	1990	343
2171780	L-Leucine	Poli V	IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP.	Cell	1990	162
9525995	L-Leucine	Patti ME	Bidirectional modulation of insulin action by amino acids.	The Journal of clinical investigation	1998	104
15985529	L-Leucine	Lee JM	Nrf2, a multi-organ protector?	FASEB journal 	2005	116
17280616	L-Leucine	Lin ML	Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.	Breast cancer research 	2007	55
17925455	L-Leucine	She P	Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism.	American journal of physiology. Endocrinology and metabolism	2007	102
19717560	L-Leucine	Donkor J	A conserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin-1 and lipin-2.	The Journal of biological chemistry	2009	51
20127796	L-Leucine	Hou W	MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins.	Hepatology	2010	59
20584763	L-Leucine	Lech M	Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice.	International immunology	2010	44
21125339	L-Leucine	Takahashi H	Significance of Lgr5(+ve) cancer stem cells in the colon and rectum.	Annals of surgical oncology	2011	41
21563202	L-Leucine	Kawaguchi T	Branched-chain amino acids as pharmacological nutrients in chronic liver disease.	Hepatology	2011	51
21811631	L-Leucine	Jeong YS	Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression.	PloS one	2011	41
22260996	L-Leucine	Baghy K	Decorin-TGFβ axis in hepatic fibrosis and cirrhosis.	The journal of histochemistry and cytochemistry 	2012	33
24338587	L-Leucine	García-Rodríguez JL	SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling.	Hepatology	2014	21
25013376	L-Leucine	Xu WH	Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma.	International journal of biological sciences	2014	27
25534430	L-Leucine	Lake AD	Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease.	Amino acids	2015	17
25733449	L-Leucine	Rahman SA	Molecular mechanisms of congenital hyperinsulinism.	Journal of molecular endocrinology	2015	17
26078453	L-Leucine	Daher JP	Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration.	The Journal of biological chemistry	2015	21
28358093	L-Leucine	de Sousa e Melo F	A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer.	Nature	2017	30
2690177	L-Alanine	Molyneux ME	Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children.	The Quarterly journal of medicine	1989	199
9819447	L-Alanine	Davis GL	Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.	The New England journal of medicine	1998	153
10210705	L-Alanine	Kenny-Walsh E	Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.	The New England journal of medicine	1999	147
10632283	L-Alanine	Sulkowski MS	Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.	JAMA	2000	121
11438497	L-Alanine	Dixon JB	Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.	Gastroenterology	2001	185
12029639	L-Alanine	Hsu YS	Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.	Hepatology	2002	105
12093239	L-Alanine	Prati D	Updated definitions of healthy ranges for serum alanine aminotransferase levels.	Annals of internal medicine	2002	230
12606734	L-Alanine	Hadziyannis SJ	Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.	The New England journal of medicine	2003	134
12618592	L-Alanine	Sutton A	The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria.	Pharmacogenetics	2003	82
12774006	L-Alanine	Mofrad P	Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.	Hepatology	2003	184
14512888	L-Alanine	Neuschwander-Tetri BA	Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.	Hepatology	2003	101
14699491	L-Alanine	Peters MG	Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.	Gastroenterology	2004	92
14752837	L-Alanine	Promrat K	A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.	Hepatology	2004	114
14960526	L-Alanine	Hickman IJ	Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life.	Gut	2004	73
15361502	L-Alanine	Chan HL	Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.	Gut	2004	105
15591515	L-Alanine	Kaser S	Adiponectin and its receptors in non-alcoholic steatohepatitis.	Gut	2005	67
15639293	L-Alanine	Janssen HL	Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.	Lancet	2005	165
15701910	L-Alanine	Albers GW	Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.	JAMA	2005	74
15842582	L-Alanine	Bugianesi E	A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.	The American journal of gastroenterology	2005	111
15867021	L-Alanine	Schwimmer JB	Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.	Pediatrics	2005	83
15871997	L-Alanine	Yuen MF	Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.	Gut	2005	77
16249437	L-Alanine	Hanley AJ	Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.	Diabetes	2005	85
16391218	L-Alanine	Chen CJ	Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.	JAMA	2006	487
16405537	L-Alanine	Ioannou GN	The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002.	The American journal of gastroenterology	2006	63
16611275	L-Alanine	Capanni M	Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study.	Alimentary pharmacology & therapeutics	2006	77
16682043	L-Alanine	Schindhelm RK	Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.	Atherosclerosis	2007	76
16832839	L-Alanine	Schindhelm RK	Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.	Diabetes/metabolism research and reviews	2006	69
16912127	L-Alanine	Burgert TS	Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat.	The Journal of clinical endocrinology and metabolism	2006	79
17021358	L-Alanine	Saukkonen JJ	An official ATS statement: hepatotoxicity of antituberculosis therapy.	American journal of respiratory and critical care medicine	2006	149
17077998	L-Alanine	Flaig TW	A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.	Investigational new drugs	2007	58
17087951	L-Alanine	Hadziyannis SJ	Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.	Gastroenterology	2006	150
17214506	L-Alanine	Abdulla MH	Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor.	PLoS medicine	2007	74
17379663	L-Alanine	Heidel JD	Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA.	Proceedings of the National Academy of Sciences of the United States of America	2007	88
17439526	L-Alanine	Coco B	Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.	Journal of viral hepatitis	2007	114
17505501	L-Alanine	Kindmark A	Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis.	The pharmacogenomics journal	2008	71
17595248	L-Alanine	Kotronen A	Liver fat in the metabolic syndrome.	The Journal of clinical endocrinology and metabolism	2007	80
18053320	L-Alanine	Klonoff DC	Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.	Current medical research and opinion	2008	153
18054554	L-Alanine	Fraser A	Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.	Gastroenterology	2007	80
18054848	L-Alanine	Spadaro L	Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease.	Digestive and liver disease 	2008	57
18081738	L-Alanine	Jarrar MH	Adipokines and cytokines in non-alcoholic fatty liver disease.	Alimentary pharmacology & therapeutics	2008	74
18095306	L-Alanine	Arena U	Acute viral hepatitis increases liver stiffness values measured by transient elastography.	Hepatology	2008	114
18366115	L-Alanine	Kim WR	Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease.	Hepatology	2008	75
18384521	L-Alanine	Leite NC	Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus.	Liver international 	2009	88
18390575	L-Alanine	Harrison SA	Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.	Gut	2008	97
18421281	L-Alanine	Larson-Meyer DE	Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function.	Obesity	2008	54
18637092	L-Alanine	Pai M	Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis.	The American journal of gastroenterology	2008	54
18673426	L-Alanine	Chan HL	Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.	Journal of viral hepatitis	2009	70
18752330	L-Alanine	Marcellin P	Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.	Hepatology	2008	51
18752331	L-Alanine	Fracanzani AL	Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.	Hepatology	2008	105
18940312	L-Alanine	Yuan X	Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.	American journal of human genetics	2008	122
18945255	L-Alanine	Loomba R	Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.	Alimentary pharmacology & therapeutics	2009	54
19010326	L-Alanine	Goessling W	Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.	Gastroenterology	2008	66
19013463	L-Alanine	Patton HM	Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.	Gastroenterology	2008	53
19038698	L-Alanine	Kirpich IA	Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study.	Alcohol	2008	78
19100265	L-Alanine	Ruhl CE	Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.	Gastroenterology	2009	66
19131466	L-Alanine	Fraser A	Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis.	Diabetes care	2009	77
19267406	L-Alanine	Wong VW	High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B.	International journal of cancer	2009	62
19291789	L-Alanine	Gastaldelli A	Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population.	Hepatology	2009	64
19302335	L-Alanine	Nguyen VT	Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.	Journal of viral hepatitis	2009	74
19414484	L-Alanine	Johnson AD	Genome-wide association meta-analysis for total serum bilirubin levels.	Human molecular genetics	2009	57
19470388	L-Alanine	Oliviero B	Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.	Gastroenterology	2009	124
19523535	L-Alanine	Shah AG	Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.	Clinical gastroenterology and hepatology 	2009	95
19524579	L-Alanine	Kotronen A	Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.	Gastroenterology	2009	77
19585618	L-Alanine	Feldstein AE	Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study.	Hepatology	2009	128
19747917	L-Alanine	Ahlenstiel G	Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.	Gastroenterology	2010	98
19842207	L-Alanine	Zhang JY	Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.	Hepatology	2010	95
19844213	L-Alanine	Romeo S	Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent.	International journal of obesity	2010	56
19877169	L-Alanine	Ratziu V	Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial.	Hepatology	2010	56
19931264	L-Alanine	Valenti L	HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.	Gastroenterology	2010	50
20064512	L-Alanine	Schwimmer JB	SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.	Gastroenterology	2010	54
20222092	L-Alanine	Das K	Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.	Hepatology	2010	64
20227758	L-Alanine	Raal FJ	Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.	Lancet	2010	135
20648474	L-Alanine	Valenti L	I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.	Hepatology	2010	61
20648476	L-Alanine	Neuschwander-Tetri BA	Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.	Hepatology	2010	98
20658466	L-Alanine	Ghouri N	Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.	Hepatology	2010	47
20664019	L-Alanine	Lazo M	Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes.	Diabetes care	2010	54
20708005	L-Alanine	Chalasani N	Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.	Gastroenterology	2010	76
20815808	L-Alanine	Gui J	Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.	Clinical science	2011	71
20858492	L-Alanine	Williams CD	Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.	Gastroenterology	2011	398
20889864	L-Alanine	Trung DT	Liver involvement associated with dengue infection in adults in Vietnam.	The American journal of tropical medicine and hygiene	2010	43
20959817	L-Alanine	Yin J	Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma.	The American journal of gastroenterology	2011	39
21109302	L-Alanine	Athyros VG	Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.	Lancet	2010	103
21139063	L-Alanine	Thomson EC	Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men.	Gut	2011	46
21254163	L-Alanine	Zhang Z	Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients.	Hepatology	2011	45
21254164	L-Alanine	Stickel F	Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians.	Hepatology	2011	63
21319195	L-Alanine	Valenti L	Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.	Hepatology	2011	65
21319198	L-Alanine	Brunt EM	Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.	Hepatology	2011	138
21323729	L-Alanine	Chen CJ	Natural history of chronic hepatitis B REVEALed.	Journal of gastroenterology and hepatology	2011	46
21378535	L-Alanine	Jani IV	Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing.	AIDS	2011	53
21381068	L-Alanine	Sookoian S	Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.	Hepatology	2011	155
21423260	L-Alanine	Kwon H	Hepatitis B therapy.	Nature reviews. Gastroenterology & hepatology	2011	71
21497551	L-Alanine	Yang HI	Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.	The Lancet. Oncology	2011	77
21505361	L-Alanine	Vajro P	Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease.	Journal of pediatric gastroenterology and nutrition	2011	52
21521847	L-Alanine	Lavine JE	Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.	JAMA	2011	172
21525259	L-Alanine	Azadbakht L	The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients.	The Journal of nutrition	2011	42
21538343	L-Alanine	Zhu AX	Phase 1/2 study of everolimus in advanced hepatocellular carcinoma.	Cancer	2011	55
21540183	L-Alanine	Gao Z	Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity.	The Journal of biological chemistry	2011	51
21602530	L-Alanine	Wong VW	Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.	Gut	2011	40
21608000	L-Alanine	Peng L	Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes.	Hepatology	2011	78
21688282	L-Alanine	Bhala N	The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.	Hepatology	2011	88
21741920	L-Alanine	Ahlenstiel G	Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.	Gastroenterology	2011	58
21783417	L-Alanine	Zhou C	Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study.	The Lancet. Oncology	2011	839
21826694	L-Alanine	Mandrekar P	An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice.	Hepatology	2011	68
21846782	L-Alanine	Wong VW	Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.	Gut	2012	68
21971536	L-Alanine	Rizzo L	Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.	The American journal of gastroenterology	2011	40
21985374	L-Alanine	Tang Y	Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.	Clinical and experimental immunology	2011	47
21987488	L-Alanine	Bambha K	Ethnicity and nonalcoholic fatty liver disease.	Hepatology	2012	40
22023985	L-Alanine	Parker HM	Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis.	Journal of hepatology	2012	83
22055504	L-Alanine	Timmers S	Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.	Cell metabolism	2011	236
22066022	L-Alanine	Bihrer V	Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.	PloS one	2011	48
22183689	L-Alanine	Lomonaco R	Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.	Hepatology	2012	56
22266604	L-Alanine	Antoine DJ	Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity.	Journal of hepatology	2012	116
22271511	L-Alanine	Kim D	Nonalcoholic fatty liver disease is associated with coronary artery calcification.	Hepatology	2012	59
22328022	L-Alanine	Eguchi Y	Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.	Journal of gastroenterology	2012	38
22362824	L-Alanine	van der Lely AJ	Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY.	The Journal of clinical endocrinology and metabolism	2012	35
22414768	L-Alanine	Keating SE	Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis.	Journal of hepatology	2012	53
22473858	L-Alanine	Lampertico P	IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B.	Hepatology	2013	27
22537612	L-Alanine	Kornek M	Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.	Gastroenterology	2012	33
22546742	L-Alanine	Karlsson CL	The microbiota of the gut in preschool children with normal and excessive body weight.	Obesity	2012	73
22707395	L-Alanine	Bedossa P	Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.	Hepatology	2012	55
22894884	L-Alanine	Di Giacomo AM	Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.	The Lancet. Oncology	2012	53
22941922	L-Alanine	Tseng TC	Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.	Hepatology	2013	39
22993296	L-Alanine	Pollock NR	A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing.	Science translational medicine	2012	43
23032418	L-Alanine	Thio CL	Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort.	AIDS	2013	29
23060426	L-Alanine	Stein EA	Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.	Circulation	2012	42
23197664	L-Alanine	Shi M	Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients.	Stem cells translational medicine	2012	38
23273292	L-Alanine	Metra M	Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.	Journal of the American College of Cardiology	2013	63
23355498	L-Alanine	Loomba R	Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.	American journal of epidemiology	2013	28
23390034	L-Alanine	Antoine DJ	Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.	Hepatology	2013	96
23416328	L-Alanine	Hernaez R	Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.	Clinical gastroenterology and hepatology 	2013	30
23444397	L-Alanine	HPS2-THRIVE Collaborative Group.	HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.	European heart journal	2013	104
23463346	L-Alanine	Beyoğlu D	Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification.	Hepatology	2013	46
23535911	L-Alanine	Kitamoto T	Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.	Human genetics	2013	39
23564522	L-Alanine	Asahina Y	α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C.	Hepatology	2013	40
23592832	L-Alanine	Holmberg SD	Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.	Clinical infectious diseases 	2013	30
23696515	L-Alanine	Noureddin M	Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.	Hepatology	2013	65
23703931	L-Alanine	Noureddin M	Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis.	Hepatology	2013	36
23715754	L-Alanine	Cariou B	Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects.	Diabetes care	2013	30
23718573	L-Alanine	Hoofnagle JH	Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.	Alimentary pharmacology & therapeutics	2013	29
23727264	L-Alanine	Mudaliar S	Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.	Gastroenterology	2013	102
23732714	L-Alanine	Chou R	Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review.	Annals of internal medicine	2013	43
23763360	L-Alanine	Verma S	Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).	Liver international 	2013	34
23824655	L-Alanine	Fall T	The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis.	PLoS medicine	2013	53
23928932	L-Alanine	Venkatesh SK	Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B.	European radiology	2014	35
23991091	L-Alanine	Miller AM	MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice.	PloS one	2013	35
24090188	L-Alanine	Rao H	Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection.	Journal of gastroenterology and hepatology	2014	24
24102757	L-Alanine	Saab S	Impact of coffee on liver diseases: a systematic review.	Liver international 	2014	22
24107395	L-Alanine	Gordon SC	Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.	Clinical gastroenterology and hepatology 	2014	29
24123097	L-Alanine	Wong GL	On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.	Hepatology	2014	26
24184132	L-Alanine	Everson GT	Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection.	Gastroenterology	2014	42
24262277	L-Alanine	Yin H	Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.	Gastroenterology	2014	40
24290406	L-Alanine	Bateman DN	Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial.	Lancet	2014	21
24316260	L-Alanine	Lambert JE	Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.	Gastroenterology	2014	78
24401715	L-Alanine	Eslamparast T	Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study.	The American journal of clinical nutrition	2014	37
24436062	L-Alanine	Konerman MA	Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.	Hepatology	2014	23
24462733	L-Alanine	El-Serag HB	A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.	Gastroenterology	2014	34
24477042	L-Alanine	Lin YC	Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.	The American journal of clinical nutrition	2014	22
24569542	L-Alanine	Chiu S	Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials.	European journal of clinical nutrition	2014	34
24582567	L-Alanine	Chachay VS	Resveratrol does not benefit patients with nonalcoholic fatty liver disease.	Clinical gastroenterology and hepatology 	2014	36
24681128	L-Alanine	Fontana RJ	Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.	Gastroenterology	2014	26
24704526	L-Alanine	Robles-Diaz M	Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.	Gastroenterology	2014	24
24738701	L-Alanine	Alisi A	Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis.	Alimentary pharmacology & therapeutics	2014	38
24893048	L-Alanine	Shi Y	MR elastography for the assessment of hepatic fibrosis in patients with chronic hepatitis B infection: does histologic necroinflammation influence the measurement of hepatic stiffness?	Radiology	2014	20
24973316	L-Alanine	Pirola CJ	Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.	Gut	2015	68
25019921	L-Alanine	Weiß J	Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment.	Deutsches Arzteblatt international	2014	22
25042054	L-Alanine	Yamasaki K	Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.	Hepatology	2014	24
25092309	L-Alanine	Ward J	Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis.	Proceedings of the National Academy of Sciences of the United States of America	2014	42
25099546	L-Alanine	Chung M	Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.	The American journal of clinical nutrition	2014	30
25145475	L-Alanine	Maximos M	The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.	Hepatology	2015	20
25251399	L-Alanine	Dongiovanni P	Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease.	Hepatology	2015	52
25306266	L-Alanine	Nabavi S	Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease.	Journal of dairy science	2014	21
25311610	L-Alanine	Faghihzadeh F	Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.	Nutrition research	2014	30
25468160	L-Alanine	Neuschwander-Tetri BA	Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.	Lancet	2015	205
25482832	L-Alanine	Loomba R	Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial).	Hepatology	2015	51
25577300	L-Alanine	Chen S	Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.	Digestive and liver disease 	2015	23
25645567	L-Alanine	Blonde L	Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes.	Cardiovascular diabetology	2015	17
25721064	L-Alanine	Papadopoulos KP	Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor.	Cancer chemotherapy and pharmacology	2015	19
25776943	L-Alanine	Guo K	Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals.	Obesity	2015	18
25873639	L-Alanine	Kwok R	Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.	Gut	2016	18
25893821	L-Alanine	Grandone A	TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children.	Pediatric obesity	2016	11
25981818	L-Alanine	Li J	Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial.	The Lancet. Oncology	2015	57
26055949	L-Alanine	Ma J	Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts.	Journal of hepatology	2015	28
26171685	L-Alanine	Koehler EM	Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study.	Hepatology	2016	15
26234526	L-Alanine	Faghihzadeh F	The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.	The British journal of nutrition	2015	19
26352813	L-Alanine	Burton BK	A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.	The New England journal of medicine	2015	19
26409216	L-Alanine	Liang HW	Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122.	Journal of hepatology	2016	13
26457389	L-Alanine	Goffredo M	Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study.	Hepatology	2016	14
26512983	L-Alanine	Anderson EL	The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis.	PloS one	2015	34
26547499	L-Alanine	Wilder JM	Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.	Hepatology	2016	14
26632633	L-Alanine	Verma VK	Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles.	Journal of hepatology	2016	26
26650570	L-Alanine	Wilson CG	Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.	Endocrinology	2016	17
26667191	L-Alanine	Ballestri S	Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.	Journal of gastroenterology and hepatology	2016	33
26677985	L-Alanine	Imajo K	Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.	Gastroenterology	2016	30
26714945	L-Alanine	Sun JJ	Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion.	Annals of surgical oncology	2016	15
26858343	L-Alanine	Wieser V	Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors.	Gut	2017	9
27002799	L-Alanine	Nelson JE	Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?	The American journal of gastroenterology	2016	15
27075625	L-Alanine	Wang H	NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis.	Science translational medicine	2016	21
27151177	L-Alanine	Cui J	Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.	Journal of hepatology	2016	15
27296321	L-Alanine	Bracaglia C	Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.	Annals of the rheumatic diseases	2017	9
27725647	L-Alanine	McPherson S	Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.	The American journal of gastroenterology	2017	8
27995906	L-Alanine	Kwo PY	ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.	The American journal of gastroenterology	2017	8
28183444	L-Alanine	Katsagoni CN	Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis.	Metabolism	2017	10
28958502	L-Alanine	Wu YL	Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial.	The Lancet. Oncology	2017	10
9770465	Rifampin	Bertilsson G	Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.	Proceedings of the National Academy of Sciences of the United States of America	1998	138
10331074	Rifampin	Guengerich FP	Cytochrome P-450 3A4: regulation and role in drug metabolism.	Annual review of pharmacology and toxicology	1999	171
10628745	Rifampin	Jones SA	The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution.	Molecular endocrinology	2000	111
15331414	Rifampin	Tateno C	Near completely humanized liver in mice shows human-type metabolic responses to drugs.	The American journal of pathology	2004	85
20406852	Rifampin	Leonhardt M	Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters.	Drug metabolism and disposition	2010	41
25808545	Rifampin	Avior Y	Microbial-derived lithocholic acid and vitamin K2 drive the metabolic maturation of pluripotent stem cells-derived and fetal hepatocytes.	Hepatology	2015	16
19817501	Dextromethorphan	Zhou SF	Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.	Clinical pharmacokinetics	2009	84
23985325	Dextromethorphan	Wang D	Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity.	Human molecular genetics	2014	26
11266382	Palmitic acid	Sanyal AJ	Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.	Gastroenterology	2001	336
14676196	Palmitic acid	Schoch GA	Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site.	The Journal of biological chemistry	2004	74
19207680	Palmitic acid	Ricchi M	Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.	Journal of gastroenterology and hepatology	2009	83
21042596	Palmitic acid	Bertola A	Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients.	PloS one	2010	53
22408252	Palmitic acid	Tan SH	Induction of autophagy by palmitic acid via protein kinase C-mediated signaling pathway independent of mTOR (mammalian target of rapamycin).	The Journal of biological chemistry	2012	47
22753171	Palmitic acid	Matsuzaka T	Elovl6 promotes nonalcoholic steatohepatitis.	Hepatology	2012	37
22952180	Palmitic acid	Sevastianova K	Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans.	The American journal of clinical nutrition	2012	40
24297848	Palmitic acid	Kurdiova T	Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.	The Journal of physiology	2014	50
24670599	Palmitic acid	Pirazzi C	PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells.	Human molecular genetics	2014	43
24947355	Palmitic acid	Tubbs E	Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance.	Diabetes	2014	36
26764184	Palmitic acid	Hirsova P	Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.	Gastroenterology	2016	31
27637015	Palmitic acid	Tanaka S	Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.	Hepatology	2016	11
28323973	Palmitic acid	Søndergaard E	How to Measure Adipose Tissue Insulin Sensitivity.	The Journal of clinical endocrinology and metabolism	2017	5
17318265	Liothyronine	Trajkovic M	Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8.	The Journal of clinical investigation	2007	68
24692351	Liothyronine	Mullur R	Thyroid hormone regulation of metabolism.	Physiological reviews	2014	99
9747868	17a-Ethynylestradiol	Fisher B	Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.	Journal of the National Cancer Institute	1998	717
18974155	17a-Ethynylestradiol	Studebaker AW	Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner.	Cancer research	2008	70
19027010	17a-Ethynylestradiol	Liu WH	MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.	Gastroenterology	2009	65
19318219	17a-Ethynylestradiol	Geer EB	Gender differences in insulin resistance, body composition, and energy balance.	Gender medicine	2009	122
19421758	17a-Ethynylestradiol	Fang YJ	Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.	International journal of colorectal disease	2009	47
20219941	17a-Ethynylestradiol	Schmidt D	A CTCF-independent role for cohesin in tissue-specific transcription.	Genome research	2010	159
20484465	17a-Ethynylestradiol	Fu Z	Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice.	Endocrinology	2010	42
21212030	17a-Ethynylestradiol	Rønneberg JA	Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer.	Molecular oncology	2011	52
22108298	17a-Ethynylestradiol	Piotrowska H	Biological activity of piceatannol: leaving the shadow of resveratrol.	Mutation research	2012	48
22829776	17a-Ethynylestradiol	Coviello AD	A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation.	PLoS genetics	2012	35
23303913	17a-Ethynylestradiol	Tchernof A	Pathophysiology of human visceral obesity: an update.	Physiological reviews	2013	249
23569315	17a-Ethynylestradiol	Rimawi MF	Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006.	Journal of clinical oncology 	2013	45
24217577	17a-Ethynylestradiol	Merenbakh-Lamin K	D538G mutation in estrogen receptor-α: A novel mechanism for acquired endocrine resistance in breast cancer.	Cancer research	2013	70
24258260	17a-Ethynylestradiol	Sørensen KP	Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer.	Breast cancer research and treatment	2013	66
24288332	17a-Ethynylestradiol	Nelson ER	27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology.	Science	2013	122
24373287	17a-Ethynylestradiol	Serandour AA	Development of an Illumina-based ChIP-exonuclease method provides insight into FoxA1-DNA binding properties.	Genome biology	2013	25
24975878	17a-Ethynylestradiol	Li CL	Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma.	International journal of cancer	2015	15
25009010	17a-Ethynylestradiol	De Mattos-Arruda L	Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.	Annals of oncology 	2014	63
26261103	17a-Ethynylestradiol	Chu D	ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients.	Clinical cancer research 	2016	32
26286584	17a-Ethynylestradiol	Strong AL	Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers.	Breast cancer research 	2015	20
26311719	17a-Ethynylestradiol	Deng L	MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.	Circulation research	2015	26
26919573	17a-Ethynylestradiol	Klair JS	A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease.	Hepatology	2016	12
27939373	17a-Ethynylestradiol	Nault JC	Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.	Gastroenterology	2017	7
28585217	17a-Ethynylestradiol	Engin A	Obesity-associated Breast Cancer: Analysis of risk factors.	Advances in experimental medicine and biology	2017	7
18024863	Platinum	Burger RA	Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.	Journal of clinical oncology 	2007	198
20022809	Platinum	Mitsudomi T	Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.	The Lancet. Oncology	2010	870
21468130	Platinum	Forster MD	Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer.	Nature reviews. Clinical oncology	2011	42
23724913	Platinum	Shaw AT	Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.	The New England journal of medicine	2013	697
24035405	Platinum	Calabrò L	Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial.	The Lancet. Oncology	2013	48
25225436	Platinum	du Bois A	Incorporation of pazopanib in maintenance therapy of ovarian cancer.	Journal of clinical oncology 	2014	46
27932068	Platinum	Rudin CM	Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.	The Lancet. Oncology	2017	23
11687800	Thymidine	Mandel H	The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA.	Nature genetics	2001	97
15763604	Thymidine	Walko CM	Capecitabine: a review.	Clinical therapeutics	2005	77
16905462	Thymidine	Kim JH	Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF.	Molecular therapy 	2006	86
18523066	Thymidine	Bading JR	Imaging of cell proliferation: status and prospects.	Journal of nuclear medicine 	2008	63
3056758	D-Fructose	Reaven GM	Banting lecture 1988. Role of insulin resistance in human disease.	Diabetes	1988	1244
11780753	D-Fructose	Joost HG	The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review).	Molecular membrane biology	2001	99
12021254	D-Fructose	Hajri T	Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice.	The Journal of clinical investigation	2002	87
15181085	D-Fructose	Teff KL	Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women.	The Journal of clinical endocrinology and metabolism	2004	146
15723702	D-Fructose	Basciano H	Fructose, insulin resistance, and metabolic dyslipidemia.	Nutrition & metabolism	2005	138
17684197	D-Fructose	Zivkovic AM	Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease.	The American journal of clinical nutrition	2007	82
18327257	D-Fructose	Vitart V	SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.	Nature genetics	2008	191
18641190	D-Fructose	Thuy S	Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.	The Journal of nutrition	2008	81
19254570	D-Fructose	Nagai Y	The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance.	Cell metabolism	2009	60
19381015	D-Fructose	Stanhope KL	Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.	The Journal of clinical investigation	2009	324
20029377	D-Fructose	Perez-Pozo SE	Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response.	International journal of obesity	2010	60
20048381	D-Fructose	Dong B	Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters.	Journal of lipid research	2010	48
21389266	D-Fructose	Wu M	Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2011	44
21875310	D-Fructose	Smith BW	Non-alcoholic fatty liver disease.	Critical reviews in clinical laboratory sciences	2011	65
21957486	D-Fructose	Sharma S	GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy.	PloS one	2011	47
22585902	D-Fructose	Moore MC	Regulation of hepatic glucose uptake and storage in vivo.	Advances in nutrition	2012	58
24550457	D-Fructose	Kratzer JT	Evolutionary history and metabolic insights of ancient mammalian uricases.	Proceedings of the National Academy of Sciences of the United States of America	2014	38
24652725	D-Fructose	Bray GA	Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: health be damned! Pour on the sugar.	Diabetes care	2014	62
25685689	D-Fructose	Dushay JR	Fructose ingestion acutely stimulates circulating FGF21 levels in humans.	Molecular metabolism	2015	40
25888330	D-Fructose	Bettaieb A	Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.	Gastroenterology	2015	18
27387598	D-Fructose	Herman MA	The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis.	Trends in endocrinology and metabolism	2016	17
27669460	D-Fructose	Kim MS	ChREBP regulates fructose-induced glucose production independently of insulin signaling.	The Journal of clinical investigation	2016	22
28123933	D-Fructose	Fisher FM	A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.	Molecular metabolism	2017	17
28214020	D-Fructose	Mosca A	Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents.	Journal of hepatology	2017	11
1532777	L-Tyrosine	DeFronzo RA	Pathogenesis of NIDDM. A balanced overview.	Diabetes care	1992	218
1846706	L-Tyrosine	Bottaro DP	Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.	Science	1991	382
1922387	L-Tyrosine	Pulverer BJ	Phosphorylation of c-jun mediated by MAP kinases.	Nature	1991	298
9083067	L-Tyrosine	Kreppel LK	Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats.	The Journal of biological chemistry	1997	190
9988270	L-Tyrosine	Irby RB	Activating SRC mutation in a subset of advanced human colon cancers.	Nature genetics	1999	111
10395191	L-Tyrosine	Hotamisligil GS	The role of TNFalpha and TNF receptors in obesity and insulin resistance.	Journal of internal medicine	1999	97
11297536	L-Tyrosine	Mahadev K	Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade.	The Journal of biological chemistry	2001	119
11743208	L-Tyrosine	Bouchard MJ	Calcium signaling by HBx protein in hepatitis B virus DNA replication.	Science	2001	102
11756186	L-Tyrosine	Kelly LM	FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model.	Blood	2002	101
12045255	L-Tyrosine	Nguyen G	Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin.	The Journal of clinical investigation	2002	273
12686563	L-Tyrosine	Lai J	Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.	The Journal of biological chemistry	2003	90
12773095	L-Tyrosine	Heinrich PC	Principles of interleukin (IL)-6-type cytokine signalling and its regulation.	The Biochemical journal	2003	627
14517187	L-Tyrosine	Morgan B	Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies.	Journal of clinical oncology 	2003	105
14988838	L-Tyrosine	Shintani Y	Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.	Gastroenterology	2004	133
15054042	L-Tyrosine	Rombouts EJ	Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia.	Blood	2004	72
15082519	L-Tyrosine	Watson RT	Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes.	Endocrine reviews	2004	91
15520383	L-Tyrosine	Zhang EE	Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism.	Proceedings of the National Academy of Sciences of the United States of America	2004	99
15749926	L-Tyrosine	Xu C	Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium.	Stem cells	2005	76
15830281	L-Tyrosine	Llovet JM	Updated treatment approach to hepatocellular carcinoma.	Journal of gastroenterology	2005	129
15918149	L-Tyrosine	Roberts LR	Hepatocellular carcinoma: molecular pathways and new therapeutic targets.	Seminars in liver disease	2005	67
16039586	L-Tyrosine	Ding Q	Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.	Molecular cell	2005	184
16122278	L-Tyrosine	Peng B	Clinical pharmacokinetics of imatinib.	Clinical pharmacokinetics	2005	69
16170173	L-Tyrosine	Philip PA	Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer.	Journal of clinical oncology 	2005	95
16186396	L-Tyrosine	Plomgaard P	Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.	Diabetes	2005	96
16317688	L-Tyrosine	Aleffi S	Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells.	Hepatology	2005	77
16908937	L-Tyrosine	Abou-Alfa GK	Phase II study of sorafenib in patients with advanced hepatocellular carcinoma.	Journal of clinical oncology 	2006	269
17178882	L-Tyrosine	Liu L	Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.	Cancer research	2006	298
17295177	L-Tyrosine	Villanueva A	Genomics and signaling pathways in hepatocellular carcinoma.	Seminars in liver disease	2007	156
17435539	L-Tyrosine	DeMatteo RP	Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor.	Annals of surgery	2007	61
17517630	L-Tyrosine	Qian X	Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.	Proceedings of the National Academy of Sciences of the United States of America	2007	56
17623837	L-Tyrosine	Thomas MB	Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma.	Cancer	2007	71
17709744	L-Tyrosine	Tremblay F	Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2007	133
17785413	L-Tyrosine	Tward AD	Distinct pathways of genomic progression to benign and malignant tumors of the liver.	Proceedings of the National Academy of Sciences of the United States of America	2007	71
18224294	L-Tyrosine	Bessette DC	PRL PTPs: mediators and markers of cancer progression.	Cancer metastasis reviews	2008	63
18281274	L-Tyrosine	Zabolotny JM	Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.	The Journal of biological chemistry	2008	91
18395971	L-Tyrosine	Zeng ZS	c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases.	Cancer letters	2008	55
18483217	L-Tyrosine	Andrae J	Role of platelet-derived growth factors in physiology and medicine.	Genes & development	2008	482
18620091	L-Tyrosine	Wagh PK	Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.	Advances in cancer research	2008	58
18823985	L-Tyrosine	Taura K	Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.	Gastroenterology	2008	67
18829493	L-Tyrosine	Huynh H	Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.	Clinical cancer research 	2008	59
19318488	L-Tyrosine	Eder JP	Novel therapeutic inhibitors of the c-Met signaling pathway in cancer.	Clinical cancer research 	2009	143
19470923	L-Tyrosine	Zhu AX	Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study.	Journal of clinical oncology 	2009	143
19501581	L-Tyrosine	Meshkani R	Hepatic insulin resistance, metabolic syndrome and cardiovascular disease.	Clinical biochemistry	2009	68
20124232	L-Tyrosine	Rosenbloom J	Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies.	Annals of internal medicine	2010	70
20145120	L-Tyrosine	Holland SJ	R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.	Cancer research	2010	121
20371362	L-Tyrosine	Huynh H	Molecularly targeted therapy in hepatocellular carcinoma.	Biochemical pharmacology	2010	40
20551596	L-Tyrosine	Nakamura T	The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine.	Proceedings of the Japan Academy. Series B, Physical and biological sciences	2010	73
20799954	L-Tyrosine	Shen Q	Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.	Molecular cancer	2010	55
20940188	L-Tyrosine	Sequist LV	Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancer.	Journal of clinical oncology 	2010	101
21199531	L-Tyrosine	Nakamura T	Hepatocyte growth factor twenty years on: Much more than a growth factor.	Journal of gastroenterology and hepatology	2011	90
21205925	L-Tyrosine	Chen KF	Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells.	The Journal of pharmacology and experimental therapeutics	2011	69
21220499	L-Tyrosine	Nagai T	Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma.	Molecular cancer therapeutics	2011	39
21253578	L-Tyrosine	Gu TL	Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma.	PloS one	2011	96
21317930	L-Tyrosine	Mudduluru G	Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer.	Oncogene	2011	75
21354226	L-Tyrosine	Tai WT	Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma.	Journal of hepatology	2011	46
21519015	L-Tyrosine	O'Neil BH	Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma.	Journal of clinical oncology 	2011	38
21690253	L-Tyrosine	Pilati C	Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas.	The Journal of experimental medicine	2011	64
21752724	L-Tyrosine	Chu E	An update on the current and emerging targeted agents in metastatic colorectal cancer.	Clinical colorectal cancer	2012	39
22059152	L-Tyrosine	Guo D	An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.	Cancer discovery	2011	70
22144665	L-Tyrosine	Ying W	Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy.	Molecular cancer therapeutics	2012	64
22170610	L-Tyrosine	Png KJ	A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.	Nature	2011	151
22178589	L-Tyrosine	Andersen JB	Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.	Gastroenterology	2012	86
22180308	L-Tyrosine	Tai WT	Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3.	Molecular cancer therapeutics	2012	36
22257673	L-Tyrosine	Baselga J	Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.	Lancet	2012	236
22282022	L-Tyrosine	Doebele RC	Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.	Cancer	2012	55
22322096	L-Tyrosine	Stokes MP	PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS.	Molecular & cellular proteomics 	2012	35
22535374	L-Tyrosine	De Boeck A	Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling.	Gut	2013	37
22641068	L-Tyrosine	Buurman R	Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.	Gastroenterology	2012	52
22738912	L-Tyrosine	Yaqoob U	Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment.	Cancer research	2012	36
22833179	L-Tyrosine	Toh HC	Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma.	Cancer	2013	26
22949154	L-Tyrosine	Cortes JE	Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.	Journal of clinical oncology 	2012	69
22966038	L-Tyrosine	Liby KT	Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.	Pharmacological reviews	2012	75
22996189	L-Tyrosine	Chen J	Hepatitis B virus polymerase impairs interferon-α-induced STA T activation through inhibition of importin-α5 and protein kinase C-δ.	Hepatology	2013	32
22996586	L-Tyrosine	Yan Y	MicroRNA-10a is involved in the metastatic process by regulating Eph tyrosine kinase receptor A4-mediated epithelial-mesenchymal transition and adhesion in hepatoma cells.	Hepatology	2013	42
23045285	L-Tyrosine	Gusenbauer S	HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors.	Oncogene	2013	37
23318457	L-Tyrosine	Sia D	Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies.	Oncogene	2013	49
23362324	L-Tyrosine	Zhu AX	Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study.	Clinical cancer research 	2013	25
23388504	L-Tyrosine	Goyal L	Targeting the HGF/c-MET pathway in hepatocellular carcinoma.	Clinical cancer research 	2013	57
23407558	L-Tyrosine	Yu HA	Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors.	Journal of thoracic oncology 	2013	57
23908138	L-Tyrosine	Tai WT	Discovery of novel Src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma.	Hepatology	2014	24
24045150	L-Tyrosine	Giordano S	Met as a therapeutic target in HCC: facts and hopes.	Journal of hepatology	2014	29
24122810	L-Tyrosine	Arai Y	Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.	Hepatology	2014	45
24233839	L-Tyrosine	Lee HJ	Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma.	Carcinogenesis	2014	21
24323901	L-Tyrosine	Touil Y	Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.	Clinical cancer research 	2014	40
24384534	L-Tyrosine	Maroun CR	The Met receptor tyrosine kinase: a key player in oncogenesis and drug resistance.	Pharmacology & therapeutics	2014	39
24384849	L-Tyrosine	Corless CL	Gastrointestinal stromal tumors: what do we know now?	Modern pathology 	2014	25
24503127	L-Tyrosine	Gao Q	Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.	Gastroenterology	2014	26
24510746	L-Tyrosine	Scartozzi M	VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.	International journal of cancer	2014	22
24563076	L-Tyrosine	Ross JS	New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.	The oncologist	2014	61
24632616	L-Tyrosine	Hardy S	The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis.	Oncogene	2015	19
24837095	L-Tyrosine	Graham RP	Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma.	Human pathology	2014	28
24867389	L-Tyrosine	Simbolo M	Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.	Oncotarget	2014	33
25193986	L-Tyrosine	Zhang JX	MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.	Annals of oncology 	2014	22
25220640	L-Tyrosine	He RJ	Protein tyrosine phosphatases as potential therapeutic targets.	Acta pharmacologica Sinica	2014	30
25251599	L-Tyrosine	Reichl P	Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma.	Hepatology	2015	26
25369307	L-Tyrosine	Rizvi S	Cholangiocarcinoma: molecular pathways and therapeutic opportunities.	Seminars in liver disease	2014	31
25479139	L-Tyrosine	Bernsmeier C	Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.	Gastroenterology	2015	17
25865556	L-Tyrosine	Han T	PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.	Journal of hepatology	2015	19
26416732	L-Tyrosine	Bertotti A	The genomic landscape of response to EGFR blockade in colorectal cancer.	Nature	2015	65
26563355	L-Tyrosine	Sartore-Bianchi A	Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.	Journal of the National Cancer Institute	2016	13
26655421	L-Tyrosine	Chanan-Khan A	Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.	The Lancet. Oncology	2016	28
26698910	L-Tyrosine	Shaw AT	Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.	The New England journal of medicine	2016	62
26724471	L-Tyrosine	Lin JJ	Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.	Journal of thoracic oncology 	2016	24
26969090	L-Tyrosine	Haas NB	Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.	Lancet	2016	41
27002617	L-Tyrosine	Wang Y	Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma.	Tumour biology 	2016	14
27083334	L-Tyrosine	Park K	Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial.	The Lancet. Oncology	2016	78
27245147	L-Tyrosine	Katoh M	FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).	International journal of molecular medicine	2016	14
27527746	L-Tyrosine	Feldman A	Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.	The American journal of gastroenterology	2017	11
27613527	L-Tyrosine	Yu HA	A Phase 1/2 Trial of Ruxolitinib and Erlotinib in Patients with EGFR-Mutant Lung Adenocarcinomas with Acquired Resistance to Erlotinib.	Journal of thoracic oncology 	2017	5
27637985	L-Tyrosine	O'Brien S	Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study.	The Lancet. Oncology	2016	14
28271729	L-Tyrosine	Ahn MJ	EGFR TKI combination with immunotherapy in non-small cell lung cancer.	Expert opinion on drug safety	2017	10
16061184	L-Lysine	Vakoc CR	Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin.	Molecular cell	2005	244
18787082	L-Lysine	Robertson AG	Genome-wide relationship between histone H3 lysine 4 mono- and tri-methylation and transcription factor binding.	Genome research	2008	88
20571512	L-Lysine	Wilting RH	Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis.	The EMBO journal	2010	65
21512140	L-Lysine	Cheng AS	EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.	Cancer research	2011	61
21753189	L-Lysine	Mishima Y	The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.	Blood	2011	39
22370893	L-Lysine	Au SL	Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.	Hepatology	2012	73
22824796	L-Lysine	Wang P	Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.	Oncogene	2013	81
22921934	L-Lysine	Stender JD	Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20.	Molecular cell	2012	48
24133372	L-Lysine	Yuan H	The emerging and diverse roles of sirtuins in cancer: a clinical perspective.	OncoTargets and therapy	2013	49
24165275	L-Lysine	Zhang J	Long non-coding RNA HOTAIR in carcinogenesis and metastasis.	Acta biochimica et biophysica Sinica	2014	42
24315375	L-Lysine	Rardin MJ	SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks.	Cell metabolism	2013	102
24844570	L-Lysine	Chiba T	Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.	International journal of cancer	2015	16
25200183	L-Lysine	Ryu D	A SIRT7-dependent acetylation switch of GABPβ1 controls mitochondrial function.	Cell metabolism	2014	40
25457206	L-Lysine	Page A	Alcohol directly stimulates epigenetic modifications in hepatic stellate cells.	Journal of hepatology	2015	16
25603177	L-Lysine	Hu Y	BRD4 inhibitor inhibits colorectal cancer growth and metastasis.	International journal of molecular sciences	2015	15
26031919	L-Lysine	Cui S	The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice.	Blood	2015	17
26172293	L-Lysine	Li H	LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2.	Oncotarget	2015	30
26376677	L-Lysine	Li H	miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.	Oncotarget	2015	18
9794114	N-Acetylneuraminic acid	Pickup JC	Is type II diabetes mellitus a disease of the innate immune system?	Diabetologia	1998	161
11133773	N-Acetylneuraminic acid	Hartnell A	Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations.	Blood	2001	86
23623390	N-Acetylneuraminic acid	Chen Y	Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome.	Lancet	2013	246
12739169	Pyruvic acid	Halestrap AP	The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.	Pflugers Archiv 	2004	170
16885160	Pyruvic acid	Ma L	ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver.	The Journal of biological chemistry	2006	119
17132539	Pyruvic acid	Sugden MC	Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases.	Archives of physiology and biochemistry	2006	65
17283074	Pyruvic acid	Hsu SC	Characterization of a novel tripartite nuclear localization sequence in the EGFR family.	The Journal of biological chemistry	2007	91
18098322	Pyruvic acid	Gershwin ME	The causes of primary biliary cirrhosis: Convenient and inconvenient truths.	Hepatology	2008	90
19185000	Pyruvic acid	Lleo A	Apotopes and the biliary specificity of primary biliary cirrhosis.	Hepatology	2009	61
19553674	Pyruvic acid	Noland RC	Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control.	The Journal of biological chemistry	2009	93
21789790	Pyruvic acid	Bluemlein K	No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis.	Oncotarget	2011	72
24361892	Pyruvic acid	Cheng P	Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.	Biochemical and biophysical research communications	2014	20
25043065	Pyruvic acid	Zhang J	Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis.	Hepatology	2014	23
25514599	Pyruvic acid	Liu WR	PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.	Oncotarget	2015	16
25576919	Pyruvic acid	Chen Z	Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.	Oncotarget	2015	19
25662011	Pyruvic acid	Perry RJ	Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes.	Cell	2015	96
26365179	Pyruvic acid	Dupuy F	PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.	Cell metabolism	2015	51
26727229	Pyruvic acid	Samuel VT	The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.	The Journal of clinical investigation	2016	78
26745603	Pyruvic acid	Tang R	MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.	Oncotarget	2016	17
11984517	Ribavirin	Poynard T	Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.	Gastroenterology	2002	161
15765399	Ribavirin	Romero-Gómez M	Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.	Gastroenterology	2005	124
15887125	Ribavirin	Chen L	Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection.	Gastroenterology	2005	146
16107837	Ribavirin	Feld JJ	Mechanism of action of interferon and ribavirin in treatment of hepatitis C.	Nature	2005	240
16136646	Ribavirin	Di Bisceglie AM	Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.	Journal of hepatology	2005	75
16299039	Ribavirin	Walsh MJ	Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1.	Gut	2006	65
16960776	Ribavirin	Romero AI	Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.	The Journal of infectious diseases	2006	65
17087946	Ribavirin	Marcello T	Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.	Gastroenterology	2006	196
18046027	Ribavirin	McHutchison JG	Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.	The New England journal of medicine	2007	71
18467494	Ribavirin	Sarasin-Filipowicz M	Interferon signaling and treatment outcome in chronic hepatitis C.	Proceedings of the National Academy of Sciences of the United States of America	2008	229
19749758	Ribavirin	Suppiah V	IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.	Nature genetics	2009	536
19900446	Ribavirin	Chen L	Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection.	Gastroenterology	2010	43
19933795	Ribavirin	Hopkins S	SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro.	Antimicrobial agents and chemotherapy	2010	43
20162613	Ribavirin	Petta S	Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.	Hepatology	2010	101
20389235	Ribavirin	Rallón NI	Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.	AIDS	2010	54
20434452	Ribavirin	Honda M	Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.	Gastroenterology	2010	138
20621700	Ribavirin	Mangia A	An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.	Gastroenterology	2010	87
20708617	Ribavirin	Fukuhara T	Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.	Gastroenterology	2010	55
20931559	Ribavirin	Urban TJ	IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.	Hepatology	2010	129
21111740	Ribavirin	Dill MT	Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.	Gastroenterology	2011	95
21254157	Ribavirin	Yu ML	Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients.	Hepatology	2011	63
21468124	Ribavirin	Hofmann WP	A new standard of care for the treatment of chronic HCV infection.	Nature reviews. Gastroenterology & hepatology	2011	53
21480323	Ribavirin	Makowska Z	Interferon-β and interferon-λ signaling is not affected by interferon-induced refractoriness to interferon-α in vivo.	Hepatology	2011	36
21931540	Ribavirin	Suppiah V	IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.	PLoS medicine	2011	43
21951981	Ribavirin	Asselah T	IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.	Journal of hepatology	2012	35
22212565	Ribavirin	European Association of the Study of the Liver.	2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines.	Liver international 	2012	36
22351713	Ribavirin	Liu S	New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis.	Annals of internal medicine	2012	53
22869577	Ribavirin	McPhee F	Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032).	Antimicrobial agents and chemotherapy	2012	38
22878466	Ribavirin	Schaefer M	Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement.	Journal of hepatology	2012	38
23063572	Ribavirin	Heim MH	Innate immunity and HCV.	Journal of hepatology	2013	33
23323209	Ribavirin	Kuno A	A serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis.	Scientific reports	2013	31
23669289	Ribavirin	Hézode C	Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.	Journal of hepatology	2013	102
23994384	Ribavirin	Coilly A	Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.	Journal of hepatology	2014	38
24269472	Ribavirin	Younossi ZM	Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients.	Journal of hepatology	2014	34
24444658	Ribavirin	Lok AS	Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders.	Journal of hepatology	2014	21
24983321	Ribavirin	Meissner EG	Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.	The Journal of clinical investigation	2014	37
25048716	Ribavirin	Rehermann B	Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.	Hepatology	2015	32
25080450	Ribavirin	Hézode C	Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study.	Gut	2015	23
25218783	Ribavirin	van der Ree MH	Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients.	Antiviral research	2014	29
25218788	Ribavirin	Gordon SC	Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.	Journal of hepatology	2015	23
25385103	Ribavirin	Ottosen S	In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122.	Antimicrobial agents and chemotherapy	2015	30
25443342	Ribavirin	Heim MH	Innate and adaptive immune responses in HCV infections.	Journal of hepatology	2014	32
25619871	Ribavirin	Younossi ZM	Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection.	Alimentary pharmacology & therapeutics	2015	23
25754160	Ribavirin	Serti E	Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.	Gastroenterology	2015	30
25820703	Ribavirin	Linas BP	The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.	Annals of internal medicine	2015	23
25909356	Ribavirin	Zeuzem S	Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial.	Annals of internal medicine	2015	75
25920094	Ribavirin	Pawlotsky JM	From non-A, non-B hepatitis to hepatitis C virus cure.	Journal of hepatology	2015	44
26033798	Ribavirin	Saxena V	Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis.	Hepatology	2015	18
26187031	Ribavirin	Kohli A	Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study.	The Lancet. Infectious diseases	2015	34
26319013	Ribavirin	Negro F	Extrahepatic morbidity and mortality of chronic hepatitis C.	Gastroenterology	2015	28
26476290	Ribavirin	Feld JJ	Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12weeks.	Journal of hepatology	2016	17
26733671	Ribavirin	Serti E	Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα.	Gut	2017	12
27085252	Ribavirin	Maasoumy B	Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens.	Journal of hepatology	2016	11
27296509	Ribavirin	Sarrazin C	Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir.	Gastroenterology	2016	22
17916356	LPS with O-antigen	Dolganiuc A	Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection.	Gastroenterology	2007	67
19721001	LPS with O-antigen	Lee JW	Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung.	Proceedings of the National Academy of Sciences of the United States of America	2009	178
20423716	LPS with O-antigen	Saito C	c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity.	Toxicology and applied pharmacology	2010	77
21940902	LPS with O-antigen	Bajaj JS	Linkage of gut microbiome with cognition in hepatic encephalopathy.	American journal of physiology. Gastrointestinal and liver physiology	2012	81
22427130	LPS with O-antigen	Volynets V	Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD).	Digestive diseases and sciences	2012	33
23160966	LPS with O-antigen	Piya MK	Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin.	The Journal of endocrinology	2013	45
21216939	Docetaxel	Carrasco RA	Antisense inhibition of survivin expression as a cancer therapeutic.	Molecular cancer therapeutics	2011	37
22454414	Docetaxel	Kelly WK	Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.	Journal of clinical oncology 	2012	143
22491949	Docetaxel	Hrkach J	Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.	Science translational medicine	2012	221
23200175	Docetaxel	Jänne PA	Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.	The Lancet. Oncology	2013	181
24276076	Docetaxel	Yin L	CYP17 inhibitors--abiraterone, C17,20-lyase inhibitors and multi-targeting agents.	Nature reviews. Urology	2014	23
24616308	Docetaxel	Goldkorn A	Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.	Journal of clinical oncology 	2014	50
27506431	Docetaxel	Yadav MP	177Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment.	European journal of nuclear medicine and molecular imaging	2017	9
12222994	Omeprazole	Desta Z	Clinical significance of the cytochrome P450 2C19 genetic polymorphism.	Clinical pharmacokinetics	2002	119
15258107	Omeprazole	Li XQ	Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.	Drug metabolism and disposition	2004	83
16413245	Omeprazole	Sim SC	A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.	Clinical pharmacology and therapeutics	2006	119
15930419	Warfarin	Rieder MJ	Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.	The New England journal of medicine	2005	278
17950801	Warfarin	Ezekowitz MD	Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).	The American journal of cardiology	2007	61
19297519	Warfarin	McDonald MG	CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.	Molecular pharmacology	2009	78
19966341	Warfarin	Schulman S	Dabigatran versus warfarin in the treatment of acute venous thromboembolism.	The New England journal of medicine	2009	257
20694273	Warfarin	Weitz JI	Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation.	Thrombosis and haemostasis	2010	50
21873708	Warfarin	Fox KA	Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.	European heart journal	2011	70
26890676	Warfarin	Veitch AM	Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines.	Endoscopy	2016	16
1672732	Aflatoxin B1	Bressac B	Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.	Nature	1991	196
1849234	Aflatoxin B1	Hsu IC	Mutational hotspot in the p53 gene in human hepatocellular carcinomas.	Nature	1991	209
1905840	Aflatoxin B1	Hollstein M	p53 mutations in human cancers.	Science	1991	1330
16799619	Aflatoxin B1	Laurent-Puig P	Genetics of hepatocellular tumors.	Oncogene	2006	84
25822088	Aflatoxin B1	Schulze K	Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.	Nature genetics	2015	142
8895578	Fenofibrate	Schoonjans K	PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.	The EMBO journal	1996	188
12746275	Fenofibrate	Lee CH	Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors.	Endocrinology	2003	157
15190076	Fenofibrate	Mandard S	The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment.	The Journal of biological chemistry	2004	79
19702724	Fenofibrate	Mraz M	Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.	Clinical endocrinology	2009	61
24428677	Fenofibrate	Sahebkar A	New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.	Expert opinion on pharmacotherapy	2014	26
25516156	Fenofibrate	Blednov YA	Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans.	Alcoholism, clinical and experimental research	2015	22
25970251	Fenofibrate	Lee HY	PPAR-α and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal.	Nature	2015	23
28043905	Fenofibrate	Nicoletti P	Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.	Gastroenterology	2017	10
1309946	Sodium	Gellens ME	Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel.	Proceedings of the National Academy of Sciences of the United States of America	1992	146
2181501	Sodium	Bergman EN	Energy contributions of volatile fatty acids from the gastrointestinal tract in various species.	Physiological reviews	1990	184
14699511	Sodium	Kullak-Ublick GA	Enterohepatic bile salt transporters in normal physiology and liver disease.	Gastroenterology	2004	88
15263023	Sodium	Kögler G	A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential.	The Journal of experimental medicine	2004	186
16537974	Sodium	Brand S	IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.	American journal of physiology. Gastrointestinal and liver physiology	2006	156
16697742	Sodium	Ho RH	Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.	Gastroenterology	2006	100
17105757	Sodium	Schrier RW	Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.	The New England journal of medicine	2006	167
20546255	Sodium	Gerich JE	Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.	Diabetic medicine 	2010	82
21358696	Sodium	Mather A	Glucose handling by the kidney.	Kidney international. Supplement	2011	42
21705062	Sodium	Tahrani AA	Management of type 2 diabetes: new and future developments in treatment.	Lancet	2011	74
21955459	Sodium	DeFronzo RA	The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia.	Diabetes, obesity & metabolism	2012	83
22238392	Sodium	Bolinder J	Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin.	The Journal of clinical endocrinology and metabolism	2012	109
24114175	Sodium	Pajor AM	Sodium-coupled dicarboxylate and citrate transporters from the SLC13 family.	Pflugers Archiv 	2014	24
24317697	Sodium	Zhou X	Structural basis of the alternating-access mechanism in a bile acid transporter.	Nature	2014	22
24375576	Sodium	Belcher JM	Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.	Hepatology	2014	37
24390325	Sodium	Yan H	Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.	Journal of virology	2014	35
25418280	Sodium	Peng L	The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B.	Hepatology	2015	17
25488697	Sodium	Scheen AJ	Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus.	Drugs	2015	31
25894829	Sodium	Bonner C	Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.	Nature medicine	2015	58
26167630	Sodium	Ogawa M	Directed differentiation of cholangiocytes from human pluripotent stem cells.	Nature biotechnology	2015	28
27358174	Sodium	Arab JP	Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.	Hepatology	2017	22
17158419	L-Lactic acid	Lê KA	A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans.	The American journal of clinical nutrition	2006	79
19286567	L-Lactic acid	Amann T	GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.	The American journal of pathology	2009	59
20086073	L-Lactic acid	Tappy L	Metabolic effects of fructose and the worldwide increase in obesity.	Physiological reviews	2010	200
21642515	L-Lactic acid	Pierga JY	High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients.	Annals of oncology 	2012	61
22885334	L-Lactic acid	Chen Y	Hedgehog controls hepatic stellate cell fate by regulating metabolism.	Gastroenterology	2012	42
24415562	L-Lactic acid	Affò S	CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis.	Gut	2014	29
24657625	L-Lactic acid	Hoque R	Lactate reduces liver and pancreatic injury in Toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity.	Gastroenterology	2014	40
24847880	L-Lactic acid	Madiraju AK	Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.	Nature	2014	164
25136121	L-Lactic acid	Crane CA	Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients.	Proceedings of the National Academy of Sciences of the United States of America	2014	28
25833956	L-Lactic acid	Cofiell R	Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.	Blood	2015	18
25862517	L-Lactic acid	Simkens LH	Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group.	Lancet	2015	49
26780750	L-Lactic acid	McCreight LJ	Metformin and the gastrointestinal tract.	Diabetologia	2016	28
27587707	L-Lactic acid	Ferdinandus J	Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with 177Lu-PSMA-617.	Journal of nuclear medicine 	2017	5
3894418	D-Glucose	DeFronzo RA	Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.	The Journal of clinical investigation	1985	184
8247074	D-Glucose	Lillioja S	Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.	The New England journal of medicine	1993	212
8945471	D-Glucose	Yamagata K	Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)	Nature	1996	216
9495343	D-Glucose	Withers DJ	Disruption of IRS-2 causes type 2 diabetes in mice.	Nature	1998	328
9867845	D-Glucose	Postic C	Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.	The Journal of biological chemistry	1999	389
10189543	D-Glucose	-	The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.	Diabetes care	1999	189
10209084	D-Glucose	Andrews RC	Glucocorticoids and insulin resistance: old hormones, new targets.	Clinical science	1999	104
10454950	D-Glucose	DeFronzo RA	Pharmacologic therapy for type 2 diabetes mellitus.	Annals of internal medicine	1999	114
11135616	D-Glucose	Chinetti G	PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.	Nature medicine	2001	173
11171994	D-Glucose	Haase VH	Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.	Proceedings of the National Academy of Sciences of the United States of America	2001	167
11289033	D-Glucose	Ryan EA	Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.	Diabetes	2001	95
11375115	D-Glucose	Delerive P	Peroxisome proliferator-activated receptors in inflammation control.	The Journal of endocrinology	2001	142
11584370	D-Glucose	Paradis V	High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis.	Hepatology	2001	92
11681809	D-Glucose	Coppack SW	Pro-inflammatory cytokines and adipose tissue.	The Proceedings of the Nutrition Society	2001	118
11742415	D-Glucose	Moller DE	New drug targets for type 2 diabetes and the metabolic syndrome.	Nature	2001	114
11826410	D-Glucose	Pagano G	Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.	Hepatology	2002	109
11826411	D-Glucose	Chitturi S	NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.	Hepatology	2002	167
11854024	D-Glucose	Berg AH	ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism.	Trends in endocrinology and metabolism	2002	199
11872682	D-Glucose	Mayerson AB	The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.	Diabetes	2002	106
12021247	D-Glucose	Hundal RS	Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes.	The Journal of clinical investigation	2002	148
12021250	D-Glucose	Petersen KF	Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.	The Journal of clinical investigation	2002	172
12028371	D-Glucose	Boden G	Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.	European journal of clinical investigation	2002	220
12242452	D-Glucose	Frayn KN	Adipose tissue as a buffer for daily lipid flux.	Diabetologia	2002	103
12399260	D-Glucose	Elliott SS	Fructose, weight gain, and the insulin resistance syndrome.	The American journal of clinical nutrition	2002	180
12518001	D-Glucose	Francis GA	Nuclear receptors and the control of metabolism.	Annual review of physiology	2003	122
12611609	D-Glucose	Díez JJ	The role of the novel adipocyte-derived hormone adiponectin in human disease.	European journal of endocrinology	2003	165
12626323	D-Glucose	Jiang G	Glucagon and regulation of glucose metabolism.	American journal of physiology. Endocrinology and metabolism	2003	128
12634421	D-Glucose	Farris W	Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2003	329
12668986	D-Glucose	Musso G	Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis.	Hepatology	2003	121
12668987	D-Glucose	Marchesini G	Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.	Hepatology	2003	457
12713871	D-Glucose	Shuda M	Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis.	Journal of hepatology	2003	106
12750520	D-Glucose	Petersen KF	Mitochondrial dysfunction in the elderly: possible role in insulin resistance.	Science	2003	471
12791994	D-Glucose	Du K	TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver.	Science	2003	250
12869762	D-Glucose	Grimsby J	Allosteric activators of glucokinase: potential role in diabetes therapy.	Science	2003	98
12959938	D-Glucose	Kelley DE	Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance.	American journal of physiology. Endocrinology and metabolism	2003	76
14699128	D-Glucose	Pajvani UB	Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.	The Journal of biological chemistry	2004	234
14749265	D-Glucose	Ferré P	The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity.	Diabetes	2004	122
14960743	D-Glucose	Petersen KF	Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.	The New England journal of medicine	2004	490
15016359	D-Glucose	Kamata K	Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase.	Structure	2004	99
15047607	D-Glucose	Morton NM	Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.	Diabetes	2004	87
15107844	D-Glucose	Koo SH	PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.	Nature medicine	2004	164
15118095	D-Glucose	Paterson JM	Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2004	85
15199412	D-Glucose	Horie Y	Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.	The Journal of clinical investigation	2004	165
15201411	D-Glucose	Klein S	Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.	The New England journal of medicine	2004	117
15265818	D-Glucose	Meier U	Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin.	Clinical chemistry	2004	118
15277403	D-Glucose	Tiikkainen M	Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.	Diabetes	2004	78
15294056	D-Glucose	Storlien L	Metabolic flexibility.	The Proceedings of the Nutrition Society	2004	74
15509521	D-Glucose	Kawaguchi T	Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.	The American journal of pathology	2004	130
15655035	D-Glucose	Lihn AS	Adiponectin: action, regulation and association to insulin sensitivity.	Obesity reviews 	2005	95
15662004	D-Glucose	Lowell BB	Mitochondrial dysfunction and type 2 diabetes.	Science	2005	502
15669880	D-Glucose	Krentz AJ	Oral antidiabetic agents: current role in type 2 diabetes mellitus.	Drugs	2005	137
15734833	D-Glucose	Petersen KF	Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.	Diabetes	2005	194
15831061	D-Glucose	Kraemer WJ	Hormonal responses and adaptations to resistance exercise and training.	Sports medicine	2005	86
15837923	D-Glucose	Xu A	Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2005	74
15842581	D-Glucose	Huang MA	One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.	The American journal of gastroenterology	2005	83
15925013	D-Glucose	Ginsberg HN	Regulation of plasma triglycerides in insulin resistance and diabetes.	Archives of medical research	2005	88
15971409	D-Glucose	Havel PJ	Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism.	Nutrition reviews	2005	139
15983199	D-Glucose	Javor ED	Long-term efficacy of leptin replacement in patients with generalized lipodystrophy.	Diabetes	2005	65
16025115	D-Glucose	Meyre D	Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes.	Nature genetics	2005	68
16037564	D-Glucose	Claudel T	The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.	Arteriosclerosis, thrombosis, and vascular biology	2005	69
16250043	D-Glucose	Bugianesi E	Insulin resistance: a metabolic pathway to chronic liver disease.	Hepatology	2005	117
16272564	D-Glucose	Mandard S	The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity.	The Journal of biological chemistry	2006	97
16409152	D-Glucose	Beaven SW	Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.	Annual review of medicine	2006	78
16456680	D-Glucose	Yki-Järvinen H	Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.	Diabetologia	2006	84
16460270	D-Glucose	Kalaany NY	LXRS and FXR: the yin and yang of cholesterol and fat metabolism.	Annual review of physiology	2006	147
16463046	D-Glucose	Adiels M	Overproduction of large VLDL particles is driven by increased liver fat content in man.	Diabetologia	2006	110
16470636	D-Glucose	Wolfram S	Anti-obesity effects of green tea: from bedside to bench.	Molecular nutrition & food research	2006	62
16511589	D-Glucose	Lefebvre P	Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis.	The Journal of clinical investigation	2006	191
16541101	D-Glucose	Houten SM	Endocrine functions of bile acids.	The EMBO journal	2006	120
16543404	D-Glucose	Waxman DJ	Growth hormone regulation of sex-dependent liver gene expression.	Molecular endocrinology	2006	121
16563942	D-Glucose	Petersen KF	Etiology of insulin resistance.	The American journal of medicine	2006	174
16567827	D-Glucose	Stefan N	Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.	Diabetes care	2006	96
16613757	D-Glucose	Bastard JP	Recent advances in the relationship between obesity, inflammation, and insulin resistance.	European cytokine network	2006	413
16644654	D-Glucose	Abdul-Ghani MA	Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.	Diabetes care	2006	150
16731817	D-Glucose	Cancello R	Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity.	Diabetes	2006	112
16860976	D-Glucose	Vuksan V	Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety.	Nutrition, metabolism, and cardiovascular diseases 	2008	52
16890538	D-Glucose	Uyeda K	Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis.	Cell metabolism	2006	150
16908160	D-Glucose	Lee FY	FXR, a multipurpose nuclear receptor.	Trends in biochemical sciences	2006	67
17114290	D-Glucose	Petersen KF	Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.	Proceedings of the National Academy of Sciences of the United States of America	2006	89
17130488	D-Glucose	Wolins NE	OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization.	Diabetes	2006	103
17130651	D-Glucose	Morino K	Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.	Diabetes	2006	205
17192339	D-Glucose	Abdul-Ghani MA	Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test.	Diabetes care	2007	86
17285001	D-Glucose	Delarue J	Free fatty acids and insulin resistance.	Current opinion in clinical nutrition and metabolic care	2007	87
17341552	D-Glucose	Cobelli C	Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests.	American journal of physiology. Endocrinology and metabolism	2007	77
17344645	D-Glucose	Ferré P	SREBP-1c transcription factor and lipid homeostasis: clinical perspective.	Hormone research	2007	59
17498512	D-Glucose	Parekh S	Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.	Gastroenterology	2007	76
17618858	D-Glucose	Klöting N	Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass.	Cell metabolism	2007	92
17666010	D-Glucose	Tremblay F	Role of dietary proteins and amino acids in the pathogenesis of insulin resistance.	Annual review of nutrition	2007	60
17671651	D-Glucose	Lyssenko V	Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.	The Journal of clinical investigation	2007	204
17681171	D-Glucose	Gastaldelli A	Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.	Gastroenterology	2007	98
17690317	D-Glucose	Kotronen A	Fatty liver: a novel component of the metabolic syndrome.	Arteriosclerosis, thrombosis, and vascular biology	2008	167
17885689	D-Glucose	Nogueiras R	The central melanocortin system directly controls peripheral lipid metabolism.	The Journal of clinical investigation	2007	129
17928588	D-Glucose	Holst JJ	The physiology of glucagon-like peptide 1.	Physiological reviews	2007	487
17977954	D-Glucose	Taksali SE	High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype.	Diabetes	2008	76
17981116	D-Glucose	Pospisilik JA	Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes.	Cell	2007	154
17997608	D-Glucose	Li S	The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts.	PLoS genetics	2007	91
18023282	D-Glucose	Reue K	The lipin protein family: dual roles in lipid biosynthesis and gene expression.	FEBS letters	2008	58
18039092	D-Glucose	Waki H	Endocrine functions of adipose tissue.	Annual review of pathology	2007	83
18196982	D-Glucose	Stanhope KL	Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance.	Current opinion in lipidology	2008	62
18197261	D-Glucose	Chao KC	Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes.	PloS one	2008	70
18223156	D-Glucose	Chung J	HSP72 protects against obesity-induced insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2008	122
18252893	D-Glucose	Zhang X	Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.	Diabetes	2008	175
18323454	D-Glucose	Dentin R	Hepatic glucose sensing via the CREB coactivator CRTC2.	Science	2008	119
18323516	D-Glucose	Rigamonti E	Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.	Arteriosclerosis, thrombosis, and vascular biology	2008	67
18355813	D-Glucose	Korenblat KM	Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.	Gastroenterology	2008	117
18391974	D-Glucose	Gross DN	The role of FoxO in the regulation of metabolism.	Oncogene	2008	152
18434349	D-Glucose	Macfarlane DP	Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome.	The Journal of endocrinology	2008	71
18442638	D-Glucose	Yin J	Efficacy of berberine in patients with type 2 diabetes mellitus.	Metabolism	2008	78
18446789	D-Glucose	Sheikh MY	Hepatitis C virus infection: molecular pathways to metabolic syndrome.	Hepatology	2008	56
18460914	D-Glucose	Jump DB	N-3 polyunsaturated fatty acid regulation of hepatic gene transcription.	Current opinion in lipidology	2008	89
18474251	D-Glucose	Kotronen A	Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.	Gastroenterology	2008	56
18556336	D-Glucose	Vaxillaire M	The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.	Diabetes	2008	55
18556422	D-Glucose	Kidd M	Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants.	American journal of physiology. Gastrointestinal and liver physiology	2008	50
18598135	D-Glucose	Saggerson D	Malonyl-CoA, a key signaling molecule in mammalian cells.	Annual review of nutrition	2008	58
18612115	D-Glucose	Ix JH	Fetuin-A and incident diabetes mellitus in older persons.	JAMA	2008	67
18633113	D-Glucose	Stefan N	Plasma fetuin-A levels and the risk of type 2 diabetes.	Diabetes	2008	74
18651836	D-Glucose	Agius L	Glucokinase and molecular aspects of liver glycogen metabolism.	The Biochemical journal	2008	76
18654640	D-Glucose	Reed BD	Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes.	PLoS genetics	2008	78
18678614	D-Glucose	Orho-Melander M	Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations.	Diabetes	2008	97
18726182	D-Glucose	Iynedjian PB	Molecular physiology of mammalian glucokinase.	Cellular and molecular life sciences 	2009	80
18775919	D-Glucose	Hajer GR	Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.	European heart journal	2008	242
18929493	D-Glucose	Tilg H	Insulin resistance, inflammation, and non-alcoholic fatty liver disease.	Trends in endocrinology and metabolism	2008	85
18974394	D-Glucose	Greenberger LM	A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth.	Molecular cancer therapeutics	2008	53
19009016	D-Glucose	Rabe K	Adipokines and insulin resistance.	Molecular medicine	2008	141
19066313	D-Glucose	Gregor MF	Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss.	Diabetes	2009	141
19103600	D-Glucose	Housley MP	A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose.	The Journal of biological chemistry	2009	71
19208352	D-Glucose	Kirk E	Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction.	Gastroenterology	2009	81
19221011	D-Glucose	Ma J	Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subjects.	American journal of physiology. Gastrointestinal and liver physiology	2009	56
19252892	D-Glucose	Roberts R	Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans.	Diabetologia	2009	73
19276390	D-Glucose	Robey IF	Bicarbonate increases tumor pH and inhibits spontaneous metastases.	Cancer research	2009	160
19291785	D-Glucose	Miele L	Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.	Hepatology	2009	222
19332493	D-Glucose	Brøns C	Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men.	The Journal of physiology	2009	52
19346330	D-Glucose	Chiang JY	Bile acids: regulation of synthesis.	Journal of lipid research	2009	245
19346331	D-Glucose	Hylemon PB	Bile acids as regulatory molecules.	Journal of lipid research	2009	165
19373249	D-Glucose	Matschinsky FM	Assessing the potential of glucokinase activators in diabetes therapy.	Nature reviews. Drug discovery	2009	95
19433249	D-Glucose	Nadal A	The pancreatic beta-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes.	Molecular and cellular endocrinology	2009	53
19478200	D-Glucose	Verschuren L	MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease.	Circulation research	2009	47
19487637	D-Glucose	Chavez AO	Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.	Diabetes care	2009	71
19490822	D-Glucose	Gross DN	The role of FOXO in the regulation of metabolism.	Current diabetes reports	2009	57
19602480	D-Glucose	Prokunina-Olsson L	Tissue-specific alternative splicing of TCF7L2.	Human molecular genetics	2009	45
19620249	D-Glucose	Vigneri P	Diabetes and cancer.	Endocrine-related cancer	2009	199
19623253	D-Glucose	Muzumdar RH	Humanin: a novel central regulator of peripheral insulin action.	PloS one	2009	51
19629071	D-Glucose	Shackelford DB	The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.	Nature reviews. Cancer	2009	446
19651814	D-Glucose	Kantartzis K	Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.	Diabetes	2009	72
19670459	D-Glucose	Gastaldelli A	Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.	Hepatology	2009	49
19696361	D-Glucose	Pedersen BK	Edward F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines.	Journal of applied physiology	2009	50
19723556	D-Glucose	Galic S	Adipose tissue as an endocrine organ.	Molecular and cellular endocrinology	2010	309
19758712	D-Glucose	Fiorucci S	Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders.	Trends in pharmacological sciences	2009	51
19800084	D-Glucose	Zhang H	Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.	Metabolism	2010	56
19800254	D-Glucose	Lynn FC	Meta-regulation: microRNA regulation of glucose and lipid metabolism.	Trends in endocrinology and metabolism	2009	59
19887649	D-Glucose	Kumar N	The benzenesulfoamide T0901317 N-(2,2,2-trifluoroethyl)-N-4-2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethylphenyl-benzenesulfonamide is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist.	Molecular pharmacology	2010	61
20005308	D-Glucose	Dominy JE Jr	Nutrient-dependent regulation of PGC-1alpha's acetylation state and metabolic function through the enzymatic activities of Sirt1/GCN5.	Biochimica et biophysica acta	2010	53
20022465	D-Glucose	Das UN	Obesity: genes, brain, gut, and environment.	Nutrition	2010	49
20027213	D-Glucose	Stocks T	Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts.	PLoS medicine	2009	56
20215559	D-Glucose	Gonzalez-Angulo AM	Metformin: a therapeutic opportunity in breast cancer.	Clinical cancer research 	2010	58
20225248	D-Glucose	Gupta NA	Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway.	Hepatology	2010	79
20336705	D-Glucose	Speliotes EK	Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study.	Hepatology	2010	86
20357365	D-Glucose	Sarruf DA	Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.	Diabetes	2010	68
20370677	D-Glucose	Bugianesi E	Insulin resistance in nonalcoholic fatty liver disease.	Current pharmaceutical design	2010	55
20371664	D-Glucose	Donga E	A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects.	The Journal of clinical endocrinology and metabolism	2010	79
20375212	D-Glucose	Sell H	Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.	The Journal of clinical endocrinology and metabolism	2010	51
20376506	D-Glucose	Nicolucci A	Epidemiological aspects of neoplasms in diabetes.	Acta diabetologica	2010	48
20392876	D-Glucose	Pearen MA	Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease.	Molecular endocrinology	2010	90
20424233	D-Glucose	German JP	Leptin deficiency causes insulin resistance induced by uncontrolled diabetes.	Diabetes	2010	46
20451522	D-Glucose	Dushay J	Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.	Gastroenterology	2010	113
20480025	D-Glucose	Hanhineva K	Impact of dietary polyphenols on carbohydrate metabolism.	International journal of molecular sciences	2010	83
20530747	D-Glucose	Sun L	A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese.	Diabetes care	2010	61
20556549	D-Glucose	Cusi K	The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes.	Current diabetes reports	2010	79
20592272	D-Glucose	Manco M	Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk.	Endocrine reviews	2010	90
20609972	D-Glucose	Samuel VT	Lipid-induced insulin resistance: unravelling the mechanism.	Lancet	2010	263
20623580	D-Glucose	Li T	Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice.	Hepatology	2010	59
20631354	D-Glucose	Zhao Y	NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology.	Arteriosclerosis, thrombosis, and vascular biology	2010	63
20664173	D-Glucose	Tam J	Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity.	The Journal of clinical investigation	2010	116
20668154	D-Glucose	D'Adamo E	Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents.	Diabetes care	2010	52
20675007	D-Glucose	Li H	Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.	Journal of hepatology	2010	69
20692331	D-Glucose	Lu Y	Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice.	Free radical biology & medicine	2010	57
20798346	D-Glucose	Unger RH	Paracrinology of islets and the paracrinopathy of diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2010	71
20803499	D-Glucose	Santoro N	A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents.	Hepatology	2010	51
20816089	D-Glucose	Kim HS	Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis.	Cell metabolism	2010	128
20817486	D-Glucose	Ernst MC	Chemerin: at the crossroads of inflammation and obesity.	Trends in endocrinology and metabolism	2010	60
20842602	D-Glucose	Yessoufou A	Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.	Swiss medical weekly	2010	40
20876708	D-Glucose	Musso G	Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?	Diabetes care	2010	119
20890895	D-Glucose	Sookoian S	Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter.	Hepatology	2010	54
20943795	D-Glucose	Mozaffarian D	Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.	The American journal of clinical nutrition	2010	48
20944545	D-Glucose	Yvan-Charvet L	Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity.	Kidney international	2011	40
20952387	D-Glucose	Peterson JM	C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output.	The Journal of biological chemistry	2010	58
20970497	D-Glucose	Zhang Y	Role of nuclear receptor SHP in metabolism and cancer.	Biochimica et biophysica acta	2011	66
20978091	D-Glucose	Schauer IE	Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.	Diabetes	2011	56
21029304	D-Glucose	Ferré P	Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.	Diabetes, obesity & metabolism	2010	94
21226820	D-Glucose	Tremblay AJ	Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes.	Diabetes, obesity & metabolism	2011	41
21233852	D-Glucose	Donath MY	Type 2 diabetes as an inflammatory disease.	Nature reviews. Immunology	2011	545
21241070	D-Glucose	Graham GG	Clinical pharmacokinetics of metformin.	Clinical pharmacokinetics	2011	127
21321189	D-Glucose	Li Y	Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver.	FASEB journal 	2011	83
21325336	D-Glucose	Liu C	PGC-1 coactivators in the control of energy metabolism.	Acta biochimica et biophysica Sinica	2011	50
21363910	D-Glucose	Claus SP	Colonization-induced host-gut microbial metabolic interaction.	mBio	2011	99
21518883	D-Glucose	Kimura I	Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41).	Proceedings of the National Academy of Sciences of the United States of America	2011	101
21551454	D-Glucose	Cui X	Seipin ablation in mice results in severe generalized lipodystrophy.	Human molecular genetics	2011	41
21599535	D-Glucose	Leavens KF	Insulin signaling to hepatic lipid metabolism in health and disease.	Critical reviews in biochemistry and molecular biology	2011	41
21614570	D-Glucose	Camastra S	Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.	Diabetologia	2011	41
21708823	D-Glucose	Hallsworth K	Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss.	Gut	2011	64
21723505	D-Glucose	Yadav H	Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling.	Cell metabolism	2011	117
21745271	D-Glucose	Svegliati-Baroni G	Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.	Liver international 	2011	64
21805476	D-Glucose	Borena W	Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.	International journal of cancer	2012	41
21809358	D-Glucose	Cardinale V	Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets.	Hepatology	2011	75
21812507	D-Glucose	Baetta R	Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences.	Drugs	2011	42
21816244	D-Glucose	Kousteni S	FoxO1, the transcriptional chief of staff of energy metabolism.	Bone	2012	43
21824266	D-Glucose	D'Alessio D	The role of dysregulated glucagon secretion in type 2 diabetes.	Diabetes, obesity & metabolism	2011	55
21829446	D-Glucose	Anand SS	Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE).	PloS one	2011	36
21829658	D-Glucose	Karolina DS	MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.	PloS one	2011	88
21841783	D-Glucose	Ohtsubo K	Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport.	Nature medicine	2011	39
21864752	D-Glucose	Dimitriadis G	Insulin effects in muscle and adipose tissue.	Diabetes research and clinical practice	2011	41
21909109	D-Glucose	Kim YJ	Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits.	Nature genetics	2011	83
21979934	D-Glucose	Hussain K	An activating mutation of AKT2 and human hypoglycemia.	Science	2011	54
22021391	D-Glucose	Bailey-Downs LC	Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging.	The journals of gerontology. Series A, Biological sciences and medical sciences	2012	54
22038520	D-Glucose	Rees MG	Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.	Diabetologia	2012	31
22056763	D-Glucose	Tailleux A	Roles of PPARs in NAFLD: potential therapeutic targets.	Biochimica et biophysica acta	2012	52
22105854	D-Glucose	Santoro N	Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.	Hepatology	2012	30
22134839	D-Glucose	Beysen C	Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.	Diabetologia	2012	32
22173168	D-Glucose	Bechmann LP	The interaction of hepatic lipid and glucose metabolism in liver diseases.	Journal of hepatology	2012	103
22307032	D-Glucose	Liu J	Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice.	Gastroenterology	2012	45
22343897	D-Glucose	Ichimura A	Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human.	Nature	2012	126
22355097	D-Glucose	Dowling RJ	Metformin in cancer: translational challenges.	Journal of molecular endocrinology	2012	77
22355316	D-Glucose	Liang Y	Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models.	PloS one	2012	47
22414897	D-Glucose	Calkin AC	Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.	Nature reviews. Molecular cell biology	2012	149
22436747	D-Glucose	Rottiers V	MicroRNAs in metabolism and metabolic disorders.	Nature reviews. Molecular cell biology	2012	246
22476949	D-Glucose	Zhou B	Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity.	Diabetologia	2012	42
22546860	D-Glucose	Benhamed F	The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.	The Journal of clinical investigation	2012	92
22609541	D-Glucose	Matsubara T	FXR signaling in the enterohepatic system.	Molecular and cellular endocrinology	2013	53
22638681	D-Glucose	Simonen M	Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass.	Obesity surgery	2012	35
22659620	D-Glucose	Cho YM	Targeting the glucagon receptor family for diabetes and obesity therapy.	Pharmacology & therapeutics	2012	31
22719752	D-Glucose	Hsieh MC	The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese.	Experimental diabetes research	2012	42
22766017	D-Glucose	Baptissart M	Bile acids: from digestion to cancers.	Biochimie	2013	25
22796579	D-Glucose	Sparks JD	Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia.	Arteriosclerosis, thrombosis, and vascular biology	2012	31
22809513	D-Glucose	Zhang R	Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels.	Biochemical and biophysical research communications	2012	71
22844441	D-Glucose	Reynolds AC	Impact of five nights of sleep restriction on glucose metabolism, leptin and testosterone in young adult men.	PloS one	2012	42
22883232	D-Glucose	Ruan HB	O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability.	Cell metabolism	2012	55
22923583	D-Glucose	Yi W	Phosphofructokinase 1 glycosylation regulates cell growth and metabolism.	Science	2012	132
23102619	D-Glucose	Yoshino J	Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance.	Cell metabolism	2012	86
23107255	D-Glucose	Müller MJ	Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome.	Obesity reviews 	2012	39
23134073	D-Glucose	Woo YC	Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.	Clinical endocrinology	2013	47
23159449	D-Glucose	Zechner JF	Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans.	Gastroenterology	2013	29
23249272	D-Glucose	Passos-Silva DG	Angiotensin-(1-7): beyond the cardio-renal actions.	Clinical science	2013	37
23257294	D-Glucose	Li X	SIRT1 and energy metabolism.	Acta biochimica et biophysica Sinica	2013	42
23305646	D-Glucose	Habegger KM	Fibroblast growth factor 21 mediates specific glucagon actions.	Diabetes	2013	31
23325474	D-Glucose	Fernández-Hernando C	MicroRNAs in metabolic disease.	Arteriosclerosis, thrombosis, and vascular biology	2013	57
23337953	D-Glucose	Stefan N	The role of hepatokines in metabolism.	Nature reviews. Endocrinology	2013	42
23396737	D-Glucose	Wong VW	Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study.	Annals of hepatology	2013	43
23431266	D-Glucose	Girousse A	Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass.	PLoS biology	2013	41
23439261	D-Glucose	Safar Zadeh E	The liver diseases of lipodystrophy: the long-term effect of leptin treatment.	Journal of hepatology	2013	26
23475416	D-Glucose	Moon HS	Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.	Endocrine reviews	2013	25
23482247	D-Glucose	Basaranoglu M	Fructose as a key player in the development of fatty liver disease.	World journal of gastroenterology	2013	47
23516412	D-Glucose	de Bock M	Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial.	PloS one	2013	25
23562074	D-Glucose	Silvestri C	The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders.	Cell metabolism	2013	76
23584084	D-Glucose	Klop B	Dyslipidemia in obesity: mechanisms and potential targets.	Nutrients	2013	93
23597489	D-Glucose	Filhoulaud G	Novel insights into ChREBP regulation and function.	Trends in endocrinology and metabolism	2013	51
23597726	D-Glucose	Fabbrini E	Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals.	Gastroenterology	2013	57
23665283	D-Glucose	Zhang HJ	Irisin is inversely associated with intrahepatic triglyceride contents in obese adults.	Journal of hepatology	2013	35
23746901	D-Glucose	Yang G	Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010.	Lancet	2013	276
23781214	D-Glucose	Kwon H	Adipokines mediate inflammation and insulin resistance.	Frontiers in endocrinology	2013	73
23792151	D-Glucose	Hijmans BS	Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences.	Biochimie	2014	32
23832089	D-Glucose	Pajvani UB	Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability.	Nature medicine	2013	38
23839524	D-Glucose	Villarroya J	An endocrine role for brown adipose tissue?	American journal of physiology. Endocrinology and metabolism	2013	37
23863937	D-Glucose	Siu FY	Structure of the human glucagon class B G-protein-coupled receptor.	Nature	2013	98
23886976	D-Glucose	Geurts L	Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.	Beneficial microbes	2014	46
24037093	D-Glucose	Taniguchi CM	Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.	Nature medicine	2013	33
24141775	D-Glucose	Chen WT	GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN.	Oncogene	2014	24
24166096	D-Glucose	Yan JW	The emerging role of miR-375 in cancer.	International journal of cancer	2014	38
24215793	D-Glucose	Mezza T	Insulin resistance alters islet morphology in nondiabetic humans.	Diabetes	2014	31
24222088	D-Glucose	Xu X	Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP.	Seminars in liver disease	2013	30
24230488	D-Glucose	Kellow NJ	Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials.	The British journal of nutrition	2014	26
24238363	D-Glucose	Oh KJ	CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis.	BMB reports	2013	32
24241533	D-Glucose	Bojsen-Møller KN	Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.	Diabetes	2014	31
24362249	D-Glucose	Nakamura MT	Regulation of energy metabolism by long-chain fatty acids.	Progress in lipid research	2014	80
24384568	D-Glucose	Boucher J	Insulin receptor signaling in normal and insulin-resistant states.	Cold Spring Harbor perspectives in biology	2014	78
24411942	D-Glucose	Roberts LD	β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors.	Cell metabolism	2014	75
24467746	D-Glucose	Pyke C	GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.	Endocrinology	2014	68
24531544	D-Glucose	Lien F	Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk.	The Journal of clinical investigation	2014	21
24629563	D-Glucose	Yang SJ	Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation.	Metabolism	2014	20
24651807	D-Glucose	Cobelli C	The oral minimal model method.	Diabetes	2014	28
24670948	D-Glucose	Shao M	Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARα axis signalling.	Nature communications	2014	24
24731669	D-Glucose	Yki-Järvinen H	Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.	The lancet. Diabetes & endocrinology	2014	83
24813368	D-Glucose	Gallego-Escuredo JM	Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.	International journal of obesity	2015	18
24819989	D-Glucose	Zhou H	Bile acids are nutrient signaling hormones.	Steroids	2014	32
24848981	D-Glucose	Albert JS	Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes.	The New England journal of medicine	2014	30
24931034	D-Glucose	Kleinridders A	Insulin action in brain regulates systemic metabolism and brain function.	Diabetes	2014	52
24997608	D-Glucose	Oh DY	A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice.	Nature medicine	2014	32
25035342	D-Glucose	Lim S	Links between ectopic fat and vascular disease in humans.	Arteriosclerosis, thrombosis, and vascular biology	2014	32
25043058	D-Glucose	Suh JM	Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer.	Nature	2014	32
25073467	D-Glucose	Li T	Bile acid signaling in metabolic disease and drug therapy.	Pharmacological reviews	2014	72
25111123	D-Glucose	Jin R	Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD.	Nutrients	2014	22
25111690	D-Glucose	Choi YJ	Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes.	Laboratory investigation; a journal of technical methods and pathology	2014	25
25179915	D-Glucose	Haahr H	A review of the pharmacological properties of insulin degludec and their clinical relevance.	Clinical pharmacokinetics	2014	23
25242225	D-Glucose	Soccio RE	Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes.	Cell metabolism	2014	52
25281430	D-Glucose	Murahovschi V	WISP1 is a novel adipokine linked to inflammation in obesity.	Diabetes	2015	16
25288136	D-Glucose	Coffee and Caffeine Genetics Consortium.	Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption.	Molecular psychiatry	2015	24
25304002	D-Glucose	Vrhovac I	Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart.	Pflugers Archiv 	2015	23
25307742	D-Glucose	Haeusler RA	Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.	Nature communications	2014	32
25421524	D-Glucose	Thorens B	GLUT2, glucose sensing and glucose homeostasis.	Diabetologia	2015	42
25445538	D-Glucose	Szkudelski T	Resveratrol and diabetes: from animal to human studies.	Biochimica et biophysica acta	2015	24
25457209	D-Glucose	Zhou Y	Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2.	Journal of hepatology	2015	16
25476696	D-Glucose	Everard A	Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status.	Nature communications	2014	42
25485909	D-Glucose	Finan B	A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents.	Nature medicine	2015	30
25563886	D-Glucose	Goos JA	Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.	Annals of surgery	2016	10
25584736	D-Glucose	Li T	Bile acids as metabolic regulators.	Current opinion in gastroenterology	2015	27
25596529	D-Glucose	Keembiyehetty C	Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis.	The Journal of biological chemistry	2015	20
25637831	D-Glucose	Satin LS	Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes.	Molecular aspects of medicine	2015	19
25688231	D-Glucose	Ma X	Control of adipocyte differentiation in different fat depots; implications for pathophysiology or therapy.	Frontiers in endocrinology	2015	17
25703085	D-Glucose	Francque S	PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis.	Journal of hepatology	2015	24
25705637	D-Glucose	Ali AH	Recent advances in the development of farnesoid X receptor agonists.	Annals of translational medicine	2015	30
25726255	D-Glucose	Higuchi C	Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes.	Metabolism	2015	26
25747274	D-Glucose	Monga SP	β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis.	Gastroenterology	2015	58
25755205	D-Glucose	Navarro G	The role of androgens in metabolism, obesity, and diabetes in males and females.	Obesity	2015	18
25825943	D-Glucose	Schwarz JM	Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat.	The Journal of clinical endocrinology and metabolism	2015	25
25885947	D-Glucose	Portillo-Sanchez P	High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.	The Journal of clinical endocrinology and metabolism	2015	27
25961460	D-Glucose	Fu X	MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.	The Journal of clinical investigation	2015	24
26077345	D-Glucose	Abu-Farha M	Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance.	Scientific reports	2015	22
26197299	D-Glucose	Flynn CR	Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery.	Nature communications	2015	19
26248647	D-Glucose	Pajvani UB	The new biology of diabetes.	Diabetologia	2015	17
26303352	D-Glucose	Schmidt JB	Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial.	International journal of obesity	2016	10
26355033	D-Glucose	Boden G	Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men.	Science translational medicine	2015	15
26394161	D-Glucose	Armstrong MJ	Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.	Journal of hepatology	2016	18
26409295	D-Glucose	Dongiovanni P	Genetics of nonalcoholic fatty liver disease.	Metabolism	2016	14
26422395	D-Glucose	Cao Y	SIRT1 and insulin resistance.	Journal of diabetes and its complications	2016	10
26542580	D-Glucose	Perelis M	Pancreatic β cell enhancers regulate rhythmic transcription of genes controlling insulin secretion.	Science	2015	49
26556368	D-Glucose	Yki-Järvinen H	Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.	Nutrients	2015	16
26577417	D-Glucose	Buse JB	Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5.	Diabetes care	2016	12
26619117	D-Glucose	Denechaud PD	E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis.	The Journal of clinical investigation	2016	13
26694027	D-Glucose	Bennett BJ	Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains.	PLoS genetics	2015	17
26743209	D-Glucose	An H	Current understanding of metformin effect on the control of hyperglycemia in diabetes.	The Journal of endocrinology	2016	14
26947067	D-Glucose	Kung CP	The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction.	Cell reports	2016	18
26993047	D-Glucose	Wang ZV	Adiponectin, the past two decades.	Journal of molecular cell biology	2016	18
27002059	D-Glucose	Steven S	Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders.	Diabetes care	2016	12
27099265	D-Glucose	Willeit P	Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?	European heart journal	2016	11
27111510	D-Glucose	Jazayeri A	Extra-helical binding site of a glucagon receptor antagonist.	Nature	2016	25
27196572	D-Glucose	Duparc T	Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.	Gut	2017	14
27238018	D-Glucose	Zhao X	Circadian Amplitude Regulation via FBXW7-Targeted REV-ERBα Degradation.	Cell	2016	11
27335433	D-Glucose	Tanimura Y	Acute exercise increases fibroblast growth factor 21 in metabolic organs and circulation.	Physiological reports	2016	10
27500523	D-Glucose	Zhou K	Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.	Nature genetics	2016	13
27636730	D-Glucose	Gross B	PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.	Nature reviews. Endocrinology	2017	26
27901631	D-Glucose	O'Reilly MW	11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.	The Journal of clinical endocrinology and metabolism	2017	10
27928162	D-Glucose	Hashimoto N	Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus.	Journal of human genetics	2017	6
28039838	D-Glucose	Gómez-Sámano MÁ	Fibroblast growth factor 21 and its novel association with oxidative stress.	Redox biology	2017	7
28053201	D-Glucose	Noakes TD	Evidence that supports the prescription of low-carbohydrate high-fat diets: a narrative review.	British journal of sports medicine	2017	5
28123934	D-Glucose	Lundsgaard AM	Circulating FGF21 in humans is potently induced by short term overfeeding of carbohydrates.	Molecular metabolism	2017	7
28211512	D-Glucose	Perakakis N	Physiology and role of irisin in glucose homeostasis.	Nature reviews. Endocrinology	2017	10
28293093	D-Glucose	Rinaldi L	Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis.	World journal of gastroenterology	2017	5
28314735	D-Glucose	Adams LA	Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.	Gut	2017	12
28533672	D-Glucose	Gelli C	Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.	World journal of gastroenterology	2017	5
8033210	L-Cysteine	Warren AJ	The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development.	Cell	1994	157
11034317	L-Cysteine	Krause A	LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity.	FEBS letters	2000	208
11113131	L-Cysteine	Park CH	Hepcidin, a urinary antimicrobial peptide synthesized in the liver.	The Journal of biological chemistry	2001	352
14581476	L-Cysteine	Cirman T	Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins.	The Journal of biological chemistry	2004	97
14871816	L-Cysteine	Caldwell GM	The Wnt antagonist sFRP1 in colorectal tumorigenesis.	Cancer research	2004	75
15239102	L-Cysteine	Feldstein AE	Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway.	Hepatology	2004	162
18783549	L-Cysteine	Gressner OA	Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases.	Liver international 	2008	73
20213804	L-Cysteine	Sonnylal S	Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis.	Arthritis and rheumatism	2010	57
20683959	L-Cysteine	Tuyama AC	Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis.	Hepatology	2010	67
21442631	L-Cysteine	Schrader J	Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells.	Hepatology	2011	81
22048958	L-Cysteine	Maue RA	A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.	Human molecular genetics	2012	32
22182510	L-Cysteine	King TD	Frizzled7 as an emerging target for cancer therapy.	Cellular signalling	2012	35
22348534	L-Cysteine	Yoo NJ	Somatic mutations of the KEAP1 gene in common solid cancers.	Histopathology	2012	37
24854385	L-Cysteine	Shen WJ	Scavenger receptor class B type I (SR-BI): a versatile receptor with multiple functions and actions.	Metabolism	2014	22
26760765	L-Cysteine	Reina S	VDAC3 as a sensor of oxidative state of the intermembrane space of mitochondria: the putative role of cysteine residue modifications.	Oncotarget	2016	15
28336545	L-Cysteine	Karl JP	Changes in intestinal microbiota composition and metabolism coincide with increased intestinal permeability in young adults under prolonged physiological stress.	American journal of physiology. Gastrointestinal and liver physiology	2017	11
12016314	24,25-Dihydroxyvitamin D	Makishima M	Vitamin D receptor as an intestinal bile acid sensor.	Science	2002	189
15128933	24,25-Dihydroxyvitamin D	Cheng JB	Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase.	Proceedings of the National Academy of Sciences of the United States of America	2004	104
16697362	24,25-Dihydroxyvitamin D	Speeckaert M	Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism.	Clinica chimica acta; international journal of clinical chemistry	2006	106
16720650	24,25-Dihydroxyvitamin D	Singh RJ	C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status.	The Journal of clinical endocrinology and metabolism	2006	99
16749856	24,25-Dihydroxyvitamin D	Zollner G	Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.	Molecular pharmaceutics	2006	61
21793032	24,25-Dihydroxyvitamin D	Gal-Tanamy M	Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes.	Hepatology	2011	37
22535896	24,25-Dihydroxyvitamin D	Nagy L	Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response.	Physiological reviews	2012	51
22710573	24,25-Dihydroxyvitamin D	Majumdar A	Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma.	Nature reviews. Gastroenterology & hepatology	2012	32
23905916	24,25-Dihydroxyvitamin D	Kiss M	The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology.	The Journal of allergy and clinical immunology	2013	35
23982684	24,25-Dihydroxyvitamin D	Schaap FG	Bile acid receptors as targets for drug development.	Nature reviews. Gastroenterology & hepatology	2014	61
24483159	24,25-Dihydroxyvitamin D	Schwartz JB	A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations.	The Journal of clinical endocrinology and metabolism	2014	36
24644045	24,25-Dihydroxyvitamin D	Fedirko V	Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study.	Hepatology	2014	22
24703048	24,25-Dihydroxyvitamin D	Afzal S	Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study.	The lancet. Diabetes & endocrinology	2014	28
25259922	24,25-Dihydroxyvitamin D	Sherman MH	Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.	Cell	2014	124
26895659	24,25-Dihydroxyvitamin D	Dongiovanni P	Nutritional therapy for nonalcoholic fatty liver disease.	The Journal of nutritional biochemistry	2016	14
10385606	Alpha-Tocopherol	Brigelius-Flohé R	Vitamin E: function and metabolism.	FASEB journal 	1999	154
11997390	Alpha-Tocopherol	Sontag TJ	Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status.	The Journal of biological chemistry	2002	84
12788804	Alpha-Tocopherol	Rigotti A	The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues.	Endocrine reviews	2003	109
12883485	Alpha-Tocopherol	Kugelmas M	Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.	Hepatology	2003	88
16968800	Alpha-Tocopherol	Utzschneider KM	Review: The role of insulin resistance in nonalcoholic fatty liver disease.	The Journal of clinical endocrinology and metabolism	2006	103
17439363	Alpha-Tocopherol	Traber MG	Vitamin E regulatory mechanisms.	Annual review of nutrition	2007	55
19053049	Alpha-Tocopherol	Harrison SA	Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.	Hepatology	2009	85
20181810	Alpha-Tocopherol	Bakker GC	An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach.	The American journal of clinical nutrition	2010	45
22326434	Alpha-Tocopherol	Cusi K	Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.	Gastroenterology	2012	130
23363012	Alpha-Tocopherol	Masuoka HC	Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals.	Annals of the New York Academy of Sciences	2013	50
24849310	Alpha-Tocopherol	Guy CD	Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity.	Hepatology	2015	15
25596209	Alpha-Tocopherol	Ng K	Vitamin E in New-Generation Lipid Emulsions Protects Against Parenteral Nutrition-Associated Liver Disease in Parenteral Nutrition-Fed Preterm Pigs.	JPEN. Journal of parenteral and enteral nutrition	2016	11
26266980	Alpha-Tocopherol	Saeed M	SEC14L2 enables pan-genotype HCV replication in cell culture.	Nature	2015	23
27052013	Alpha-Tocopherol	Hannah WN Jr	Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.	Digestive diseases and sciences	2016	10
27646933	Alpha-Tocopherol	Rotman Y	Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease.	Gut	2017	20
11752169	Heparin	Rabinowitz JE	Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.	Journal of virology	2002	227
17764540	Heparin	Eriksson BI	Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.	Journal of thrombosis and haemostasis 	2007	108
17869635	Heparin	Eriksson BI	Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.	Lancet	2007	126
18318435	Heparin	Lai JP	Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.	Hepatology	2008	68
18534438	Heparin	RE-MOBILIZE Writing Committee.	Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.	The Journal of arthroplasty	2009	82
21225098	Heparin	Eriksson BI	Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.	Thrombosis and haemostasis	2011	59
11297957	Bilirubin	Imbert-Bismut F	Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.	Lancet	2001	233
16055434	Bilirubin	Adams LA	Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.	Clinical chemistry	2005	88
16327492	Bilirubin	Balzan S	The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy.	Annals of surgery	2005	120
16556705	Bilirubin	Gordon MY	Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor.	Stem cells	2006	61
16778155	Bilirubin	Terai S	Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.	Stem cells	2006	106
16879391	Bilirubin	Durnez A	The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.	Histopathology	2006	70
17239480	Bilirubin	Varela M	Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.	Journal of hepatology	2007	155
17291602	Bilirubin	Geier A	Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration.	Biochimica et biophysica acta	2007	65
18509182	Bilirubin	Brunner TB	Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.	Journal of clinical oncology 	2008	51
19766639	Bilirubin	Salem R	Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.	Gastroenterology	2010	170
20066715	Bilirubin	Carr BI	Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.	Cancer	2010	46
21618574	Bilirubin	Sangro B	Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.	Hepatology	2011	117
22278680	Bilirubin	Sancho-Bru P	Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis.	Hepatology	2012	44
22357140	Bilirubin	Kantarjian H	Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study.	The Lancet. Oncology	2012	70
23641933	Bilirubin	Cassol E	Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors.	BMC infectious diseases	2013	29
24423918	Bilirubin	El-Khoueiry AB	S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma.	British journal of cancer	2014	21
25524924	Bilirubin	Liu X	Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer.	Carcinogenesis	2015	19
26095784	Bilirubin	Zhu AX	Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.	The Lancet. Oncology	2015	58
26235536	Bilirubin	Thakurdas SM	Jagged1 heterozygosity in mice results in a congenital cholangiopathy which is reversed by concomitant deletion of one copy of Poglut1 (Rumi).	Hepatology	2016	12
26838806	Bilirubin	Zhang Y	Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function.	Scientific reports	2016	17
27620474	Bilirubin	Ong V	Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin.	Antimicrobial agents and chemotherapy	2016	12
27677712	Bilirubin	Vitale A	Personalized treatment of patients with very early hepatocellular carcinoma.	Journal of hepatology	2017	7
28323125	Bilirubin	Urban TJ	Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.	Journal of hepatology	2017	5
12867431	Sulfate	Barth H	Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate.	The Journal of biological chemistry	2003	149
16024626	Sulfate	Capurro MI	Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling.	Cancer research	2005	117
18052531	Sulfate	Avirutnan P	Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E.	PLoS pathogens	2007	71
19008778	Sulfate	Arumugam TV	Toll-like receptors in ischemia-reperfusion injury.	Shock	2009	79
19360105	Sulfate	Zcharia E	Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases.	PloS one	2009	51
16729314	Cytidine	Bonvin M	Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.	Hepatology	2006	87
20523896	Cytidine	Vartanian JP	Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.	PLoS pathogens	2010	54
23369223	Cytidine	Karahoca M	Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy.	Clinical epigenetics	2013	56
24557838	Cytidine	Lucifora J	Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.	Science	2014	152
25298230	Cytidine	Caval V	A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.	Nature communications	2014	33
27007129	Cytidine	Ciccolini J	Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective.	Cancer chemotherapy and pharmacology	2016	14
15363638	L-Carnitine	Bonnefont JP	Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects.	Molecular aspects of medicine	2004	91
17473959	L-Carnitine	Koepsell H	Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.	Pharmaceutical research	2007	191
17704301	L-Carnitine	Westerbacka J	Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.	Diabetes	2007	80
20054868	L-Carnitine	Stienstra R	Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity.	Hepatology	2010	85
24928512	L-Carnitine	Ge X	High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD).	The Journal of biological chemistry	2014	31
7674678	Ethanol	Bohn MJ	The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings.	Journal of studies on alcohol	1995	171
9121257	Ethanol	Poynard T	Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.	Lancet	1997	421
10498659	Ethanol	Benhamou Y	Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group.	Hepatology	1999	214
11343240	Ethanol	Llovet JM	Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.	Hepatology	2001	85
12395331	Ethanol	Hassan MM	Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.	Hepatology	2002	143
12717385	Ethanol	Paik YH	Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.	Hepatology	2003	166
12759473	Ethanol	Lencioni RA	Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection.	Radiology	2003	129
15505132	Ethanol	Kim HJ	Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.	Archives of internal medicine	2004	85
15578509	Ethanol	Lin SM	Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.	Gastroenterology	2004	104
15951401	Ethanol	Carbone DL	Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease.	The Journal of pharmacology and experimental therapeutics	2005	69
15973779	Ethanol	Salmon-Ceron D	Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.	Journal of hepatology	2005	68
16151628	Ethanol	Elsharkawy AM	The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis.	Apoptosis 	2005	98
16182404	Ethanol	Bräu N	Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.	Journal of hepatology	2006	91
16527702	Ethanol	El-Serag HB	The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.	Clinical gastroenterology and hepatology 	2006	154
16573591	Ethanol	Crews FT	Cytokines and alcohol.	Alcoholism, clinical and experimental research	2006	104
16756501	Ethanol	Hammes-Schiffer S	Relating protein motion to catalysis.	Annual review of biochemistry	2006	190
17461418	Ethanol	Huang H	A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C.	Hepatology	2007	89
17663417	Ethanol	Bioulac-Sage P	Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.	Hepatology	2007	88
17728149	Ethanol	Adams LA	Nonalcoholic fatty liver disease.	Annals of epidemiology	2007	70
17998146	Ethanol	Schmitz KJ	Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection.	Journal of hepatology	2008	66
18045675	Ethanol	Albano E	Oxidative mechanisms in the pathogenesis of alcoholic liver disease.	Molecular aspects of medicine	2008	55
18162065	Ethanol	Tang Y	Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease.	Alcoholism, clinical and experimental research	2008	99
18304676	Ethanol	Llovet JM	Novel advancements in the management of hepatocellular carcinoma in 2008.	Journal of hepatology	2008	202
18393390	Ethanol	Straub BK	Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis.	Hepatology	2008	58
18433021	Ethanol	Ladeiro Y	MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.	Hepatology	2008	198
18666317	Ethanol	Gomaa AI	Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.	World journal of gastroenterology	2008	139
19029462	Ethanol	Weikert C	Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke.	Circulation	2008	62
19168210	Ethanol	Schuckit MA	Alcohol-use disorders.	Lancet	2009	89
19250206	Ethanol	Berasain C	Inflammation and liver cancer: new molecular links .	Annals of the New York Academy of Sciences	2009	113
19534673	Ethanol	Heymann F	Monocytes and macrophages as cellular targets in liver fibrosis.	Inflammation & allergy drug targets	2009	54
19803417	Ethanol	Eklund CM	Proinflammatory cytokines in CRP baseline regulation.	Advances in clinical chemistry	2009	51
19946271	Ethanol	Tian C	Variant in PNPLA3 is associated with alcoholic liver disease.	Nature genetics	2010	93
20022654	Ethanol	Dragani TA	Risk of HCC: genetic heterogeneity and complex genetics.	Journal of hepatology	2010	40
20238398	Ethanol	Szabo G	Alcoholic liver disease and the gut-liver axis.	World journal of gastroenterology	2010	101
20309940	Ethanol	Xu Y	A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.	International journal of cancer	2011	49
20628345	Ethanol	Yang JD	Hepatocellular carcinoma: A global view.	Nature reviews. Gastroenterology & hepatology	2010	286
20639898	Ethanol	Whittaker S	The role of signaling pathways in the development and treatment of hepatocellular carcinoma.	Oncogene	2010	208
20664081	Ethanol	Malhi H	Hepatocyte death: a clear and present danger.	Physiological reviews	2010	108
20684021	Ethanol	Rotman Y	The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.	Hepatology	2010	96
20930130	Ethanol	Zhang Y	Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases.	Clinical chemistry	2010	115
20953207	Ethanol	Severi T	Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.	Acta pharmacologica Sinica	2010	48
21128245	Ethanol	Ertle J	Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.	International journal of cancer	2011	78
21146242	Ethanol	Fabris C	IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.	Journal of hepatology	2011	55
21146512	Ethanol	Lambert MP	Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.	Journal of hepatology	2011	48
21252049	Ethanol	Gao B	Innate immunity in alcoholic liver disease.	American journal of physiology. Gastrointestinal and liver physiology	2011	64
21284667	Ethanol	Miller AM	Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.	Alcoholism, clinical and experimental research	2011	46
21488075	Ethanol	Trépo E	Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.	Hepatology	2011	55
21497748	Ethanol	Starkel P	Animal models for the study of hepatic fibrosis.	Best practice & research. Clinical gastroenterology	2011	40
21497796	Ethanol	Li D	Strong association of the alcohol dehydrogenase 1B gene (ADH1B) with alcohol dependence and alcohol-induced medical diseases.	Biological psychiatry	2011	52
21525758	Ethanol	Szabo G	Gut-liver axis and sensing microbes.	Digestive diseases	2010	44
21544812	Ethanol	Wang C	Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies.	International journal of cancer	2012	75
21721028	Ethanol	Marabita F	Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection.	Hepatology	2011	39
21822264	Ethanol	Li M	Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.	Nature genetics	2011	138
21826088	Ethanol	Altamirano J	Alcoholic liver disease: pathogenesis and new targets for therapy.	Nature reviews. Gastroenterology & hepatology	2011	62
22109347	Ethanol	Silverberg MJ	HIV infection, immunodeficiency, viral replication, and the risk of cancer.	Cancer epidemiology, biomarkers & prevention 	2011	70
22245895	Ethanol	Zelber-Sagi S	Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up.	Journal of hepatology	2012	33
22320924	Ethanol	Gao B	Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease.	Journal of gastroenterology and hepatology	2012	51
22446023	Ethanol	Chen Y	Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies.	European journal of cancer	2012	32
22561517	Ethanol	Guichard C	Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.	Nature genetics	2012	311
22841474	Ethanol	Meng F	Epigenetic regulation of miR-34a expression in alcoholic liver injury.	The American journal of pathology	2012	41
23022478	Ethanol	Gao B	Natural killer and natural killer T cells in liver fibrosis.	Biochimica et biophysica acta	2013	29
23142622	Ethanol	Aravinthan A	Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.	Journal of hepatology	2013	31
23143785	Ethanol	Gupta SC	Therapeutic roles of curcumin: lessons learned from clinical trials.	The AAPS journal	2013	154
23349936	Ethanol	Gonzalez-Quintela A	Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity.	PloS one	2013	30
23392276	Ethanol	Hebbring SJ	A PheWAS approach in studying HLA-DRB1*1501.	Genes and immunity	2013	39
23532958	Ethanol	Bertola A	Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin.	Hepatology	2013	77
23665288	Ethanol	Pais R	A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.	Journal of hepatology	2013	67
23666091	Ethanol	Gaggini M	Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease.	Nutrients	2013	86
23689081	Ethanol	Szabo G	MicroRNAs in liver disease.	Nature reviews. Gastroenterology & hepatology	2013	117
23703888	Ethanol	Lazo M	Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.	American journal of epidemiology	2013	136
23712313	Ethanol	Edenberg HJ	Genetics and alcoholism.	Nature reviews. Gastroenterology & hepatology	2013	27
23729174	Ethanol	Morales-Ibanez O	Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.	Hepatology	2013	37
23855300	Ethanol	Orman ES	Alcoholic liver disease: pathogenesis, management, and novel targets for therapy.	Journal of gastroenterology and hepatology	2013	49
23857333	Ethanol	Tikhanovich I	Regulation of FOXO3 by phosphorylation and methylation in hepatitis C virus infection and alcohol exposure.	Hepatology	2014	22
23921128	Ethanol	Chen CL	Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.	The Journal of clinical investigation	2013	46
24122827	Ethanol	Chen L	Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells.	Hepatology	2014	37
24382882	Ethanol	Chen CH	Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.	Physiological reviews	2014	62
24400890	Ethanol	McDaniel K	The functional role of microRNAs in alcoholic liver injury.	Journal of cellular and molecular medicine	2014	34
24445574	Ethanol	Singal AG	The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis.	The American journal of gastroenterology	2014	46
24525690	Ethanol	Kranzler HR	Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.	The American journal of psychiatry	2014	45
24638984	Ethanol	Giannelli G	Transforming growth factor-β as a therapeutic target in hepatocellular carcinoma.	Cancer research	2014	50
24705689	Ethanol	Muñoz M	Involvement of substance P and the NK-1 receptor in human pathology.	Amino acids	2014	23
24828436	Ethanol	Bala S	Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals.	PloS one	2014	51
25422909	Ethanol	Bagnardi V	Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis.	British journal of cancer	2015	65
25447847	Ethanol	Szabo G	Gut-liver axis in alcoholic liver disease.	Gastroenterology	2015	71
25479137	Ethanol	Markwick LJ	Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis.	Gastroenterology	2015	32
25492813	Ethanol	Topletz AR	Induction of CYP26A1 by metabolites of retinoic acid: evidence that CYP26A1 is an important enzyme in the elimination of active retinoids.	Molecular pharmacology	2015	16
25561778	Ethanol	Stojsavljević S	Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.	World journal of gastroenterology	2014	32
25645722	Ethanol	Villanueva A	DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma.	Hepatology	2015	26
25747273	Ethanol	Lee JH	Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.	Gastroenterology	2015	42
25930080	Ethanol	Roh YS	TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration.	American journal of physiology. Gastrointestinal and liver physiology	2015	17
26121746	Ethanol	Vendruscolo LF	Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals.	The Journal of clinical investigation	2015	24
26264599	Ethanol	Momen-Heravi F	Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.	Journal of translational medicine	2015	37
26482880	Ethanol	Buch S	A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis.	Nature genetics	2015	35
26582088	Ethanol	Uthaya Kumar DB	TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.	Gastroenterology	2016	11
26724859	Ethanol	Chen CL	NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.	Cell metabolism	2016	15
26769846	Ethanol	Wang S	Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury.	Oncotarget	2016	11
26844476	Ethanol	Jamali R	Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.	Medicine	2016	12
26850495	Ethanol	Mancina RM	The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.	Gastroenterology	2016	26
27575312	Ethanol	Stickel F	The genetics of alcohol dependence and alcohol-related liver disease.	Journal of hepatology	2017	5
27639178	Ethanol	Eguchi A	Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood.	Hepatology	2017	8
28107775	Ethanol	Varga ZV	β-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice.	British journal of pharmacology	2018	6
28467924	Ethanol	Søberg S	FGF21 Is a Sugar-Induced Hormone Associated with Sweet Intake and Preference in Humans.	Cell metabolism	2017	9
28530644	Ethanol	Yang AM	Intestinal fungi contribute to development of alcoholic liver disease.	The Journal of clinical investigation	2017	9
17408664	Sulfite	Park IY	Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.	Gastroenterology	2007	73
21969817	Sulfite	He Y	Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma.	Neoplasia	2011	37
22689435	Sulfite	Neumann O	Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.	Hepatology	2012	42
23704319	Sulfite	Hur K	Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis.	Gut	2014	55
23931760	Sulfite	Ahrens M	DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery.	Cell metabolism	2013	63
25608619	Sulfite	Zhang Z	microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.	Molecular cancer	2015	20
25641194	Sulfite	Zhuo H	The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma.	Molecular carcinogenesis	2016	33
9053482	Cisplatin	-	International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.	Journal of clinical oncology 	1997	198
9270026	Cisplatin	Kool M	Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.	Cancer research	1997	114
16289418	Cisplatin	Sieghart W	Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.	Journal of hepatology	2006	62
17923843	Cisplatin	Li SD	Tumor-targeted delivery of siRNA by self-assembled nanoparticles.	Molecular therapy 	2008	95
21257722	Cisplatin	Dickson MA	A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors.	Clinical cancer research 	2011	39
21327457	Cisplatin	Yang Z	Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation.	Annals of surgical oncology	2011	221
21334406	Cisplatin	Chen X	Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations.	Journal of hepatology	2011	38
21726833	Cisplatin	Lee TK	CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.	Cell stem cell	2011	148
22406827	Cisplatin	Guo XL	Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells.	Cancer letters	2012	44
22473773	Cisplatin	Shan J	Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.	Hepatology	2012	74
23483142	Cisplatin	Xu Y	miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells.	Oncology reports	2013	39
23542177	Cisplatin	Mao B	SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma.	Oncogene	2014	30
25385148	Cisplatin	Dai T	Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway.	The Journal of pathology	2015	19
26822397	Cisplatin	Fujitani K	Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.	The Lancet. Oncology	2016	32
27071093	Cisplatin	Menghi F	The tandem duplicator phenotype as a distinct genomic configuration in cancer.	Proceedings of the National Academy of Sciences of the United States of America	2016	10
27102149	Cisplatin	Chong DQ	The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets.	Oncotarget	2016	15
28027578	Cisplatin	Li D	Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis.	Hepatology	2017	17
28240761	Cisplatin	Elia G	Hepatocellular carcinoma and CXCR3 chemokines: a narrative review.	La Clinica terapeutica	2017	6
8008069	Sirolimus	Brown EJ	A mammalian protein targeted by G1-arresting rapamycin-receptor complex.	Nature	1994	424
15604215	Sirolimus	Khamzina L	Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.	Endocrinology	2005	152
17273556	Sirolimus	Le Bacquer O	Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.	The Journal of clinical investigation	2007	97
17465001	Sirolimus	Pazienza V	The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms.	Hepatology	2007	64
17609423	Sirolimus	Mingozzi F	Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver.	Blood	2007	79
18393362	Sirolimus	Yin XM	Autophagy in the liver.	Hepatology	2008	76
18722871	Sirolimus	Curatolo P	Tuberous sclerosis.	Lancet	2008	171
18821591	Sirolimus	Llovet JM	Molecular targeted therapies in hepatocellular carcinoma.	Hepatology	2008	288
18929564	Sirolimus	Villanueva A	Pivotal role of mTOR signaling in hepatocellular carcinoma.	Gastroenterology	2008	186
19072831	Sirolimus	Vinciguerra M	Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes.	Hepatology	2009	53
19208038	Sirolimus	Chen JS	Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9.	Hepatology research 	2009	69
19223493	Sirolimus	Yu G	Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer.	Clinical cancer research 	2009	51
19301157	Sirolimus	Zhou L	The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma.	Medical oncology	2010	44
19665249	Sirolimus	Newell P	Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.	Journal of hepatology	2009	52
19706799	Sirolimus	Desbois-Mouthon C	Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.	Clinical cancer research 	2009	59
19917848	Sirolimus	Missiaglia E	Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway.	Journal of clinical oncology 	2010	97
19948145	Sirolimus	Laplante M	An emerging role of mTOR in lipid biosynthesis.	Current biology 	2009	156
20157535	Sirolimus	Armour SM	Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy.	Aging	2009	65
20175032	Sirolimus	Hoshida Y	Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.	Seminars in liver disease	2010	94
20501828	Sirolimus	Fornari F	MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.	Cancer research	2010	129
20630061	Sirolimus	Javle MM	Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies.	BMC cancer	2010	41
20664473	Sirolimus	Boudreaux JP	The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum.	Pancreas	2010	58
20860370	Sirolimus	Liu Q	Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzoh1,6naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer.	Journal of medicinal chemistry	2010	68
21187475	Sirolimus	Gedaly R	PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.	Anticancer research	2010	45
21269838	Sirolimus	Howell JJ	mTOR couples cellular nutrient sensing to organismal metabolic homeostasis.	Trends in endocrinology and metabolism	2011	113
21878637	Sirolimus	Li D	MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.	The Journal of biological chemistry	2011	85
21993994	Sirolimus	Ho C	AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways.	Hepatology	2012	55
22234835	Sirolimus	Fang Y	MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.	Hepatology	2012	103
22449814	Sirolimus	Bakan I	Connecting mTORC1 signaling to SREBP-1 activation.	Current opinion in lipidology	2012	39
22457330	Sirolimus	Menon S	Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice.	Science signaling	2012	51
22466652	Sirolimus	Ai D	Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice.	The Journal of clinical investigation	2012	35
22504094	Sirolimus	Chang Y	miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions.	Gastroenterology	2012	53
22773877	Sirolimus	Yuan M	Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.	The Journal of biological chemistry	2012	49
22927400	Sirolimus	Owen JL	Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase.	Proceedings of the National Academy of Sciences of the United States of America	2012	58
22983984	Sirolimus	Iwaya T	Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway.	Carcinogenesis	2012	50
22994652	Sirolimus	Welker MW	Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge.	Transplant international 	2013	35
22994804	Sirolimus	Akimova T	Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients.	American journal of transplantation 	2012	32
23929677	Sirolimus	Sinha RA	Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.	Hepatology	2014	48
23973332	Sirolimus	Lamming DW	A Central role for mTOR in lipid homeostasis.	Cell metabolism	2013	72
24308993	Sirolimus	Matter MS	Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends.	Journal of hepatology	2014	41
24401568	Sirolimus	Liu B	Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation.	Autophagy	2014	29
24662006	Sirolimus	Chen J	Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders.	International journal of developmental neuroscience 	2014	23
24910242	Sirolimus	Umemura A	Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition.	Cell metabolism	2014	27
24947615	Sirolimus	Park HW	Hepatoprotective role of Sestrin2 against chronic ER stress.	Nature communications	2014	26
25082895	Sirolimus	Cornu M	Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.	Proceedings of the National Academy of Sciences of the United States of America	2014	34
25099355	Sirolimus	Lu L	Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions.	Proceedings of the National Academy of Sciences of the United States of America	2014	33
25361980	Sirolimus	Treilleux I	Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer.	Annals of oncology 	2015	18
25557953	Sirolimus	Cornella H	Unique genomic profile of fibrolamellar hepatocellular carcinoma.	Gastroenterology	2015	20
25682869	Sirolimus	Zhu M	Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells.	Oncotarget	2015	20
26389641	Sirolimus	Park YY	Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.	Hepatology	2016	14
26476289	Sirolimus	Li L	Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.	Journal of hepatology	2016	12
26540343	Sirolimus	Ji J	LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway.	Oncotarget	2015	33
26788992	Sirolimus	Safinia N	Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation.	Oncotarget	2016	20
26826241	Sirolimus	Goh CC	Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.	Journal of immunology	2016	13
27597759	Sirolimus	Sargent G	PEX2 is the E3 ubiquitin ligase required for pexophagy during starvation.	The Journal of cell biology	2016	13
27671674	Sirolimus	Clark CA	Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.	Cancer research	2016	18
28079894	Sirolimus	Jin F	MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.	Cell death & disease	2017	16
1309942	Vitamin A	Levin AA	9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha.	Nature	1992	201
8156941	Vitamin A	Thissen JP	Nutritional regulation of the insulin-like growth factors.	Endocrine reviews	1994	136
9679048	Vitamin A	Bachem MG	Identification, culture, and characterization of pancreatic stellate cells in rats and humans.	Gastroenterology	1998	178
17341558	Vitamin A	Balagopal P	Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation.	The Journal of clinical endocrinology and metabolism	2007	63
18376398	Vitamin A	Sato Y	Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone.	Nature biotechnology	2008	94
21529158	Vitamin A	Ross AC	Cytochrome P450s in the regulation of cellular retinoic acid metabolism.	Annual review of nutrition	2011	64
21763780	Vitamin A	Shirakami Y	Hepatic metabolism of retinoids and disease associations.	Biochimica et biophysica acta	2012	38
22200617	Vitamin A	Harwood HJ Jr	The adipocyte as an endocrine organ in the regulation of metabolic homeostasis.	Neuropharmacology	2012	51
22828276	Vitamin A	Cox CL	Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans.	Nutrition & metabolism	2012	31
23105095	Vitamin A	Alapatt P	Liver retinol transporter and receptor for serum retinol-binding protein (RBP4).	The Journal of biological chemistry	2013	30
24106281	Vitamin A	Amengual J	Two carotenoid oxygenases contribute to mammalian provitamin A metabolism.	The Journal of biological chemistry	2013	27
24265236	Vitamin A	Puche JE	Hepatic stellate cells and liver fibrosis.	Comprehensive Physiology	2013	82
25002123	Vitamin A	Palczewski G	Evidence for compartmentalization of mammalian carotenoid metabolism.	FASEB journal 	2014	22
25543955	Vitamin A	di Masi A	Retinoic acid receptors: from molecular mechanisms to cancer therapy.	Molecular aspects of medicine	2015	25
26022934	Vitamin A	Fasshauer M	Adipokines in health and disease.	Trends in pharmacological sciences	2015	47
15244495	Tacrolimus	Staatz CE	Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.	Clinical pharmacokinetics	2004	82
16868252	Tacrolimus	Jiang H	Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy.	Blood	2006	105
20170205	Tacrolimus	Staatz CE	Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.	Clinical pharmacokinetics	2010	51
21804023	Tacrolimus	Hutchinson JA	Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients.	Journal of immunology	2011	48
23721554	Tacrolimus	Kaneku H	De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.	American journal of transplantation 	2013	30
18845355	NADPH	Carmona-Cuenca I	Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity.	Journal of hepatology	2008	59
19661994	NADPH	Guengerich FP	Measurement of cytochrome P450 and NADPH-cytochrome P450 reductase.	Nature protocols	2009	52
23049784	NADPH	Sancho P	NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.	PloS one	2012	38
23333322	NADPH	Zanger UM	Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.	Pharmacology & therapeutics	2013	223
24440789	NADPH	Williams CD	Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans.	Toxicology and applied pharmacology	2014	40
24494202	NADPH	Jiang F	NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses.	Redox biology	2014	33
25501551	NADPH	Dattaroy D	Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis.	American journal of physiology. Gastrointestinal and liver physiology	2015	23
26811478	NADPH	Xu IM	Transketolase counteracts oxidative stress to drive cancer development.	Proceedings of the National Academy of Sciences of the United States of America	2016	18
26818617	NADPH	Arriazu E	Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury.	Gut	2017	12
12406645	Midazolam	Lamba JK	Genetic contribution to variable human CYP3A-mediated metabolism.	Advanced drug delivery reviews	2002	143
19514965	Midazolam	Klotz U	Pharmacokinetics and drug metabolism in the elderly.	Drug metabolism reviews	2009	50
9062340	Sterol	Shimomura I	Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells.	The Journal of clinical investigation	1997	165
11371634	Sterol	Ou J	Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR.	Proceedings of the National Academy of Sciences of the United States of America	2001	90
11375416	Sterol	Werstuck GH	Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways.	The Journal of clinical investigation	2001	156
11504730	Sterol	Fu X	27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells.	The Journal of biological chemistry	2001	89
12193651	Sterol	Tangirala RK	Identification of macrophage liver X receptors as inhibitors of atherosclerosis.	Proceedings of the National Academy of Sciences of the United States of America	2002	97
15085196	Sterol	Engelking LJ	Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis.	The Journal of clinical investigation	2004	80
15531889	Sterol	Kong W	Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.	Nature medicine	2004	190
15677715	Sterol	Maxwell KN	Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment.	Proceedings of the National Academy of Sciences of the United States of America	2005	79
15805190	Sterol	Rashid S	Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9.	Proceedings of the National Academy of Sciences of the United States of America	2005	161
16251601	Sterol	Jump DB	Fatty acid regulation of hepatic gene transcription.	The Journal of nutrition	2005	83
16423920	Sterol	Boyer JL	Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.	American journal of physiology. Gastrointestinal and liver physiology	2006	62
18522832	Sterol	Ge L	The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1.	Cell metabolism	2008	72
20037595	Sterol	Villablanca EJ	Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses.	Nature medicine	2010	51
20541520	Sterol	Sato R	Sterol metabolism and SREBP activation.	Archives of biochemistry and biophysics	2010	41
20566875	Sterol	Marquart TJ	miR-33 links SREBP-2 induction to repression of sterol transporters.	Proceedings of the National Academy of Sciences of the United States of America	2010	182
20809793	Sterol	Jia L	Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.	Annual review of physiology	2011	37
21226579	Sterol	Vergeer M	Genetic variant of the scavenger receptor BI in humans.	The New England journal of medicine	2011	73
21325464	Sterol	Pettinelli P	Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction.	The Journal of clinical endocrinology and metabolism	2011	43
21459322	Sterol	Seo YK	Genome-wide localization of SREBP-2 in hepatic chromatin predicts a role in autophagy.	Cell metabolism	2011	49
21548778	Sterol	Moore KJ	The role of microRNAs in cholesterol efflux and hepatic lipid metabolism.	Annual review of nutrition	2011	41
22012398	Sterol	Rayner KJ	Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.	Nature	2011	214
23499676	Sterol	Zhong D	MicroRNA-1 and microRNA-206 suppress LXRα-induced lipogenesis in hepatocytes.	Cellular signalling	2013	27
23547260	Sterol	Goedeke L	A regulatory role for microRNA 33* in controlling lipid metabolism gene expression.	Molecular and cellular biology	2013	44
23708292	Sterol	Li Q	Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly.	Nature medicine	2013	57
23959186	Sterol	Spann NJ	Sterols and oxysterols in immune cell function.	Nature immunology	2013	44
23973703	Sterol	Urban D	Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.	Journal of the American College of Cardiology	2013	37
24657242	Sterol	Sirtori CR	The pharmacology of statins.	Pharmacological research	2014	25
16932311	1,1-Dimethylbiguanide	Roden M	Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.	Nature clinical practice. Endocrinology & metabolism	2006	76
17609683	1,1-Dimethylbiguanide	Shu Y	Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.	Clinical pharmacology and therapeutics	2008	98
19536068	1,1-Dimethylbiguanide	Tzvetkov MV	The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.	Clinical pharmacology and therapeutics	2009	50
19591196	1,1-Dimethylbiguanide	Nies AT	Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.	Hepatology	2009	76
19930006	1,1-Dimethylbiguanide	Jendle J	Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue.	Diabetes, obesity & metabolism	2009	48
21103969	1,1-Dimethylbiguanide	Nies AT	Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.	Handbook of experimental pharmacology	2011	79
22194737	1,1-Dimethylbiguanide	Mazza A	The role of metformin in the management of NAFLD.	Experimental diabetes research	2012	37
22326465	1,1-Dimethylbiguanide	Baffy G	Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.	Journal of hepatology	2012	152
23381014	1,1-Dimethylbiguanide	Singh S	Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.	The American journal of gastroenterology	2013	51
28127194	1,1-Dimethylbiguanide	Kostrzewski T	Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease.	World journal of gastroenterology	2017	6
16983400	Phytonadione	Wadelius M	Pharmacogenetics of warfarin: current status and future challenges.	The pharmacogenomics journal	2007	63
18391209	Phytonadione	Kalyuzhniy O	Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2008	138
19054062	Phytonadione	Li Q	Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms.	Experimental dermatology	2009	58
25450201	Phytonadione	Poté N	Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.	Journal of hepatology	2015	21
26614531	Phytonadione	Konishi H	Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma.	Cancer science	2016	14
28296720	Phytonadione	Park SJ	Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.	Medicine	2017	5
14996776	Simvastatin	Nissen SE	Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.	JAMA	2004	224
15660968	Simvastatin	Schachter M	Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.	Fundamental & clinical pharmacology	2005	116
16714062	Simvastatin	Shitara Y	Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions.	Pharmacology & therapeutics	2006	71
18033751	Simvastatin	Careskey HE	Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9.	Journal of lipid research	2008	63
18650507	Simvastatin	SEARCH Collaborative Group.	SLCO1B1 variants and statin-induced myopathy--a genomewide study.	The New England journal of medicine	2008	370
19159124	Simvastatin	Golomb BA	Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.	American journal of cardiovascular drugs 	2008	86
19785645	Simvastatin	Kalliokoski A	Impact of OATP transporters on pharmacokinetics.	British journal of pharmacology	2009	119
21795660	Simvastatin	Sano M	A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease.	Neurology	2011	52
23311897	Simvastatin	Nies AT	Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1.	Genome medicine	2013	26
24176465	Simvastatin	Needham M	Statin myotoxicity: a review of genetic susceptibility factors.	Neuromuscular disorders 	2014	20
24743428	Simvastatin	Byrne CD	Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.	Arteriosclerosis, thrombosis, and vascular biology	2014	28
27545498	Simvastatin	Guixé-Muntet S	Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injury.	Journal of hepatology	2017	7
10646872	Nitric oxide	Jaiswal M	Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism.	Cancer research	2000	112
11867742	Nitric oxide	Leoni F	The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.	Proceedings of the National Academy of Sciences of the United States of America	2002	130
15690474	Nitric oxide	Sirica AE	Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy.	Hepatology	2005	98
15728243	Nitric oxide	Barshes NR	Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts.	Journal of leukocyte biology	2005	91
15832402	Nitric oxide	de la Lastra CA	Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications.	Molecular nutrition & food research	2005	98
17030071	Nitric oxide	Malhi H	Cholangiocarcinoma: modern advances in understanding a deadly old disease.	Journal of hepatology	2006	69
17229978	Nitric oxide	Guzik TJ	Adipocytokines - novel link between inflammation and vascular function?	Journal of physiology and pharmacology 	2006	87
21038415	Nitric oxide	Karlmark KR	The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.	Hepatology	2010	60
21362471	Nitric oxide	Mukhopadhyay P	Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.	Free radical biology & medicine	2011	35
22517765	Nitric oxide	Zimmerman MA	Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells.	American journal of physiology. Gastrointestinal and liver physiology	2012	51
22711689	Nitric oxide	Metz P	Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.	Hepatology	2012	55
12883497	L-Aspartic acid	Wai CT	A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.	Hepatology	2003	571
19224197	L-Aspartic acid	Kotronen A	A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans.	Diabetologia	2009	72
21606975	L-Aspartic acid	Bihrer V	Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.	The American journal of gastroenterology	2011	60
21726511	L-Aspartic acid	Sandler NG	Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.	Gastroenterology	2011	96
22390675	L-Aspartic acid	Vella SJ	Measuring markers of liver function using a micropatterned paper device designed for blood from a fingerstick.	Analytical chemistry	2012	33
23002959	L-Aspartic acid	Li T	Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis.	Stem cells and development	2013	102
23316013	L-Aspartic acid	Sieghart W	The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma.	Hepatology	2013	42
24623375	L-Aspartic acid	Kazankov K	Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.	Hepatology	2014	25
26109530	L-Aspartic acid	Lemoine M	The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.	Gut	2016	25
26944023	L-Aspartic acid	Friedman S	Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design.	Contemporary clinical trials	2016	18
28246107	L-Aspartic acid	De Velasco G	Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients.	Cancer immunology research	2017	9
17326147	L-Glutamine	Di Tommaso L	Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis.	Hepatology	2007	63
22271347	L-Glutamine	D'Ambrosio R	A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis.	Hepatology	2012	44
24748404	L-Glutamine	Hammad S	Protocols for staining of bile canalicular and sinusoidal networks of human, mouse and pig livers, three-dimensional reconstruction and quantification of tissue microarchitecture by image processing and analysis.	Archives of toxicology	2014	21
25123086	L-Glutamine	Nault JC	Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.	Hepatology	2014	44
25248380	L-Glutamine	Friemel J	Intratumor heterogeneity in hepatocellular carcinoma.	Clinical cancer research 	2015	35
26724577	L-Glutamine	Bhutia YD	Glutamine transporters in mammalian cells and their functions in physiology and cancer.	Biochimica et biophysica acta	2016	12
10347145	L-Threonine	Nakae J	Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway.	The Journal of biological chemistry	1999	143
14532286	L-Threonine	Chan FK	A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses.	The Journal of biological chemistry	2003	134
15461589	L-Threonine	Murray JT	Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3.	The Biochemical journal	2004	115
15940637	L-Threonine	Kobayashi S	Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells.	Gastroenterology	2005	73
19075230	L-Threonine	Rychahou PG	Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis.	Proceedings of the National Academy of Sciences of the United States of America	2008	65
19762341	L-Threonine	Miyazono K	Bone morphogenetic protein receptors and signal transduction.	Journal of biochemistry	2010	240
21652557	L-Threonine	Chung KF	p38 mitogen-activated protein kinase pathways in asthma and COPD.	Chest	2011	39
22684109	L-Threonine	Zhao X	Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1.	The Journal of clinical investigation	2012	55
25690731	L-Threonine	Kim EK	Compromised MAPK signaling in human diseases: an update.	Archives of toxicology	2015	50
27535340	L-Threonine	Martin K	PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis.	Nature communications	2016	14
9215638	L-Serine	Hayashi H	The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling.	Cell	1997	286
10666260	L-Serine	Wölk B	Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines.	Journal of virology	2000	90
16150821	L-Serine	Lake AC	Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members.	Journal of lipid research	2005	75
16465619	L-Serine	Kotowski IK	A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.	American journal of human genetics	2006	143
17215125	L-Serine	Horton JD	Molecular biology of PCSK9: its role in LDL metabolism.	Trends in biochemical sciences	2007	112
17438296	L-Serine	Yang Y	Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor.	Proceedings of the National Academy of Sciences of the United States of America	2007	104
17573418	L-Serine	Shaw JL	Distribution of 15 human kallikreins in tissues and biological fluids.	Clinical chemistry	2007	69
18343183	L-Serine	Seidah NG	The activation and physiological functions of the proprotein convertases.	The international journal of biochemistry & cell biology	2008	100
18408718	L-Serine	Finberg KE	Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).	Nature genetics	2008	164
18503638	L-Serine	Blackman MJ	Malarial proteases and host cell egress: an 'emerging' cascade.	Cellular microbiology	2008	67
19818709	L-Serine	Kong M	Alpha4 is an essential regulator of PP2A phosphatase activity.	Molecular cell	2009	49
19958841	L-Serine	Muoio DM	Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused?	Biochimica et biophysica acta	2010	49
20200349	L-Serine	Finberg KE	Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis.	Blood	2010	45
21233335	L-Serine	Konicek BW	Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.	Cancer research	2011	52
21367592	L-Serine	Janciauskiene SM	The discovery of α1-antitrypsin and its role in health and disease.	Respiratory medicine	2011	50
21538350	L-Serine	Thaiparambil JT	Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation.	International journal of cancer	2011	55
21617040	L-Serine	Settembre C	TFEB links autophagy to lysosomal biogenesis.	Science	2011	505
21710321	L-Serine	Bidart M	BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain.	Cellular and molecular life sciences 	2012	34
22633824	L-Serine	Stein EA	Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial.	Lancet	2012	96
22634722	L-Serine	Lewis EC	Expanding the clinical indications for α(1)-antitrypsin therapy.	Molecular medicine	2012	33
22982943	L-Serine	Kubes P	Sterile inflammation in the liver.	Gastroenterology	2012	126
24419221	L-Serine	Mardinoglu A	Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease.	Nature communications	2014	65
24505350	L-Serine	Nobili V	Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease.	PloS one	2014	22
24625727	L-Serine	Seidah NG	PCSK9: a key modulator of cardiovascular health.	Circulation research	2014	57
24695853	L-Serine	Shi J	TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins.	Blood	2014	20
25195567	L-Serine	Paulo JA	Effects of MEK inhibitors GSK1120212 and PD0325901 in vivo using 10-plex quantitative proteomics and phosphoproteomics.	Proteomics	2015	23
25860938	L-Serine	Principe M	Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.	Oncotarget	2015	24
7744246	All-trans-retinoic acid	Willy PJ	LXR, a nuclear receptor that defines a distinct retinoid response pathway.	Genes & development	1995	198
12033729	All-trans-retinoic acid	Draper JS	Surface antigens of human embryonic stem cells: changes upon differentiation in culture.	Journal of anatomy	2002	103
12387968	All-trans-retinoic acid	Nebert DW	Clinical importance of the cytochromes P450.	Lancet	2002	182
14561891	All-trans-retinoic acid	Levenberg S	Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds.	Proceedings of the National Academy of Sciences of the United States of America	2003	123
15003116	All-trans-retinoic acid	Sempere LF	Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation.	Genome biology	2004	524
16585524	All-trans-retinoic acid	Loo YM	Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection.	Proceedings of the National Academy of Sciences of the United States of America	2006	171
20301097	All-trans-retinoic acid	Touboul T	Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development.	Hepatology	2010	126
21068253	All-trans-retinoic acid	Kumar M	Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon.	Journal of virology	2011	35
23633945	All-trans-retinoic acid	Chen Y	HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1.	PLoS pathogens	2013	56
24360797	All-trans-retinoic acid	Hou J	Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma.	Cancer cell	2014	32
24833036	All-trans-retinoic acid	Israelow B	HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.	Hepatology	2014	23
12055599	Carbon tetrachloride	Galli A	Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.	Gastroenterology	2002	83
15122762	Carbon tetrachloride	Radaeva S	Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation.	Hepatology	2004	170
17185352	Carbon tetrachloride	Henderson NC	Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure.	Gut	2007	68
19399744	Carbon tetrachloride	Tsai PC	The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis.	Liver transplantation 	2009	55
20618941	Carbon tetrachloride	Fujii T	Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor.	BMC gastroenterology	2010	44
20625373	Carbon tetrachloride	Marquez RT	Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans.	Laboratory investigation; a journal of technical methods and pathology	2010	59
22198715	Carbon tetrachloride	Gur C	NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis.	Gut	2012	31
23842754	Carbon tetrachloride	Tan Z	IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.	Journal of immunology	2013	45
24196965	Carbon tetrachloride	Zhang Z	The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development.	The Journal of biological chemistry	2013	26
24677197	Carbon tetrachloride	Fuchs BC	Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.	Hepatology	2014	68
24728410	Carbon tetrachloride	O'Brien AJ	Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2.	Nature medicine	2014	21
26385087	Carbon tetrachloride	Klein S	Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.	Gut	2017	5
27001906	Carbon tetrachloride	Hyun J	MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.	Nature communications	2016	20
22335738	Paclitaxel	Stone RL	Paraneoplastic thrombocytosis in ovarian cancer.	The New England journal of medicine	2012	130
24122958	Paclitaxel	Huang D	miRNA27a is a biomarker for predicting chemosensitivity and prognosis in metastatic or recurrent gastric cancer.	Journal of cellular biochemistry	2014	26
25130998	Paclitaxel	de Azambuja E	Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response.	The Lancet. Oncology	2014	50
18955566	Sorafenib	Zeng Z	Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.	Blood	2009	150
19726678	Sorafenib	Bai S	MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.	The Journal of biological chemistry	2009	157
20059340	Sorafenib	Villanueva A	Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.	Annual review of medicine	2010	66
20347499	Sorafenib	Shimizu S	The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma.	Journal of hepatology	2010	87
21102438	Sorafenib	Smith FD	AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade.	Nature cell biology	2010	57
21352471	Sorafenib	Meng F	Functional analysis of microRNAs in human hepatocellular cancer stem cells.	Journal of cellular and molecular medicine	2012	41
21538283	Sorafenib	Nault JC	Genetics of hepatobiliary carcinogenesis.	Seminars in liver disease	2011	50
21816126	Sorafenib	Sangro B	Radioembolization for hepatocellular carcinoma.	Journal of hepatology	2012	62
22314428	Sorafenib	Burrel M	Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.	Journal of hepatology	2012	78
22322234	Sorafenib	Lachenmayer A	Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib.	Journal of hepatology	2012	44
22414760	Sorafenib	Personeni N	Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma.	Journal of hepatology	2012	40
22890726	Sorafenib	Arao T	FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma.	Hepatology	2013	25
23316005	Sorafenib	Huang XY	αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma.	Hepatology	2013	38
23471579	Sorafenib	Xia H	MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.	Hepatology	2013	89
23835194	Sorafenib	Pez F	Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.	Journal of hepatology	2013	56
23862748	Sorafenib	Yang F	MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.	Technology in cancer research & treatment	2014	26
23958557	Sorafenib	Govaere O	Keratin 19: a key role player in the invasion of human hepatocellular carcinomas.	Gut	2014	53
23980090	Sorafenib	Llovet JM	Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study.	Journal of clinical oncology 	2013	107
24651044	Sorafenib	Liu L	Combination therapy of sorafenib and TACE for unresectable HCC: a systematic review and meta-analysis.	PloS one	2014	24
24700742	Sorafenib	Xiang Q	Cabozantinib suppresses tumor growth and metastasis in hepatocellular carcinoma by a dual blockade of VEGFR2 and MET.	Clinical cancer research 	2014	26
24836552	Sorafenib	Takeda H	Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan.	Liver international 	2015	17
24918061	Sorafenib	Takahashi K	Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer.	FEBS open bio	2014	72
25053293	Sorafenib	Fernando J	A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells.	International journal of cancer	2015	23
25158999	Sorafenib	Fitzmorris P	Management of hepatocellular carcinoma.	Journal of cancer research and clinical oncology	2015	17
25216638	Sorafenib	Rudalska R	In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.	Nature medicine	2014	43
25633810	Sorafenib	Ohta K	MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A.	Oncotarget	2015	34
25733155	Sorafenib	Makarova-Rusher OV	The yin and yang of evasion and immune activation in HCC.	Journal of hepatology	2015	21
25832714	Sorafenib	Delire B	The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications.	European journal of clinical investigation	2015	20
25938543	Sorafenib	Dai W	By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.	Oncotarget	2015	24
26045065	Sorafenib	Liu K	miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.	Oncology reports	2015	25
26099527	Sorafenib	Zucman-Rossi J	Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.	Gastroenterology	2015	66
26154152	Sorafenib	Won C	Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma.	Hepatology	2015	21
26311740	Sorafenib	He C	MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.	Oncotarget	2015	22
26514126	Sorafenib	Lou G	Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.	Journal of hematology & oncology	2015	38
26592953	Sorafenib	Govaere O	Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche.	Journal of hepatology	2016	13
27100895	Sorafenib	Zhang PF	Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling.	Cell death & disease	2016	15
27732875	Sorafenib	Sauzay C	Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma.	Clinica chimica acta; international journal of clinical chemistry	2016	13
27849399	Sorafenib	Woo HY	New chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails?	Expert opinion on pharmacotherapy	2017	5
27849562	Sorafenib	Bollard J	Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma.	Gut	2017	8
28147363	Sorafenib	Kudo M	Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials.	Oncology	2017	17
28177886	Sorafenib	Zhang X	Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.	Oncotarget	2017	7
28344323	Sorafenib	Zhu YJ	New knowledge of the mechanisms of sorafenib resistance in liver cancer.	Acta pharmacologica Sinica	2017	12
28423574	Sorafenib	Cheng Y	Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma.	Oncotarget	2017	5
10432325	Creatinine	Sort P	Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.	The New England journal of medicine	1999	154
11113085	Creatinine	Akriviadis E	Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.	Gastroenterology	2000	125
12709468	Creatinine	Imai Y	Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome.	JAMA	2003	106
18094680	Creatinine	Portilla D	Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery.	Kidney international	2008	82
21252674	Creatinine	Devarajan P	Biomarkers for the early detection of acute kidney injury.	Current opinion in pediatrics	2011	56
22093507	Creatinine	Krawczeski CD	Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass.	Journal of the American College of Cardiology	2011	55
22240130	Creatinine	Nickolas TL	Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study.	Journal of the American College of Cardiology	2012	75
22311920	Creatinine	Ferguson MA	Established and emerging markers of kidney function.	Clinical chemistry	2012	30
23121377	Creatinine	Torres VE	Tolvaptan in patients with autosomal dominant polycystic kidney disease.	The New England journal of medicine	2012	217
23599408	Creatinine	Parikh CR	Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery.	Clinical journal of the American Society of Nephrology 	2013	57
23689653	Creatinine	McCullough PA	Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference.	Contributions to nephrology	2013	36
24067879	Creatinine	Gane EJ	Telbivudine improves renal function in patients with chronic hepatitis B.	Gastroenterology	2014	29
25882434	Creatinine	Basu RK	Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study.	BMC nephrology	2015	17
26181658	Creatinine	Pardanani A	Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial.	JAMA oncology	2015	18
27056618	Creatinine	Rahbar K	Response and Tolerability of a Single Dose of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Analysis.	Journal of nuclear medicine 	2016	19
27339817	Creatinine	Leung JC	Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients.	Hepatology	2017	9
27474473	Creatinine	Schrezenmeier EV	Biomarkers in acute kidney injury - pathophysiological basis and clinical performance.	Acta physiologica	2017	8
28076311	Creatinine	Kashani K	Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption.	Clinical chemistry and laboratory medicine	2017	8
22965965	Pteroyl-D-glutamic acid	Hoff PM	Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).	Journal of clinical oncology 	2012	37
23569301	Pteroyl-D-glutamic acid	Ye LC	Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases.	Journal of clinical oncology 	2013	55
24687833	Pteroyl-D-glutamic acid	Schwartzberg LS	PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancer.	Journal of clinical oncology 	2014	117
25337750	Pteroyl-D-glutamic acid	Loupakis F	Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.	The New England journal of medicine	2014	110
17060484	Irinotecan	Rubbia-Brandt L	Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery.	Annals of oncology 	2007	62
23881988	Irinotecan	Hurwitz HI	Efficacy and safety of bevacizumab in metastatic colorectal cancer: pooled analysis from seven randomized controlled trials.	The oncologist	2013	31
24585723	Irinotecan	Goldstein J	Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).	Annals of oncology 	2014	32
24717919	Irinotecan	Primrose J	Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial.	The Lancet. Oncology	2014	46
16007195	Decitabine	Niwa Y	Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.	Oncogene	2005	93
16763620	Decitabine	Mann J	Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis.	Cell death and differentiation	2007	64
16882708	Decitabine	Kantarjian H	Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.	Blood	2007	163
17079474	Decitabine	Wehbe H	Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression.	Cancer research	2006	60
17241887	Decitabine	Isomoto H	Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.	Gastroenterology	2007	66
17621267	Decitabine	Meng F	Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes.	Oncogene	2008	85
21703189	Decitabine	Alpini G	Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.	Journal of hepatology	2011	41
21747116	Decitabine	Stefanska B	Definition of the landscape of promoter DNA hypomethylation in liver cancer.	Cancer research	2011	57
23079745	Decitabine	Kim JK	Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.	Hepatology	2013	68
3283935	Cholesterol	Mahley RW	Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.	Science	1988	637
8349823	Cholesterol	Ishibashi S	Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.	The Journal of clinical investigation	1993	348
9163428	Cholesterol	Kozarsky KF	Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels.	Nature	1997	129
9356497	Cholesterol	Rigotti A	A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism.	Proceedings of the National Academy of Sciences of the United States of America	1997	197
9808609	Cholesterol	Staels B	Mechanism of action of fibrates on lipid and lipoprotein metabolism.	Circulation	1998	197
10192396	Cholesterol	Jaye M	A novel endothelial-derived lipase that modulates HDL metabolism.	Nature genetics	1999	96
10225972	Cholesterol	Raabe M	Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice.	The Journal of clinical investigation	1999	100
10334992	Cholesterol	Makishima M	Identification of a nuclear receptor for bile acids.	Science	1999	413
10430941	Cholesterol	Trigatti B	Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.	Proceedings of the National Academy of Sciences of the United States of America	1999	114
10657556	Cholesterol	Yudkin JS	Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?	Atherosclerosis	2000	233
10872459	Cholesterol	Krieger M	Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI.	Annual review of biochemistry	1999	105
11030331	Cholesterol	Lu TT	Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.	Molecular cell	2000	294
11149950	Cholesterol	Laffitte BA	LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.	Proceedings of the National Academy of Sciences of the United States of America	2001	139
11248085	Cholesterol	Staudinger JL	The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity.	Proceedings of the National Academy of Sciences of the United States of America	2001	238
11790787	Cholesterol	Joseph SB	Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors.	The Journal of biological chemistry	2002	141
11882522	Cholesterol	Eichner JE	Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review.	American journal of epidemiology	2002	159
12093894	Cholesterol	Pullinger CR	Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype.	The Journal of clinical investigation	2002	82
12297848	Cholesterol	Forns X	Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.	Hepatology	2002	175
12690094	Cholesterol	Tontonoz P	Liver X receptor signaling pathways in cardiovascular disease.	Molecular endocrinology	2003	143
12718892	Cholesterol	Downes M	A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR.	Molecular cell	2003	76
12730697	Cholesterol	Abifadel M	Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.	Nature genetics	2003	408
12815072	Cholesterol	Holt JA	Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis.	Genes & development	2003	166
15130581	Cholesterol	Fayard E	LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis.	Trends in cell biology	2004	95
15188351	Cholesterol	Nishimoto N	Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.	Arthritis and rheumatism	2004	125
15538359	Cholesterol	Soutschek J	Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.	Nature	2004	459
16054053	Cholesterol	Kennedy MA	ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation.	Cell metabolism	2005	177
16403839	Cholesterol	Vaziri ND	Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.	American journal of physiology. Renal physiology	2006	90
16424607	Cholesterol	Chmurzyńska A	The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism.	Journal of applied genetics	2006	107
16565705	Cholesterol	Zimmermann TS	RNAi-mediated gene silencing in non-human primates.	Nature	2006	302
16567568	Cholesterol	Ix JH	Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.	Circulation	2006	64
16709608	Cholesterol	Dumitrescu AM	Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice.	Endocrinology	2006	70
17080197	Cholesterol	Lagace TA	Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice.	The Journal of clinical investigation	2006	133
17108811	Cholesterol	Pasanen MK	SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.	Pharmacogenetics and genomics	2006	83
17215532	Cholesterol	Cuchel M	Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.	The New England journal of medicine	2007	84
17242417	Cholesterol	Graham MJ	Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic mice.	Journal of lipid research	2007	58
17380167	Cholesterol	Soutar AK	Mechanisms of disease: genetic causes of familial hypercholesterolemia.	Nature clinical practice. Cardiovascular medicine	2007	84
17387133	Cholesterol	Tardif JC	Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.	JAMA	2007	143
17495599	Cholesterol	Lara-Castro C	Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.	Current opinion in lipidology	2007	63
18024853	Cholesterol	Risérus U	Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.	Diabetes	2008	62
18039658	Cholesterol	Poirier S	The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2.	The Journal of biological chemistry	2008	82
18160725	Cholesterol	Packard RR	Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction.	Clinical chemistry	2008	191
18193044	Cholesterol	Kathiresan S	Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.	Nature genetics	2008	496
18223541	Cholesterol	Williams KJ	Rapid regression of atherosclerosis: insights from the clinical and experimental literature.	Nature clinical practice. Cardiovascular medicine	2008	70
18354138	Cholesterol	Grefhorst A	Plasma PCSK9 preferentially reduces liver LDL receptors in mice.	Journal of lipid research	2008	57
18368051	Cholesterol	Elmén J	LNA-mediated microRNA silencing in non-human primates.	Nature	2008	503
18399797	Cholesterol	Ooi EM	Apolipoprotein C-III: understanding an emerging cardiovascular risk factor.	Clinical science	2008	62
18462017	Cholesterol	Schadt EE	Mapping the genetic architecture of gene expression in human liver.	PLoS biology	2008	497
18565848	Cholesterol	Adiels M	Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.	Arteriosclerosis, thrombosis, and vascular biology	2008	135
18695239	Cholesterol	Frank-Kamenetsky M	Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates.	Proceedings of the National Academy of Sciences of the United States of America	2008	150
18782619	Cholesterol	Hong C	Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors.	Current opinion in genetics & development	2008	66
19060906	Cholesterol	Kathiresan S	Common variants at 30 loci contribute to polygenic dyslipidemia.	Nature genetics	2009	487
19064999	Cholesterol	Rader DJ	The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis.	Journal of lipid research	2009	148
19085950	Cholesterol	Song KH	Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.	Hepatology	2009	94
19164855	Cholesterol	Semple RK	Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis.	The Journal of clinical investigation	2009	85
19203419	Cholesterol	Elahi MM	Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice.	The British journal of nutrition	2009	47
19221221	Cholesterol	McGillicuddy FC	Inflammation impairs reverse cholesterol transport in vivo.	Circulation	2009	118
19402938	Cholesterol	Egert S	Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.	The British journal of nutrition	2009	54
19646654	Cholesterol	Yoon M	The role of PPARalpha in lipid metabolism and obesity: focusing on the effects of estrogen on PPARalpha actions.	Pharmacological research	2009	46
19837721	Cholesterol	Zhao C	Liver X receptor in cholesterol metabolism.	The Journal of endocrinology	2010	71
20385826	Cholesterol	Neale BM	Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC).	Proceedings of the National Academy of Sciences of the United States of America	2010	159
20615897	Cholesterol	Straarup EM	Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates.	Nucleic acids research	2010	55
20631351	Cholesterol	Calkin AC	Liver x receptor signaling pathways and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2010	75
20683951	Cholesterol	Asahina Y	Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection.	Hepatology	2010	48
20686566	Cholesterol	Musunuru K	From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus.	Nature	2010	357
20739751	Cholesterol	Rashid ST	Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.	The Journal of clinical investigation	2010	173
20816088	Cholesterol	Kjolby M	Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export.	Cell metabolism	2010	63
20854368	Cholesterol	Zlokovic BV	Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.	Journal of neurochemistry	2010	67
20888482	Cholesterol	Reynolds R	Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration.	Ophthalmology	2010	43
21084752	Cholesterol	Burkhardt R	Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice.	The Journal of clinical investigation	2010	42
21258337	Cholesterol	Bartelt A	Brown adipose tissue activity controls triglyceride clearance.	Nature medicine	2011	321
21480318	Cholesterol	Bitetto D	Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.	Hepatology	2011	41
21796212	Cholesterol	Hannedouche S	Oxysterols direct immune cell migration via EBI2.	Nature	2011	87
22009537	Cholesterol	Park JK	miR-221 silencing blocks hepatocellular carcinoma and promotes survival.	Cancer research	2011	59
22236411	Cholesterol	Vilsbøll T	Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.	BMJ	2012	128
22258222	Cholesterol	Jopling C	Liver-specific microRNA-122: Biogenesis and function.	RNA biology	2012	62
22333591	Cholesterol	Cirera-Salinas D	Mir-33 regulates cell proliferation and cell cycle progression.	Cell cycle	2012	56
22508243	Cholesterol	Savard C	Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis.	Hepatology	2013	56
22541735	Cholesterol	Jakobsson T	Liver X receptor biology and pharmacology: new pathways, challenges and opportunities.	Trends in pharmacological sciences	2012	58
22741595	Cholesterol	Liu CJ	Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.	Journal of gastroenterology and hepatology	2012	39
22751103	Cholesterol	Strong A	Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism.	The Journal of clinical investigation	2012	59
22820288	Cholesterol	Hsu SH	Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.	The Journal of clinical investigation	2012	184
23150577	Cholesterol	Quagliarini F	Atypical angiopoietin-like protein that regulates ANGPTL3.	Proceedings of the National Academy of Sciences of the United States of America	2012	83
23299969	Cholesterol	Bechmann LP	Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.	Hepatology	2013	34
23415864	Cholesterol	Zhang R	Emerging roles of Lipasin as a critical lipid regulator.	Biochemical and biophysical research communications	2013	30
23459944	Cholesterol	Wang L	MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition.	Molecular and cellular biology	2013	39
23485521	Cholesterol	Bernstein DL	Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease.	Journal of hepatology	2013	47
23583734	Cholesterol	Hirschfield GM	The genetics of complex cholestatic disorders.	Gastroenterology	2013	29
23690465	Cholesterol	Tavori H	Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.	Circulation	2013	42
23727030	Cholesterol	Yamada H	Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.	Clinica chimica acta; international journal of clinical chemistry	2013	41
23801799	Cholesterol	Gerhard GS	A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass.	Diabetes care	2013	40
23885072	Cholesterol	Paul D	Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment.	Journal of virology	2013	70
23981342	Cholesterol	Shen Y	Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.	Cardiovascular diabetology	2013	26
24013058	Cholesterol	Thomas GS	Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.	Journal of the American College of Cardiology	2013	32
24097125	Cholesterol	Park S	The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases.	Reviews in endocrine & metabolic disorders	2014	21
24162852	Cholesterol	Neculai D	Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36.	Nature	2013	49
24401224	Cholesterol	Tardy C	CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.	Atherosclerosis	2014	20
24506872	Cholesterol	Gustafsen C	The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion.	Cell metabolism	2014	33
24603306	Cholesterol	Miranda MX	The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression.	European heart journal	2015	19
24664998	Cholesterol	Vance JE	Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin.	Journal of lipid research	2014	24
24711282	Cholesterol	Oehler N	Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism.	Hepatology	2014	27
24811298	Cholesterol	Diffenderfer MR	The composition and metabolism of large and small LDL.	Current opinion in lipidology	2014	21
24936472	Cholesterol	Maetzel D	Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells.	Stem cell reports	2014	45
25101658	Cholesterol	Strong A	Sortilin and lipoprotein metabolism: making sense out of complexity.	Current opinion in lipidology	2014	20
25329562	Cholesterol	Walters JR	The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.	Alimentary pharmacology & therapeutics	2015	21
25341796	Cholesterol	Roche-Molina M	Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.	Arteriosclerosis, thrombosis, and vascular biology	2015	22
25425283	Cholesterol	Vanier MT	Complex lipid trafficking in Niemann-Pick disease type C.	Journal of inherited metabolic disease	2015	33
25592151	Cholesterol	Cui M	Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway.	Cancer research	2015	71
25754609	Cholesterol	Berbée JF	Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.	Nature communications	2015	39
25756439	Cholesterol	Besseling J	Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus.	JAMA	2015	28
25980762	Cholesterol	Dongiovanni P	Statin use and non-alcoholic steatohepatitis in at risk individuals.	Journal of hepatology	2015	25
26085104	Cholesterol	Butkinaree C	Amyloid Precursor-like Protein 2 and Sortilin Do Not Regulate the PCSK9 Convertase-mediated Low Density Lipoprotein Receptor Degradation but Interact with Each Other.	The Journal of biological chemistry	2015	16
26333678	Cholesterol	Giunzioni I	Local effects of human PCSK9 on the atherosclerotic lesion.	The Journal of pathology	2016	14
26469188	Cholesterol	Kauffman KJ	Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs.	Nano letters	2015	21
26503748	Cholesterol	Bergeron N	Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk.	Circulation	2015	15
26543096	Cholesterol	Mendivil CO	Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans.	Arteriosclerosis, thrombosis, and vascular biology	2016	16
26662987	Cholesterol	Novák J	Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis.	Advances in experimental medicine and biology	2015	22
27009502	Cholesterol	Vienberg S	MicroRNAs in metabolism.	Acta physiologica	2017	20
27077736	Cholesterol	Salvoza NC	Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.	PloS one	2016	12
27540175	Cholesterol	Franzén O	Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases.	Science	2016	25
27889186	Cholesterol	Kettner NM	Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.	Cancer cell	2016	21
27986651	Cholesterol	Reyes-Soffer G	Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.	Circulation	2017	12
16258101	Gemcitabine	Kindler HL	Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.	Journal of clinical oncology 	2005	107
16622265	Gemcitabine	Zhu AX	Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma.	Journal of clinical oncology 	2006	75
18413796	Gemcitabine	Melisi D	LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.	Molecular cancer therapeutics	2008	93
23983255	Gemcitabine	Beatty GL	A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma.	Clinical cancer research 	2013	80
24147037	Gemcitabine	Okamoto K	miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells.	PloS one	2013	28
24351397	Gemcitabine	Valle JW	Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials.	Annals of oncology 	2014	52
24859161	Gemcitabine	Li L	Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.	Gastroenterology	2014	29
25056373	Gemcitabine	Koido S	Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer.	Clinical cancer research 	2014	26
26540314	Gemcitabine	Leone F	Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).	Cancer	2016	11
26817584	Gemcitabine	Liu Y	MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.	Journal of experimental & clinical cancer research 	2016	11
28381539	Gemcitabine	Vennin C	Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.	Science translational medicine	2017	11
16234567	Doxorubicin	Yeo W	A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.	Journal of the National Cancer Institute	2005	120
17891174	Doxorubicin	Ma S	CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.	Oncogene	2008	209
19584283	Doxorubicin	Fornari F	MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.	Cancer research	2009	117
20388796	Doxorubicin	Yoo BK	Molecular mechanism of chemoresistance by astrocyte elevated gene-1.	Cancer research	2010	46
21055388	Doxorubicin	Henry JC	miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines.	Biochemical and biophysical research communications	2010	48
21527554	Doxorubicin	Chen J	Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.	Cancer research	2011	42
23563091	Doxorubicin	Gao AM	Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway.	Carcinogenesis	2013	26
24211739	Doxorubicin	Xu L	MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.	Journal of hepatology	2014	35
24565101	Doxorubicin	Zhao N	MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.	Molecular cancer	2014	32
25445786	Doxorubicin	Kiran S	Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response.	Experimental cell research	2015	17
26809111	Doxorubicin	Lencioni R	Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial.	Journal of hepatology	2016	54
28298546	Doxorubicin	Lee H	64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer.	Clinical cancer research 	2017	10
16622600	Somatostatin	Werle M	Strategies to improve plasma half life time of peptide and protein drugs.	Amino acids	2006	63
25698782	Somatostatin	Herrmann K	Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.	Journal of nuclear medicine 	2015	20
26731483	Somatostatin	Rinke A	Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival.	Neuroendocrinology	2017	25
11818366	TG(16:0/16:0/18:0)	Perlemuter G	Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis.	FASEB journal 	2002	133
11856796	TG(16:0/16:0/18:0)	Oral EA	Leptin-replacement therapy for lipodystrophy.	The New England journal of medicine	2002	203
11967537	TG(16:0/16:0/18:0)	Agarwal AK	AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.	Nature genetics	2002	104
12454259	TG(16:0/16:0/18:0)	Merkel M	Lipoprotein lipase: genetics, lipid uptake, and regulation.	Journal of lipid research	2002	116
16081640	TG(16:0/16:0/18:0)	Köster A	Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.	Endocrinology	2005	111
17680645	TG(16:0/16:0/18:0)	Joshi-Barve S	Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes.	Hepatology	2007	65
18242210	TG(16:0/16:0/18:0)	Fabbrini E	Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.	Gastroenterology	2008	104
18288265	TG(16:0/16:0/18:0)	Rakhshandehroo M	Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling.	PPAR research	2007	62
18952573	TG(16:0/16:0/18:0)	Zechner R	Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores.	Journal of lipid research	2009	147
18956292	TG(16:0/16:0/18:0)	Malhi H	Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease.	Seminars in liver disease	2008	141
19156195	TG(16:0/16:0/18:0)	Icard V	Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins.	PloS one	2009	49
19264629	TG(16:0/16:0/18:0)	Burlone ME	Hepatitis C virus cell entry: role of lipoproteins and cellular receptors.	The Journal of general virology	2009	64
19336658	TG(16:0/16:0/18:0)	Takeuchi K	Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis.	American journal of physiology. Endocrinology and metabolism	2009	89
19359149	TG(16:0/16:0/18:0)	Tessari P	Hepatic lipid metabolism and non-alcoholic fatty liver disease.	Nutrition, metabolism, and cardiovascular diseases 	2009	62
19637289	TG(16:0/16:0/18:0)	Johnson NA	Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.	Hepatology	2009	93
19706383	TG(16:0/16:0/18:0)	Fabbrini E	Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.	Proceedings of the National Academy of Sciences of the United States of America	2009	223
20335584	TG(16:0/16:0/18:0)	Petersen KF	Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.	The New England journal of medicine	2010	98
20648472	TG(16:0/16:0/18:0)	Speliotes EK	PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.	Hepatology	2010	77
21700865	TG(16:0/16:0/18:0)	Cohen JC	Human fatty liver disease: old questions and new insights.	Science	2011	488
22009142	TG(16:0/16:0/18:0)	Jensen-Urstad AP	Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?	Biochimica et biophysica acta	2012	34
22041134	TG(16:0/16:0/18:0)	Shearer GC	Fish oil -- how does it reduce plasma triglycerides?	Biochimica et biophysica acta	2012	38
22063269	TG(16:0/16:0/18:0)	Mattijssen F	Regulation of triglyceride metabolism by Angiopoietin-like proteins.	Biochimica et biophysica acta	2012	40
22213436	TG(16:0/16:0/18:0)	Sullivan S	Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.	Hepatology	2012	37
22302940	TG(16:0/16:0/18:0)	Hugo SE	A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting.	Genes & development	2012	34
22569073	TG(16:0/16:0/18:0)	Ren G	Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism.	American journal of physiology. Endocrinology and metabolism	2012	63
22820290	TG(16:0/16:0/18:0)	Tsai WC	MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis.	The Journal of clinical investigation	2012	200
22878467	TG(16:0/16:0/18:0)	Pirazzi C	Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.	Journal of hepatology	2012	46
23023705	TG(16:0/16:0/18:0)	Li JZ	Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.	The Journal of clinical investigation	2012	52
23542898	TG(16:0/16:0/18:0)	Graham MJ	Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans.	Circulation research	2013	54
23988487	TG(16:0/16:0/18:0)	Li Y	Bile acid receptors in non-alcoholic fatty liver disease.	Biochemical pharmacology	2013	27
24173232	TG(16:0/16:0/18:0)	Hueging K	Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly.	Journal of virology	2014	39
24369119	TG(16:0/16:0/18:0)	Pingitore P	Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function.	Biochimica et biophysica acta	2014	23
24390345	TG(16:0/16:0/18:0)	SIGMA Type 2 Diabetes Consortium.	Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico.	Nature	2014	84
24721265	TG(16:0/16:0/18:0)	Kersten S	Physiological regulation of lipoprotein lipase.	Biochimica et biophysica acta	2014	54
24927523	TG(16:0/16:0/18:0)	Mahdessian H	TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content.	Proceedings of the National Academy of Sciences of the United States of America	2014	44
24941081	TG(16:0/16:0/18:0)	TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute.	Loss-of-function mutations in APOC3, triglycerides, and coronary disease.	The New England journal of medicine	2014	182
24941082	TG(16:0/16:0/18:0)	Jørgensen AB	Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.	The New England journal of medicine	2014	132
24978903	TG(16:0/16:0/18:0)	Liu YL	TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.	Nature communications	2014	58
25125366	TG(16:0/16:0/18:0)	Xu X	Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis.	Hepatology	2015	21
25555214	TG(16:0/16:0/18:0)	Fabbrini E	Metabolically normal obese people are protected from adverse effects following weight gain.	The Journal of clinical investigation	2015	39
25581573	TG(16:0/16:0/18:0)	Coppola N	TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism.	Liver international 	2015	15
26100857	TG(16:0/16:0/18:0)	Xu Y	A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism.	Nature communications	2015	21
26239609	TG(16:0/16:0/18:0)	Patni N	Congenital generalized lipodystrophies--new insights into metabolic dysfunction.	Nature reviews. Endocrinology	2015	22
27799461	TG(16:0/16:0/18:0)	Wolf Greenstein A	Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.	The Journal of endocrinology	2017	5
12764143	1-Phosphatidyl-D-myo-inositol	Mottet D	Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells.	The Journal of biological chemistry	2003	87
15132991	1-Phosphatidyl-D-myo-inositol	Chung TW	Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.	FASEB journal 	2004	72
17363567	1-Phosphatidyl-D-myo-inositol	Saxena NK	Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells.	Cancer research	2007	118
21320503	1-Phosphatidyl-D-myo-inositol	Ke AW	CD151 amplifies signaling by integrin α6β1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells.	Gastroenterology	2011	43
24703947	1-Phosphatidyl-D-myo-inositol	Wang H	Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.	Molecular cell	2014	198
25475121	1-Phosphatidyl-D-myo-inositol	Huang XP	MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.	The FEBS journal	2015	20
25503676	1-Phosphatidyl-D-myo-inositol	Wei JX	Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells.	Hepatology	2015	25
28378526	1-Phosphatidyl-D-myo-inositol	Li X	Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease.	Journal of cellular and molecular medicine	2017	5
